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Scaffolds composed of extracellular matrix (ECM) have been shown to promote formation of 
site-specific, functional host tissue following implantation in a number of preclinical and clinical 
settings.  However, the exact mechanisms by which ECM scaffolds are able to promote this type 
of “constructive tissue remodeling” are unknown.  Further, the ability of ECM scaffolds to 
promote constructive tissue remodeling appears to be dependent on the methods used in their 
production and the applications in which they are utilized.  Therefore, a comprehensive 
understanding of ECM scaffold characteristics and their effects upon the host response and 
subsequent tissue remodeling outcome is essential to the design of intelligent scaffolds for 
specific clinical applications. 
The present work investigated the effects of tissue source and chemical cross-linking 
upon the resulting ECM scaffolds, showing that ECM scaffold materials have distinct 
ultrastructural and compositional characteristics which are dependant on the anatomic location 
from which the scaffolds are derived and the methods used in their production.  These 
characteristics were associated with distinct patterns of cell behavior in vitro.  
Distinct tissue remodeling outcomes were observed following implantation of a subset of 
these scaffold materials in a rat abdominal wall musculature reconstruction model.  Acellular, 
non-cross-linked ECM was associated with constructive tissue remodeling while scaffolds that 
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contained cellular components or were chemically cross-linked resulted in dense connective 
tissue deposition or encapsulation, respectively.   
Despite differences in the tissue remodeling outcome, a histologically similar population 
of macrophages was observed following implantation in each of these cases.  Therefore, the 
phenotype of the macrophage population participating in the host response was investigated.  It 
was shown that scaffolds which resulted in constructive tissue remodeling were associated with 
an increase in the M2 (regulatory, pro-wound healing) macrophage population, while scaffolds 
which resulted in the deposition of dense collagenous connective tissue or encapsulation were 
associated with an increase in the M1 (pro-inflammatory) macrophage population, suggesting 
that different macrophage populations are associated with different tissue remodeling outcomes 
following ECM scaffold implantation.  In vitro work showed that M1 and M2 macrophages had 
distinct paracrine effects upon other cell populations, further suggesting distinct roles for M1 and 
M2 macrophages in tissue remodeling. 
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1.0  INTRODUCTION AND SPECIFIC AIMS 
The work presented in this dissertation examines the effects of the tissue source and methods 
used to produce extracellular matrix (ECM) scaffold materials upon the structural and 
compositional characteristics of the resultant scaffold.  The effects of these characteristics upon 
the ability of the material to support and modulate cell growth in vitro as well as to act as an 
inductive template for the formation of functional site-specific host tissues in vivo are also 
investigated.  Lastly, the role of macrophages in determining the ability of an ECM based 
scaffold material to promote the observed, “constructive tissue remodeling”, outcome was 
investigated.  The introductory materials below are intended to provide background on ECM 
scaffold materials, their production and their use in tissue engineering and regenerative medicine.  
Additional background is provided on the host response following tissue injury and its role in 
tissue engineering and regenerative medicine, and on selected aspects of the role of macrophages 
in the host response and tissue remodeling which occurs following injury.   
1.1 EXTRACELLULAR MATRIX AS A SCAFFOLD FOR TISSUE ENGINEERING 
AND REGENERATIVE MEDICINE 
The ECM is composed of the secreted molecules produced by the resident cells of each tissue or 
organ.  Thus, the composition and three-dimensional ultrastructure of the ECM is highly related 
to resident cell phenotype and the required functions of the tissue or organ from which it is 
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derived.  The exact composition of the ECM is dependant on a number of factors that influence 
resident cell phenotype including mechanical forces, biochemical milieu, oxygen requirements, 
pH, and gene expression patterns.  The ECM, in turn, influences the phenotype, migration, and 
proliferation of resident cells, and serves as a medium for signal transfer between cells (2-5). For 
these reasons, the ECM is considered to be in a state of dynamic reciprocity (3) with the resident 
cell population and to play an important role in normal tissue and organ morphogenesis (6).   
The components of the ECM include collagen, fibronectin, elastin, laminin, 
glycosaminoglycans, and growth factors, among others. Collagen comprises nearly 90% of the 
dry weight of most ECM (7), with collagen type I being the predominant type found in most 
tissues and organs.  Other types of collagen are known to exist within the ECM depending on the 
tissue or organ of interest (7).  Among them are collagen type II, III, IV, V, VI, and VII (1, 8-10).  
Each collagen type plays a specific role in maintaining the structure and function of the tissue or 
organ of interest.  Collagen can also be associated with a number of other proteins and molecules 
related to the structural and functional requirements of the tissue.  Among the functional 
molecules found within ECM are growth factors including vascular endothelial growth factor 
(VEGF), members of the fibroblast growth factor (FGF) family, stromal derived growth factor 
(SDF-1), epidermal growth factor (EGF), transforming growth factor beta (TGF-β), 
keratinocytes growth factor (KGF), hepatocyte growth factor (HGF), platelet derived growth 
factor (PDGF), and bone morphogenetic protein (BMP) (11-13).  The exact type and amount of 
each component within the ECM are highly tissue dependant and related to the specific 
functional requirements of the tissue. 
Individual components of the ECM, such as collagen I, collagen IV, laminin, and 
fibronectin, have been used as surface coatings for biomaterials to facilitate cell attachment and 
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growth and to promote biocompatibility (14, 15).  The advantages of using whole, intact, 
acellular, non-cross-linked ECM as a scaffold for cell growth or tissue reconstruction as opposed 
to individual components of the ECM include the presence of tissue-specific ECM constituents 
in the same relative amounts that exist in nature and in their native ultrastructure.  In some 
respects, an ECM scaffold can be thought of as a reservoir of tissue-specific structural and 
functional proteins. Many groups have attempted to create ECM analogues using individual 
ECM components and/or synthetic materials (16-18); however, the diversity and complex 
structure of the molecules that make up the ECM predict the difficulty of creating such a scaffold 
in vitro.  It is for these reasons that the isolation of ECM through the decellularization of tissues 
and organs is an effective method for the production of materials to be used in tissue engineering 
and regenerative medicine approaches to tissue reconstruction. 
ECM based scaffold materials have been derived from numerous xenogeneic and 
allogeneic source tissues and organs including cardiac tissues, blood vessels, skin, nerves, 
skeletal muscle, tendons, ligaments, small intestine, urinary bladder, trachea, and liver (Table 1).  
These scaffolds have been used successfully as templates for tissue reconstruction in a similarly 
wide variety of preclinical tissue engineering and regenerative medicine applications including 
orthopedic, esophageal, tracheal, cartilage, lower urinary tract, dermal, cardiovascular, central 
nervous system, and skeletal muscle  (Table 1).  Biologic scaffolds composed of various types of 
ECM are also commercially available for use in human clinical applications, and ECM scaffolds 
derived from porcine small intestinal submucosa (SIS) alone have been implanted in more than 2 
million human patients to date.  A partial list of the sources from which ECM scaffold materials 
have been derived, the configurations into which they have been processed, and the tissue 
engineering and regenerative medicine applications in which they have been used is provided in 
  4 
Table 1.  A list of commercially available ECM scaffolds, their source material, and 
configuration is provided in Table 2. 
 
 
Table 1 A partial list of ECM scaffold donor sources, configurations, and applications. 
Donor Configuration Application 
   
Source Sheet  Abdominal Wall (19, 20) 
 Multilaminate Sheet (21) Artery (22, 23) 
Allogeneic Powder (24) Bladder (25-27) 
Xenogeneic Gel (28) Bone (29, 30) 
 3D Construct (31, 32) Cartilage (33, 34) 
Species Intact Decellularized Organ (35, 36) Dura Mater (37, 38) 
  Esophagus (32, 39) 
Bovine  Heart (40) 
Equine  Liver (41) 
Porcine  Nerve (42, 43) 
Human  Skin (44-47) 
  Tendon (48-51) 
Age  Thoracic Wall (52) 
  Trachea (53, 54) 
Fetal  Tympanic Membrane (55) 
Adult  Vocal Fold (56, 57) 
   
Organ   
   
Bladder (26, 58, 59)   
Heart (35, 60)   
Liver (41)   
Muscle (61)   
Nerve (42, 62)   
Skin (63, 64)   
Small Intestine (22)   
Tendon (65, 66)    
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Table 2 A partial list of commercially available scaffold materials composed of extracellular matrix. 
Product Company Material   Form Use 
AlloDerm Lifecell Human skin Cross-linked Dry Sheet Abdominal wall, breast, 
ENT/head & neck 
reconstruction, grafting 
AlloPatch® Musculoskeletal 
Transplant 
Foundation 
Human fascia lata Cross-linked Dry Sheet Orthpedic applications 
Axis™ dermis Mentor Human dermis Natural Dry Sheet Pelvic organ prolapse 
CollaMend® Bard Porcine dermis Cross-linked Dry Sheet Soft tissue repair 
CuffPatch™ Arthrotek Porcine small intestinal 
submucosa (SIS) 
Cross-linked Hydrated 
Sheet 
Reinforcement of soft tissues 
DurADAPT™ Pegasus 
Biologicals 
Horse pericardium Cross-linked   Repair dura matter after 
craniotomy  
Dura-Guard® Synovis 
Surgical 
Bovine pericardium   Hydrated 
Sheet 
Spinal and cranial repair 
Durasis® Cook SIS Porcine small intestinal 
submucosa (SIS) 
Natural Dry Sheet Repair dura matter  
Durepair® TEI Biosciences Fetal bovine skin Natural Dry Sheet Repair of cranial or spinal dura 
FasLata® Bard Cadaveric fascia lata Natural Dry Sheet Soft tissue repair 
Graft Jacket® Wright Medical 
Tech 
Human skin Cross-linked Dry Sheet Foot ulcers 
Oasis® Healthpoint Porcine small intestinal 
submucosa (SIS) 
Natural Dry Sheet Partial & full thickness 
wounds; superficial and second 
degree burns 
OrthADAPT™ Pegasus 
Biologicals 
Horse pericardium Cross-linked   Reinforcement, repair and 
reconstruction of soft tissue in 
orthopedics 
Pelvicol® Bard Porcine dermis Cross-linked Hydrated 
Sheet 
Soft tissue repair 
Peri-Guard® Synovis 
Surgical 
Bovine pericardium     Pericardial and soft tissue 
repair 
Permacol™ Tissue Science 
Laboratories 
Porcine skin Cross-linked Hydrated 
Sheet 
Soft connective tissue repair 
PriMatrix™ TEI Biosciences Fetal bovine skin Natural Dry Sheet Wound management 
Restore™ DePuy Porcine small intestinal 
submucosa (SIS) 
Natural Sheet Reinforcement of soft tissues 
Stratasis® Cook SIS Porcine small intestinal 
submucosa (SIS) 
Natural Dry Sheet Treatment of urinary 
incontinence 
SurgiMend™ TEI Biosciences Fetal bovine skin Natural Dry Sheet Surgical repair of damaged or 
ruptured soft tissue membranes 
Surgisis® Cook SIS Porcine small intestinal 
submucosa (SIS) 
Natural Dry Sheet Soft tissue repair and 
reinforcement 
Suspend™ Mentor Human fascia lata Natural Dry Sheet Urethral sling 
TissueMend® TEI Biosciences Fetal bovine skin Natural Dry Sheet Surgical repair and 
reinforcement of soft tissue in 
rotator cuff 
Vascu-Guard® Synovis 
Surgical 
Bovine pericardium     Reconstruction of blood vessels 
in neck, legs, and arms 
Veritas® Synovis 
Surgical 
Bovine pericardium   Hydrated 
Sheet 
Soft tissue repair  
Xelma™ Molnlycke ECM protein, PGA, 
water 
  Gel Venous leg ulcers 
Xenform™ TEI Biosciences Fetal bovine skin Natural Dry Sheet Repair of colon, rectal, urethral, 
and vaginal prolapse, pelvic 
reconstruction, urethral sling 
Zimmer Collagen 
Patch ® 
Tissue Science 
Laboratories 
Procine dermis Cross-linked Dry Sheet Orthpedic applications 
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1.1.1 Production of ECM Scaffolds  
The production of ECM scaffolds requires the use of mechanical, chemical, and enzymatic, 
processing methods that decellularize and terminally sterilize the scaffold (67).  These methods 
can affect the composition, ultrastructure, and mechanical properties of the resulting scaffold, 
thus potentially affecting the host response associated with its use.  The goal of a 
decellularization protocol is to remove as much of the cellular material as possible with minimal 
effects upon the tissue-specific structural and functional components of the scaffold.  The 
efficacy of a decellularization protocol is dependent upon the tissue being decellularized as well 
as the methods used to decellularize it. It has been shown that ECM scaffolds, almost regardless 
of the methods used in their production, retain small amounts of DNA and cellular debris 
following processing (68).  The consequences of these small amounts of cellular material that 
remain in an ECM scaffold are as of yet unclear.  However, as will be discussed in subsequent 
sections, it is logical to assume that large quantities of cellular material may be associated with 
an adverse host immune response to an implanted ECM scaffold. 
Chemical cross-linking is used in the production of many ECM scaffolds to slow or 
prevent degradation, to inhibit recognition of surface epitope by the host, and to increase 
strength.  While slowed degradation due to cross-linking may be beneficial in some cases where 
additional mechanical support from the scaffold is required, inhibiting scaffold degradation via 
chemical cross-linking may alter the presentation and conformation of ligands on the surface of 
an ECM scaffold, potentially altering ligand-receptor interactions that may be important in 
determining the outcome of cell-scaffold interactions.  In general, the in vivo consequence of 
inhibiting scaffold degradation via chemical cross-linking has been shown to be less constructive 
tissue remodeling than has been observed with the use of non-cross-linked ECM scaffolds (69).   
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1.1.2 ECM Configuration 
 
Following the decellularization of a tissue or organ, the resulting ECM may take on a 
variety of shapes and sizes which are dependant on the particular architecture of the 
decellularized organ of interest or the methods used in the decellularization process (67).  Many 
tissues and organs such as dermis, small intestine, and urinary bladder are typically processed 
into a sheet-like configuration prior to decellularization.  However, the sheet form may be 
insufficient in its mechanical properties and/or three-dimensional morphology (i.e., shape and 
size) depending on the application of interest.  Therefore, a number of methods have been 
utilized for the processing of decellularized ECM scaffolds into a variety of application-specific 
shapes and sizes.  Intact ECM scaffolds have been molded and vacuum pressed into shapes that 
include tubes (39), cones (70), and multi-laminate sheets among others (21) (Table 1).  These 
scaffolds have been utilized in applications ranging from esophageal repair (tubular) (39), to 
gastro-esophageal junction repair (cone-shaped) (70), and orthopedic applications (multilaminate 
sheets) (50).  ECM materials have also been comminuted to create a powder form of the scaffold 
which is of interest for injectable and space filling applications (24).  A hydrogel form of ECM 
has also been produced via enzymatic degradation of ECM scaffolds (28).  The ability of ECM 
scaffolds to be formed into varied shapes and sizes further adds to their utility as scaffolds for 
tissue engineering and regenerative medicine applications.   
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1.1.3 Mechanisms by which ECM Scaffolds Promote Constructive tissue remodeling 
While the exact mechanisms which underlie the ability of ECM based scaffold materials to 
promote constructive tissue remodeling remain largely unknown, there are a number of elements 
which are believed to play key roles.  Among these elements are the ability of the scaffold 
material to degrade rapidly with concomitant release of bioactive matricryptic peptides, the 
ability of the scaffold material to recruit progenitor and other tissue-specific cell populations to 
sites of tissue remodeling, the ability of the scaffold material to respond to local environmental 
stimuli, and the ability of the scaffold material to elicit a host response which does not result in a 
foreign body response or immunologic rejection of the implant.  Each of these elements is 
outlined below, and multiple elements are explored in further detail in the studies which follow. 
1.1.3.1 Degradation of ECM Scaffolds 
 ECM scaffolds degrade rapidly in vivo.  A recent study showed that 10-layer scaffolds 
composed of 14C labeled ECM were 60% degraded at 30 days post implantation and 100% 
degraded by 90 days in a model of canine Achilles tendon repair (48).  During this period, the 
scaffold was populated and degraded by host-derived cells and resulted in the formation of site-
specific functional host tissue which was histologically indistinguishable from native tissue.  The 
major mechanism of excretion of the degraded scaffold was found to be via hematogenous 
circulation and elimination by the kidneys, urine and exhaled CO2.  The mechanisms of in vivo 
degradation of ECM scaffolds are complex and include both cellular and enzymatic pathways. 
The process is mediated by inflammatory cells, such as macrophages, which produce oxidants as 
well as proteolytic enzymes that aid in the degradation of the matrix (71).  A recent study 
showed that peripheral blood monocytes are required for the early and rapid degradation of both 
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ECM scaffolds and autologous body wall control tissues, and that chemically cross-linked ECM 
scaffolds are resistant to macrophage-mediated degradation (72).  
ECM scaffolds have also been degraded in vitro by chemical and physical methods.  
Recent findings suggest that the degradation products of ECM scaffolds are bioactive (73-78).  
Studies have shown antimicrobial activity associated with the degradation products of ECM 
scaffolds; however, in the absence of degradation, antimicrobial activity was not seen, 
suggesting that some of the bioactive properties of the ECM are derived from its degradation 
products rather than from whole molecules present within the ECM (73, 77, 79). Degradation 
products of ECM scaffolds have also been shown to be chemoattractants for progenitor and non-
progenitor cell populations (74-76, 78).  An ECM scaffold that cannot degrade (i.e. is chemically 
cross-linked) may not release bioactive degradation products, including those bioactive 
molecules that may be responsible for modulating the host response towards a constructive tissue 
remodeling response.  
1.1.3.2 Chemoattraction of Progenitor Cells By Remodeling ECM Scaffolds 
One of the biologic effects of the degradation of ECM scaffolds is the ability to recruit 
progenitor cells to sites of ECM degradation during in vivo remodeling (49, 80, 81).  A study of 
ECM scaffold remodeling in a model of mouse Achilles tendon repair examined the ability of 
ECM scaffolds and autograft tissue to recruit bone marrow derived cells (49).  Bone marrow 
derived cells were observed in the sites of remodeling associated with both ECM scaffolds and 
autograft control tissue among what appeared to be predominantly mononuclear cells at early 
time points (1 and 2 weeks) post surgery.  Both scaffold types remodeled into tissue resembling 
the native Achilles tendon; however, by 16 weeks the presence of bone marrow derived cells was 
observed only in the ECM treated group.  Another study, also utilizing a model of mouse 
  10 
Achilles tendon repair, examined the ability of ECM scaffold explants to cause the chemotaxis of 
progenitor cells after 3, 7, and 14 days of in vivo remodeling (81).  The results of the study 
showed greater migration of progenitor cells towards tendons repaired with ECM scaffolds 
compared to tendons repaired with autologous tissue and uninjured normal contralateral tendon.  
These results suggest that ECM scaffolds are capable of recruiting progenitor cells to the site of 
implantation to participate in constructive tissue remodeling over the long-term. The exact 
components of the ECM which are responsible for the recruitment of progenitor cells, the 
mechanisms by which ECM scaffolds recruit progenitor cell populations during in vivo 
remodeling, and the specific phenotype of the cells recruited remains largely unknown.   
1.1.3.3 Angiogenesis and New ECM Deposition 
 Angiogenesis is implicit in the success of many tissue engineering and regenerative 
medicine strategies involving biomaterials.  The in-growth of vessels into a tissue-engineered 
construct provides a means for nourishing the tissue growing on or within the implanted 
material.  In the absence of angiogenesis, many implanted biomaterials may fail to integrate with 
the surrounding tissue and/or fail to support cell populations that have been seeded onto or 
migrate into the material.  Angiogenesis has been shown to be a prominent feature of ECM 
scaffold remodeling and is commonly observed within the first 1-3 days following scaffold 
implantation (69, 82).  These vessels remain within the implantation site and continue to provide 
a blood supply to the remodeling tissue throughout the remodeling process.  It has been shown 
that certain ECM scaffolds contain bioactive VEGF (a potent angiogenic factor) and bFGF (83).  
Factors such as these may account, in part, for the ability of ECM scaffolds promote 
angiogenesis at early time points following implantation. 
  11 
1.1.3.4 Response to Mechanical Stimuli 
ECM scaffolds derived from a number of different sources have been used to promote 
site-specific formation of functional host tissue (Table 1).  It is unknown whether there is an 
advantage to the use of ECM derived from the same tissue as that being reconstructed; however, 
it is known that ECM scaffold materials derived from a single tissue, urinary bladder (urinary 
bladder matrix; UBM) for example, can remodel into a variety of site-specific tissues.  UBM has 
been shown capable of supporting the formation of bladder, trachea, myocardium, and 
fibrocartilage, among others (25, 40, 53).  This suggests that there are environmental cues which 
direct site-specific tissue formation following the implantation of ECM scaffolds.  These cues 
likely include pH, local gene expression, and oxygen tension, among others.  However, of these 
cues, mechanical stimuli has been shown to be essential to the formation of a constructive tissue 
remodeling response in a number of applications (25, 51, 84).  
A recent study utilized UBM to reconstruct the bladder following partial cystectomy in a 
canine model (25).  Following implantation, animals were exposed either to short-term 
catheterization (24 hours post-surgery or to long-term catheterization (4 weeks post-surgery).  In 
those animals which were subjected to only short-term catheterization, remodeling of the UBM 
scaffold material resulted in the formation of a urothelial layer, angiogenesis, smooth muscle 
actin and smooth muscle myosin heavy chain expressing cells and neuronal processes within the 
site of implantation at early time points (4 weeks) and the formation of a highly differentiated 
urothelium and islands of smooth muscle within the site of remodeling in the long-term (12 
weeks).  In contrast, in those animals which were subjected to long-term catheterization, 
remodeling of the UBM scaffold resulted in the presence of myofibroblasts and the formation of 
granulation tissue at early time points (4 weeks) and a response consistent with fibrosis in the 
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long-term (12 weeks).  These results show that early mechanical loading is essential to the 
formation of a constructive tissue remodeling response and that the mechanical stimulation 
which occurred following removal of the catheter was insufficient to overcome the lack of early 
mechanical stimuli. 
Another study investigated the role of mechanical forces in a model Achillie’s tendon 
repair (84).  Rabbits were subjected to 1.5 cm ligament repair using SIS with and without post-
surgical immobilization.   In those animals which were allowed to return to partial or full range 
of motion shortly after surgery, replacement of the scaffold with organized connective tissue 
resembling that of the native tendon was observed.  Limiting the range of motion resulted in 
degradation of the scaffold with limited cellular infiltration and limited extracellular matrix 
deposition.  Again, showing that mechanical forces have an impact upon the type and quality of 
tissue which results from the tissue remodeling process. 
Many studies have examined the effects of mechanical stimulation upon the phenotype of 
a wide variety of cells, including progenitor cells.  The mechanical forces experienced by the 
progenitor cell populations recruited to sites of extracellular matrix mediated tissue remodeling, 
in combination with other microenvironmental factors, may guide their differentiation into 
tissue-specific phenotypes. 
1.1.3.5 Host Response to Extracellular Matrix Scaffolds 
 The effects of the host response in general, and the host macrophage response in 
particular, which occurs following the implantation of ECM scaffolds is a central theme of this 
dissertation and is explored in-depth in the studies which follow.  Therefore, the following 
section is intended to give the reader a basic understanding of the aspects of the host response to 
ECM scaffolds which are not examined in great detail hereafter. 
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The mechanisms of the host cell and humoral response to whole organ transplantation are 
reasonably well understood.  Xenogeneic and allogeneic cellular antigens are recognized by the 
host, elicit immune activation, and cause the production of pro-inflammatory mediators with 
downstream cytotoxicity and transplant tissue rejection.  The mechanisms of the host immune 
response to acellular scaffolds derived from ECM, either allogeneic or xenogeneic, are neither as 
well studied nor as well understood as whole organ and tissue transplantation (85). The 
preparation of ECM scaffolds for tissue engineering and regenerative medicine applications 
involves the decellularization of the tissue or organ from which the ECM is to be harvested (40).  
The removal of the cellular component produces a different type of ‘tissue graft’ than is typically 
presented with autogeneic, allogeneic, or xenogeneic whole organ grafts.  An acellular ECM 
scaffold consists primarily of the ECM constituent molecules, the majority of which have been 
found to be conserved across species (7), thus mitigating many adverse components of host the 
immune response (86). 
While the majority of the components which remain following decellularization are 
conserved across species and largely non-immunogenic, many ECM scaffolds have been shown 
to contain a number of components that are known to induce adverse host immune and/or 
rejection type responses when present in large quantities. These components include the Galα1-
3Galβ1-4GlcNAcβ-R (α-Gal) epitope and DNA.  The α-Gal epitope is known to cause 
hyperacute rejection of organ transplants (87-90).  However, studies of α-Gal positive ECM 
scaffold implantation have not shown adverse responses that can be attributed to the α-Gal 
epitope (91, 92).  A recent study investigated the effects of the presence of the α-Gal epitope 
upon the remodeling of ECM scaffolds in a nonhuman primate model (91).  The study compared 
the host response to ECM derived from allogeneic, xenogeneic porcine, and xenogeneic α-Gal -
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/- porcine sources.  The results of the study showed that although those animals implanted with 
ECM scaffolds containing the α-Gal epitope exhibited an increase in serum anti-α-Gal 
antibodies, there were no adverse effects of the α-Gal epitope upon the tissue remodeling 
response.  Several studies have shown the presence of DNA fragments remaining within ECM 
scaffolds following the decellularization and sterilization processes (13, 93, 94).  A recent study 
examined the presence of DNA within a number of commercially available ECM scaffolds (95).  
The results of the study showed that, although all of the products tested contained small amounts 
of DNA, the remnants generally consisted of fragments of less than 300 bp.  Despite the presence 
of small amounts of both the α-Gal epitope and DNA within ECM scaffolds, adverse clinical 
effects have not been observed.  This is likely due to the minute amounts of these components 
present within efficiently decellularized materials and the rapid degradation of the ECM scaffold.  
However, it is probable that there is a threshold amount of these components required to induce 
adverse effects upon the remodeling response.  
In general, innate immune cells (i.e. neutrophils and macrophages) are the first cells to 
encounter and respond to implanted biomaterials.  The immediate cellular response observed 
following the implantation of an ECM scaffold consists almost exclusively of neutrophils but 
there is also a significant mononuclear cell component as well.  In the absence of large amounts 
of cellular debris within the scaffold, chemical cross-linking, or contaminants such as endotoxin, 
the neutrophil infiltrate diminishes almost entirely within 72 hours and is replaced by a 
mononuclear cell population.  As will be discussed in the following section, this type of 
response, characterized by a large infiltration of innate immune cells, has been conventionally 
interpreted as either acute or chronic inflammation with associated negative implications (i.e. 
downstream encapsulation and fibrosis).  However, the presence of these cells, especially 
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mononuclear macrophages, has been shown to be essential to the formation of the type of 
constructive tissue remodeling response that has been observed following the implantation of 
ECM scaffolds (69, 72, 96, 97). These and other aspects of macrophage involvement in tissue 
remodeling are the subject of the following sections as well as a central theme of this 
dissertation. 
A histologically similar population of neutrophils and macrophages is observed at early 
time points following the implantation of ECM scaffolds which either have or have not been 
processed using chemical cross-linking agents such as glutaraldehyde or carbodiimide; however, 
the tissue remodeling outcome observed following the implantation of chemically cross-linked 
ECM scaffolds is distinctly different than that observed following the implantation of non-cross-
linked scaffolds (69).  The host tissue response typically observed following implantation of an 
acellular ECM scaffold that has not been chemically cross-linked is characterized by a dense 
infiltration of neutrophils at early time points changing to primarily mononuclear cells thereafter.  
This infiltrate of innate immune cells is accompanied by rapid degradation of the ECM scaffold 
and replacement with organized, site-specific, functional host tissue (69, 82, 98).  If the scaffold 
has been processed using chemical cross-linking agents such as glutaraldehyde or carbodiimide, 
the host response is characterized by a similar presence of a large number of neutrophils and 
macrophages, but results in a more typical pro-inflammatory, foreign body type response 
resulting in dense fibrous tissue encapsulation and the prolonged presence of a multinucleate cell 
population (69).  Thus, while ECM scaffolds may elicit what appears to be a chronic 
inflammatory tissue response, the outcome is not necessarily scar tissue formation or 
encapsulation of the material.  Rather, non-cross-linked acellular ECM scaffolds appear to elicit 
an innate immune response which is not pro-inflammatory in nature. 
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In addition to eliciting a robust, but apparently not detrimental, host innate immune 
response, acellular non-cross-linked ECM scaffolds have been shown to evoke a Th2 type T-
lymphocyte response (86, 99).  One study utilized a mouse model of subcutaneous implantation 
to examine the T-lymphocyte response to xenogeneic muscle tissue, syngeneic muscle tissue, 
and an acellular ECM scaffold (86).  Results showed that the xenogeneic tissue implant was 
associated with a response consistent with rejection.  That is, the xenogeneic muscle implant 
showed signs of necrosis, granuloma formation and encapsulation.  The syngeneic tissue and the 
ECM scaffold elicited an acute inflammatory response that resolved with time and resulted in 
organized tissue morphology at the remodeling site.  Tissue cytokine analysis revealed that the 
ECM group elicited expression of interleukin (IL)-4 and suppressed the expression of interferon 
(IFN)-γ as compared to the xenogeneic tissue implant group.  The ECM group elicited the 
production of an ECM specific antibody response, however it was restricted to the 
immunoglobulin G (IgG) 1 isotype.  Re-implantation of the mice with another ECM scaffold led 
to a secondary anti-ECM antibody response that was also restricted to the IgG1 isotype and there 
was no evidence of the formation of a Th1 type response.  Further investigation confirmed that 
the observed responses were in fact T-lymphocyte dependant.  Finally, it has been shown that, 
while both T and B cells respond to ECM scaffolds, they are not required for constructive tissue 
remodeling of an ECM implant (86).  This finding further indicates the importance of the host 
innate immune response in driving/determining the downstream remodeling outcome following 
implantation of an ECM scaffold.   
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1.2 THE HOST RESPONSE FOLLOWING INJURY AND IMPLANTATION OF 
BIOMATERIALS 
As will be seen in the examples which follow, the host response to ECM scaffolds is highly 
complex and does not seem to follow the classic paradigms set forward for the default wound 
healing response or the response to non-degradable metallic or polymeric biomaterials intended 
for long-term implantation.  ECM scaffolds appear to be subject to what can be described as 
chronic inflammation under a classical definition (i.e. the presence of mononuclear cells within 
newly deposited ECM over time).  However, as has been shown in a number of studies (69, 96, 
100) and as will be demonstrated in the studies presented herein, this response does not 
necessarily result in the encapsulation and fibrosis of ECM scaffold materials.  In particular, 
acellular, non-chemically cross-linked ECM scaffolds have been shown to promote constructive 
tissue remodeling, even in the presence of what can be described as chronic inflammation.  
Therefore, the default wound healing response and the host response following the implantation 
of non-degradable biomaterials are reviewed here and the role of the host response to the 
components of tissue engineered constructs which may not fall into either of these categories is 
discussed as a base from which to understand the host response to ECM based scaffold materials. 
1.2.1 The Host Response to Tissue Injury 
The default mammalian host response following tissue injury is a well-documented series of 
events that typically result in the deposition of dense fibrous connective tissue within the site of 
injury (101-103). Very few tissues in adult mammals have the ability for regeneration.  Those 
which possess the ability to regenerate are known to include the bone marrow, liver, intestinal 
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epithelium, and epidermis of the skin.   The default response to tissue injury has been described 
as occurring in four stages: hemostasis, inflammation, proliferation and remodeling (102). 
1.2.1.1 Homeostasis 
 Following tissue injury and resultant damage to the vasculature, platelets contact the 
damaged tissues resulting in the release of clotting factors that initiate hemostasis. A provisional 
matrix forms consisting largely of fibrin and entrapped erythrocytes.  The provisional matrix 
provides a substrate for further cell migration into the site of injury and a medium for cell 
signaling (104).  In addition to their role in hemostasis and provisional matrix formation, 
platelets also release cytokines including PDGF, TGF-β, chemokine C-X-C motif ligand 4 
(CXCL4), and IL-1 (105-107).  These factors contribute to initial repair process via recruitment 
of multiple cell types including neutrophils, macrophages, fibroblasts, and other tissue specific 
cells to the injury site (107).   
1.2.1.2 Inflammation 
 Neutrophils are the first inflammatory cell type to arrive at the wound site.  Neutrophils 
phagocytose and destroy foreign material, bacteria, or dead cells which may have entered the 
wound site as a result of the injury and also provide further signaling molecules that recruit 
macrophages to the injury site (106).  Mast cells also participate in the early stages of wound 
healing by releasing granules containing enzymes, histamine, and other factors that modulate the 
inflammatory response (102, 108).  By 48 to 72 hours post injury, macrophages begin to 
dominate the cell population at the site of injury (109).  Activated macrophages secrete cytokines 
and chemokines which promote the further recruitment of leukocytes to the site of injury (106, 
107).  Macrophages also clear apoptotic neutrophils, the phagocytosis of which leads to a change 
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towards a more reparative macrophage phenotype and the resolution of the inflammatory phase 
of wound healing (110).  The T-lymphocyte population plays an important late regulatory role in 
the resolution of the inflammatory process through local secretion of cytokines and chemokines 
(111). 
1.2.1.3 Proliferative Phase 
 The proliferative phase of wound healing involves cellular proliferation, angiogenesis, 
new extracellular matrix deposition and the formation of granulation tissue - processes which are 
largely mediated via the effects of the local microenvironment including pH and oxygen tension, 
and cytokines secreted by macrophages, T-lymphocytes, and other cells within the wound site 
(107, 112, 113). These cytokines include EGF, basic FGF, TGF-α, TGF-β, VEGF, and others 
depending on the nature of the injured tissue (107). 
1.2.1.4 Remodeling Phase 
Following the deposition of significant amounts of extracellular matrix (predominantly 
collagens type I and III) during the proliferative phase, the remodeling phase of wound healing 
begins.  This phase is characterized by matrix metalloproteinase (MMP) and tissue inhibitor of 
metalloproteinase (TIMP) mediated degradation and remodeling of the newly deposited 
collagen, generally resulting in scar tissue formation/maturation (102, 114).  In some cases, 
prolonged remodeling leading to fibrosis or hypertrophic scar formation may occur due to 
dysregulation of the healing process (102).  Although these wound healing events are described 
as part of the default response to tissue injury, many of these events, as will be discussed in the 
sections which follow, also occur as part of a regenerative process.  The selective activation of 
components of the inflammatory, proliferation and remodeling phase can result in a constructive 
  20 
and functional outcome as opposed to scar tissue formation.  In particular, the role of 
macrophages in promoting a constructive tissue remodeling outcome following implantation of 
biomaterial scaffolds will be discussed in further detail in following sections.   
In Figure 1, an example of the default host remodeling response following injury of the 
abdominal wall musculature in a rat is shown.  By 28 days post-injury, an increasingly dense 
layer of collagenous connective tissue can be seen forming over the injured musculature.  This 
connective tissue contains spindle-shaped cells, likely fibroblasts.  Numerous mononuclear cells, 
consisting of macrophages and T-lymphocytes can also be seen within the area of the disrupted 
musculature and an angiogenic process can be observed, indicating that the inflammatory 
process is not entirely complete at this stage of tissue remodeling.  With time, the collagenous 
tissue being deposited at the site of injury will mature into dense scar tissue and the presence of 
inflammatory cells will subside, signaling complete repair of the wound by the host.  However, 
this repair does not result in the restoration of the function of the injured tissue.  This default 
response to tissue injury is important and necessary to understand if one hopes to appreciate a 
variant of the inflammatory response; specifically, the foreign body response that occurs 
following the implantation of a non-degradable or slowly degradable biomaterial. 
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Figure 1.  Hematoxylin and eosin (H&E) stained section showing host remodeling response at 28 days 
post-injury of abdominal wall musculature.  Spindle shaped cells, likely fibroblasts, within increasingly dense 
connective tissue can be observed forming at the periphery of the site of remodeling (top).   A mononuclear 
cell response is observed within the area of the injured musculature (middle) and angiogenesis is observed.  
Uninjured muscle tissue can also be observed (bottom).  Image magnification = 20X, scale bar = 100 µm. 
1.2.2 Host Response Following Biomaterial Implantation 
The host response following the long-term implantation of a non-degradable synthetic or metallic 
biomaterial involves a series of overlapping processes which include: 1) blood-material 
interaction with deposition of a protein film on the biomaterial, 2) provisional matrix formation, 
3) acute inflammation, 4) chronic inflammation, 5) granulation tissue formation, 6) foreign body 
reaction, and 7) fibrosis and tissue capsule development (115, 116). While many of these 
processes are similar to those described above for the default host response to tissue injury, there 
are a number of key differences. 
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The surgical implantation of a biomaterial is invariably associated with tissue damage 
and disruption of the vasculature at the surgical site. Release of blood into the wound site results 
in degranulation of platelets, formation of a provisional matrix and signaling which recruits 
inflammatory cells (i.e. neutrophils and macrophages) to the surgical site. Blood contact also 
results in adsorption of proteins to the surface of the biomaterial within seconds of implantation 
(117). The proteins which adsorb to a biomaterial may include components of the coagulation 
system (fibrinogen and tissue factors), complement cascade (C5), and other plasma derived 
proteins (albumin and IgG) (116, 118).  These proteins provide a substrate through which the 
inflammatory cells arriving at the site of injury interact with the surface of the biomaterial. The 
specific proteins which attach and the behavior of the attached cells are dependent on the nature 
of the biomaterial surface and on an adsorption/desorption process, which is governed by the 
affinity of the proteins for the biomaterial surface (known as the Vroman Effect) (117, 118). As 
will be described briefly below, interactions of cells with the proteins adsorbed to the surface of 
the biomaterial may lead to a variety of cellular responses including adherence, activation, or 
triggering of phagocytic pathways, among others, depending on the cell type and the proteins 
involved (119, 120).   
Acute inflammation, consisting of the emigration of neutrophils from the vasculature into 
the implant site, follows formation of the provisional matrix and the release of chemoattractant 
factors by platelets and other cells within the inflammatory site, much like the process described 
above for default wound healing.  However, upon arrival within the wound site, neutrophils 
interact with the proteins adsorbed onto the biomaterial surface through integrin receptors 
specific for the adsorbed proteins (116). For example, the adsorption of fibronectin and IgG play 
significant roles in the Mac-1 mediated attachment of neutrophils and macrophages to 
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biomaterial surfaces during the acute phase of inflammation (121). Complement and serum 
immunoglobulin adsorption to a pathogen (termed opsonization) leads to phagocytosis by 
neutrophils and or macrophages, or destruction of the pathogen via the complement pathway. In 
comparison, an opsonized biomaterial elicits phagocytosis from neutrophils (and later 
macrophages), or is subjected to frustrated phagocytosis, depending on the nature of the 
biomaterial and its size (116).  The process of frustrated phagocytosis involves the extracellular 
release of microbicidal contents at the surface of a foreign body.  This release may cause the 
erosion of implanted materials which are not intended to degrade, and may eventually lead to 
failure of the material to perform as intended. 
The chronic inflammation phase associated with the implantation of a biomaterial is 
typically characterized by the presence of activated macrophages.  This process of macrophage 
accumulation may occur for a period of days to months depending on the nature of the implanted 
material and the adsorbed proteins.  A meshwork of new extracellular matrix usually is deposited 
around the biomaterial and the accompanying angiogenic process is prominent.  The continued 
presence of macrophages at the site of biomaterial implantation is often the precursor to the 
formation of granulation tissue, the foreign body giant cell response, and the eventual 
encapsulation of the biomaterial within a dense layer of collagenous connective tissue. 
Chronic inflammation can progress to a granulation tissue phase, in which the deposition 
of new extracellular matrix and the growth of vasculature into the implantation site through the 
process of angiogenesis are conspicuous. The persistence of granulation tissue combined with 
the presence of a non-degradable biomaterial eventually leads to the formation of foreign body 
giant cells (116). The classic histologic description of a foreign body reaction consists of 
macrophages and multinucleated foreign body giant cells, formed through the fusion of the 
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macrophages, which are typically located at the surface of the biomaterial. There are a number of 
factors including the chemical composition and surface topography, which play a role in 
determining the degree to which a material elicits a foreign body giant cell response, 
predominantly through the modulation of protein adsorption (122-124). As previously stated, 
macrophages generally interact with protein adsorbed surfaces through cell surface integrin 
receptors, the ligation of which induces intracellular signaling cascades that regulate macrophage 
behavior. Depending on the type of signaling elicited and the immunologic microenvironment, 
macrophages may undergo fusion, thus forming foreign body giant cells. The exact mechanisms 
of foreign body giant cell formation are highly complex and have yet to be fully described. An 
in-depth discussion of the process of foreign body giant cell formation is beyond the scope of 
this chapter, however the topic of foreign body giant cell formation as it relates to biomaterials 
has been reviewed elsewhere (116).  In the final stage of the host response following the 
implantation of a biomaterial, an increasingly dense layer of collagenous connective tissue is 
deposited around the surface of the material, thus isolating or “encapsulating” it from the 
surrounding healthy tissue.   
Many approaches have been investigated to coat or modify the surface of a biomaterial to 
minimize the potentially detrimental processes of platelet activation, coagulation, and protein 
adsorption (125, 126).  Similarly, a number of other approaches have attempted to develop 
material coatings or other strategies that reduce the foreign body giant cell and fibrotic responses 
to non-degradable biomaterials intended for long-term implantation (127, 128).  All attempts to 
date have resulted in only modest success at best. 
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1.2.3 Role of the Host Response in Tissue Engineering and Regenerative Medicine 
The biomaterials most suitable for tissue engineering and regenerative medicine applications are 
typically degradable, manufactured from either synthetic or naturally occurring materials and are 
commonly combined with bioactive molecules or living cells. Therefore, the host tissue response 
tends to be distinctly different from that just described for metallic or polymeric biomaterials 
intended as permanent implants. While an in-depth consideration of how each of the components 
(degradable materials, bioactive factors and cells) of tissue engineered constructs affects the host 
response is beyond the scope of this chapter, a short discussion of each and examples of the host 
response elicited by commonly used degradable materials are provided below. 
In general, tissue engineering strategies utilize naturally or synthetically derived materials 
which are degradable, either in the short-term or the long-term, following implantation.  These 
materials include degradable polymers such as poly-lactic co-glycolic acid and poly-
caprolactone, among many others.  While these materials are subject to the same processes of 
protein adsorption as the non-degradable materials described above, their transient nature can 
affect both the severity and the duration of the host response.  An example of this process is 
provided in Figure 2.  In this instance, a Vicryl (Polyglactin 910) mesh has been placed in the 
abdominal wall musculature of a rat following creation of a surgical defect.  By 14 days post 
implantation, the Vicryl mesh is still largely intact and is subject to an intense foreign body giant 
cell response at the surface of the material (Figure 2a and 2b).  This multinucleate cell response 
is accompanied by the deposition of large amounts of granulation tissue consisting of newly 
deposited extracellular matrix, mononuclear cells, and blood vessels.  By 35 days post-
implantation, the Vicryl mesh is largely degraded, however is still present within the 
implantation site (Figure 2c and 2d).  The portion of the mesh which remains is surrounded by 
  26 
foreign body giant cells, with increasingly dense collagenous tissue formation at the periphery.  
The foreign body giant cell response, while reduced as compared to the response observed at 14 
days, will only resolve after the material has been completely degraded.  However, resolution of 
the inflammatory response will not result in constructive tissue remodeling in this case.  Rather, 
dense collagenous connective tissue resembling scar tissue will remain at the site of 
implantation. 
One of the advantages to the use of polymeric materials is the ability to form the material 
into specific shapes and sizes using a variety of techniques such as weaving, extrusion, or 
electrospinning, among others. The use of such processes allows for highly accurate tuning of 
many factors associated with the biomaterial construct.  These factors include three-dimensional 
configuration, mechanical and material properties, porosity and degradability.  These factors are 
known to have important effects upon the migration, proliferation, and differentiation of tissue 
specific cells when cultured during the creation of tissue-engineered constructs in vitro.  
However, the impact of these factors upon the eventual success of a biomaterial device following 
in vivo implantation appears to be limited to the immediate time period surrounding the surgical 
implantation of the construct. Surface chemistry, surface topography, and porosity have all been 
shown to have an effect upon the in vitro response of macrophages to biomaterials but few 
studies have investigated the effects of these factors upon the in vivo host response (122, 124, 
129-131).  
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Figure 2. H&E stained sections showing the host remodeling response following implantation of a 
degradable synthetic biomaterial (Vicryl mesh).  The material can be observed within the site of remodeling 
at 14 days post implantation (panels A and B) and is surrounded by a multinucleate giant cell population 
indicating a foreign body response.  Angiogenesis, a robust mononuclear cell response, and the deposition of 
new extracellular matrix (granulation tissue) can be observed further from the surface of the implanted 
material.  At 35 days post-implantation (panels C and D), a significant portion of the material has been 
degraded.  However, remnants of the material can still be observed within the site of implantation and a 
chronic inflammatory response including foreign body giant cells persists.  Increasingly dense connective 
tissue can be observed separating the implant from the native musculature (bottom).  Magnification of panels 
A and C = 10X, magnification of panels of B and D = 40X, scale bars =100 µm. 
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Other approaches to tissue engineering and regenerative medicine utilize naturally 
derived biologic materials such as the ECM of mammalian tissues or those of plant origin.  
These materials may elicit a distinctly different type of host response than those of a synthetic 
origin due to differences in the surface topology and the ligand landscape present on the surface 
of the material.  Naturally derived materials likely experience adsorption of a different repertoire 
of molecules than do synthetically derived materials and also often possess an inherent surface 
functionality which is related to the function of the biologic structure from which they are 
isolated.  There are a number of factors which influence the host response to naturally derived 
materials including the rate at which the material degrades and the molecular weight or 
composition of the material in the case of biopolymers such as chitosan.  For example, the degree 
of deacetylation of chitosan has been shown to affect the rate of degradation and the host 
response it elicits upon implantation (132).  Figure 3 shows an example of a 4-layer biologic 
material composed of UBM.  The material is surrounded by mononuclear cells, which are also 
observed to infiltrate the degrading material, at 14 days post-implantation into a rat abdominal 
wall musculature defect.  This cellular response is accompanied by the deposition of new 
extracellular matrix within the implantation site, as well as angiogenesis, similar to the example 
provided in Figure 2, although notably no foreign body giant cells are present.  However, the 
host response to the material at 35 days post-implantation is quite different than that observed in 
Figure 1.  By 35 days post-implantation, the material has degraded and is replaced with well-
organized collagen, blood vessels, and new islands of skeletal muscle.  While the response 
shown in Figure 3 represents only the beginning of the constructive tissue remodeling process, 
studies have shown that similar ECM scaffold materials are capable of promoting the formation 
of functional, innervated muscle tissue at later time points (25, 133, 134). 
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Figure 3. Hematoxylin and eosin stained sections showing the host remodeling response following 
implantation of a degradable biologic scaffold material (UBM).  At 14 days post-implantation (panels A and 
B) a robust mononuclear cell response accompanied by angiogenesis and deposition of new extracellular 
matrix are observed within and surrounding the degrading scaffold material.  Of note, no foreign body giant 
cells are observed at the surface of the material.  By 35 days post-implantation (panels C and D), the material 
is no longer identifiable in a histologic section and has been replaced by organized collagenous tissue, blood 
vessels, and bundles of skeletal muscle – a response which can be characterized as constructive tissue 
remodeling. Magnification of panels A and B = 10X, magnification of panels of C and D = 40X, scale bars 
=100 µm. 
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The two examples provided here are intended to show the diverse responses which may 
be elicited by the materials used in tissue engineering and regenerative medicine and not to 
imply that synthetic based approaches do not result in constructive tissue remodeling.  Indeed, 
there are numerous examples of tissue-engineered constructs containing polymeric components 
that facilitate what can be described as constructive tissue remodeling. Similarly, there are 
numerous examples of biologically derived scaffold materials which do not promote constructive 
tissue remodeling.  For example, chemical cross-linking of ECM based scaffold materials similar 
to those used in Figure 3 has been shown to result in fibrous tissue encapsulation as opposed to 
the constructive tissue remodeling outcome which was achieved using non-cross-linked forms of 
the same material (69).  It is also interesting to note that, although the outcome of tissue 
remodeling was different for the materials used in the examples provided in Figures 2 and 3, 
there are many similarities in the early host response to both materials.  That is, both materials 
elicited a robust mononuclear cell response and both elicited the formation of new extracellular 
matrix within the wound site.  Phenotypic differences in the cells which make up the observed 
mononuclear cell population which participates in the host response and their roles in 
determining the ability of a tissue engineered construct to promote constructive tissue 
remodeling will be examined in more detail in the studies which follow. 
Classic approaches to tissue engineering often dictate that cells be seeded into a carrier 
material and then cultured until reaching mechanical and biochemical properties which are 
similar to the tissue of interest. Other strategies involve the culture of scaffold free constructs 
containing only cells, which can then be stacked or otherwise shaped prior to implantation.  
These strategies have achieved varying levels success in a number of applications.  However, 
there is little evidence that cell based approaches result in new tissues that include the originally 
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implanted cells. There may be important and beneficial paracrine effects that initially promote 
the integration of tissue-engineered constructs or the formation of new tissue, but it is highly 
unlikely that the entire implanted cell population will survive in the host long-term.  The process 
of cell death and subsequent phagocytosis of cellular debris by neutrophils and macrophages can 
modulate the host response to a tissue engineered construct.  In particular, the mechanism of cell 
death (i.e. necrosis versus apoptosis) may play a role in determining how immune cells respond 
to cells implanted as part of a tissue engineered construct. The cells used in tissue engineering 
and regenerative medicine strategies are generally of an autologous or allogeneic nature, with 
few approaches utilizing xenogeneic cell sources.  These cells may be recognized by the adaptive 
immune system through mechanisms similar to those which have been described in detail for 
organ transplantation and rejection. Recent evidence suggests that certain cell sources may be 
capable of evading the adaptive immune system or elicit less immune activation (135, 136).  A 
number of strategies for the provision of cells that produce therapeutic molecules, such as insulin 
production by transplanted islet cells, have utilized hydrogels as encapsulating materials to 
prevent the recognition of cells by the host immune system (137, 138).  However, these 
approaches do not promote the integration of such cells into the tissue or organ of interest nor do 
they prevent the influx of potentially damaging small molecules and are, therefore, often only 
effective in the short-term.  An in depth discussion of all of the factors affecting host recognition 
of cells of an allogeneic or xenogeneic nature is beyond the scope of this chapter.  However, 
such recognition by the host and immune activation will obviously have deleterious effects upon 
the ability of the tissue-engineered construct to integrate within the host tissues and otherwise 
perform as intended.  
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The inclusion of bioactive factors such as cytokines, chemokines, and peptides within 
scaffold materials for tissue engineering and regenerative medicine have been shown to have 
wide ranging effects upon the ability of the material to the promote migration, proliferation, and 
differentiation of the cells which are seeded onto the scaffold and cultured prior to implantation .  
These same factors, when included on scaffolds prior to implantation have been shown to have 
similarly wide ranging effects, which are often dependant on the tissue or organ into which the 
constructs are implanted. Each of these factors, especially those that have immunomodulatory 
properties will logically have an effect upon the host response to the construct and, thus, affect 
the subsequent tissue remodeling outcome associated with its implantation. 
Regardless of its components (cells, biomaterials, signaling molecules), the host response 
to the implanted construct will play a much more important role in the ultimate functionality than 
the properties of the construct at the time of surgery. Therefore, strong emphasis should be 
placed upon those factors that influence the host recognition of the engineered construct and 
subsequent cellular response. Following implantation, the engineered construct will acquire a 
surface coating of adsorbed proteins, the nature of which will affect the subsequent host response 
and the interaction with the first responding cell types (neutrophils and macrophages). Further, 
the type of cells that are included may elicit recognition by the host immune system, and the 
bioactive factors may alter the nature of this host response.  The complex interplay between these 
events and others will determine whether the implanted construct is infiltrated with cells, 
degraded, integrated with the surrounding native tissue, or encapsulated. 
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1.3 MACROPHAGES 
 
The studies presented in this dissertation focus upon one major aspect of the host response to 
biologic materials used in tissue engineering and regenerative medicine, the macrophage 
response.  It is hypothesized that the phenotype of the macrophage population which participates 
in the host response following the implantation of a biologic scaffold material may be a predictor 
of the downstream outcome associated with its use.  The following section provides a brief 
background on macrophage origin, heterogeneity, plasticity, and role of the macrophage in the 
host response following tissue injury.  These concepts are then applied to the evaluation of the 
host response to ECM scaffold materials in an abdominal wall musculature defect model. 
1.3.1 Origin 
Macrophages are monocyte derived myeloid cells that develop from a common myeloid 
progenitor cell residing within the bone marrow of adult mammals (139).  This same myeloid 
progenitor cell also gives rise to the other cells of the myeloid lineage including neutrophils, 
eosinophils, basophils and dendritic cells depending upon the cytokines to which the cell is 
exposed during its development.  Monocytes are derived from the common myeloid progenitor 
cell through a cascade that includes the cytokines granulocyte-macrophage colony stimulating 
factor (GM-CSF), granulocyte colony stimulating factor (G-CSF), and macrophage colony 
stimulating factor (M-CSF).   These signals induce differentiation of the common myeloid 
progenitor to monoblasts, pro-monocytes, and finally monocytes.  Mature monocytes then leave 
the bone marrow and enter the blood stream where may they reside for several days before 
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entering tissues to become macrophages, either in a process of steady-state turnover or due to 
chemoattractant factors produced as part of a local inflammatory process.   
Prior to entering tissues and differentiating into macrophages, circulating blood 
monocytes are known to be heterogeneous with at least two general populations having been 
identified (139).  These consist of CD14hiCD16- and CD14+CD16+ populations in humans and 
Ly-6chigh (Gr1+) and Ly-6clow(Gr1-) subsets in mice, and have been grouped into two basic 
categories termed ‘inflammatory’ and ‘resident’, respectively .  Inflammatory (CD14hiCD16-/Ly-
6chigh) monocytes are characterized by their ability to migrate to sites of injury or infection and to 
propagate chronic inflammatory diseases, while resident monocytes are characterized by their 
ability to patrol the vasculature, populate normal tissues, and to act as regulators of the 
inflammatory response.  Similar cell populations to the two described above have been identified 
in other species, however species dependant differences in characteristic markers do exist. 
During normal tissue turnover monocytes differentiate into macrophages upon emigration 
from the vasculature into the tissue.  Once within the tissue, macrophages may undergo 
differentiation into a number of distinct phenotypes depending on the tissue and the 
immunologic microenvironment.  Native tissue-resident macrophage populations include those 
of the bone (osteoclast), lung (alveolar macrophage), the nervous system (microglia), connective 
tissues (histiocytes), the gut, liver (Kupffer cells), the spleen, and the peritoneum.  Each tissue-
specific macrophage performs a specific function and may be associated with specific patterns of 
gene expression and functional activity (139).  For example, macrophages present within the gut 
perform a specialized function which requires high levels of phagocytosis and low production of 
pro-inflammatory cytokines, a phenotype which is distinct from the other macrophage 
populations listed above.  It has been shown that this phenotype can be induced in other 
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macrophage populations through exposure to intestinal stromal cell products (140), showing that 
the local microenvironment plays a large role in determining the phenotype and activity of 
various macrophage populations.  This is also an example of the remarkable plasticity exhibited 
by macrophages, which will be further examined in the following section. 
1.3.2 Macrophage Polarization 
Macrophages, like the monocytes from which they derive, are a heterogeneous cell population 
with different markers and functions depending upon the signals to which they are exposed (71, 
139, 141, 142).  Upon leaving the blood stream and migration into sites of inflammation, 
macrophages become activated in response to tissue damage or infection, causing an increase in 
the production of cytokines, chemokines, and other inflammatory molecules (139, 141, 143-145).  
Macrophages have been characterized based on their distinct functional properties as well as 
their microenvironment.  Polarized macrophages are referred to as either M1 or M2 cells, 
mimicking the Th1/Th2 nomenclature (143).  M1, classically activated pro-inflammatory, 
macrophages are known to be induced by IFN-γ alone or in combination with LPS or TNF.  In 
general, M1 activated macrophages express IL-12high, IL-23high, IL-10low; metabolize arginine, 
produce high levels of inducible nitric oxide synthase (iNOS); secrete toxic reactive oxygen and 
nitric oxygen intermediates and inflammatory cytokines such as IL-1β, IL-6, and tumor necrosis 
factor (TNF); and are inducer and effector cells in Th1 type inflammatory responses (146).  In 
contrast, M2, alternatively activated, macrophages are induced by exposure to a variety of 
signals including the cytokines IL-4, IL-13, and IL-10, immune complexes, and glucocorticoid or 
secosteroid (vitamin D3) hormones.  M2 activated macrophages express IL-12low, IL23-low, and 
IL-10high; have high levels of scavenger, mannose, and galactose receptors; produce arginase in 
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the place of arginine, subsequently producing ornithine and polyamines; and are involved in 
polarized Th2 reactions (146).  It should be noted, however, that M2 alternatively activated 
macrophages have also been shown to be a heterogenous subset with three well-recognized 
subpopulations (M2a, M2b, and M2c), each with its own inducers, markers, and function.  The 
characteristics of each macrophage subtype are outlined in Figure 4. 
 
Figure 4.  Inducers and selected markers, secreted products and functionality of polarized 
macrophage populations.  Reprinted from (141) with permission from Elsevier. 
1.3.3 Role of Macrophage Polarization in Wound Healing 
To date, the causes and the effects of macrophage polarization towards an M1 or M2 phenotype 
have been studied largely in the context of the host response to pathogens and in cancer biology.  
However, a number of recent studies have shown that macrophages, and macrophage 
polarization in particular, play an essential role in the healing response following tissue injury 
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(147-149).  While the overall role of macrophages following tissue injury is well described, these 
studies show that macrophages with specific phenotypes have distinct roles in tissue remodeling, 
and that the phenotype of the macrophages which participate in tissue remodeling may play a 
role in determining the downstream outcome of the remodeling process (i.e. scar tissue formation 
vs. constructive tissue remodeling). 
A recent study examined gene expression during cutaneous wound healing following skin 
biopsies of human patients (147).  Results showed upregulation of a wide variety of genes 
throughout the duration of wound healing.  Of note, however, investigators identified two 
clusters of genes associated with macrophage M1/M2 polarization, which were upregulated 
transiently during the wound healing process.  The first was upregulated during the early, 
inflammatory stage of wound healing and contained a mixture of M1 and M2 associated genes 
(11 M1 genes and 7 M2 genes).  The second was upregulated in the later tissue remodeling and 
angiogenesis stages of healing and contained predominantly M2 associated genes (1 M1 gene 
and 9 M2 genes).  The results of this study suggest evidence for the involvement of M1/M2 
polarization in the process of cutaneous wound healing.  Similar patterns of macrophage 
polarization have been described in the myocardium following injury. 
Another study investigated the role of macrophages and macrophage polarization in the 
processes of tissue repair following injury of the spinal cord (148).  The results of the study 
showed that a predominantly M1 phenotype was induced immediately following injury and 
persisted within spinal cord lesions.  A small number of M2 macrophages were also seen in the 
site of injury at early time points; however, these cells were not observed at later time points in 
the remodeling process, suggesting that the M1 to M2 phenotype shift does not occur in the same 
way in the spinal cord as it does in some tissues following injury.  This study also showed that 
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M1 and M2 macrophages had distinct effects upon the survival of neurons and upon and neurite 
outgrowth.  Neurons which were exposed to media conditioned by M1 macrophages were shown 
to exhibit a decrease in viability as well as a decrease in neurite length, while those cells exposed 
to media conditioned by M2 macrophages showed improved survival and a greater degree of 
neurite extension.  This suggests that the default response following CNS injury is a chronic pro-
inflammatory, M1 type response which leads to decreased viability of the neurons within the site 
of injury, and that induction of a more M2 type response may be capable of promoting a more 
constructive tissue remodeling type environment. 
Polarized macrophages have also been shown to play an important role in muscle tissue 
regeneration following injury.  In one study, the role of M2 macrophages was investigated in a 
mouse model of necrotic muscle injury repair (149).  In this study it was shown that the deletion 
of two of the binding sites in the CREB-C/EBPβ pathway blocked the induction of M2 
associated genes, while M1 gene expression was not affected.  Necrotic injury was induced 
through the injection of cardiotoxin, an injury which results in rapid recovery of the injured 
muscle tissue in unaltered mice, and mice were then monitored for up to 10 days following 
injection.  In those mice in which the CREB-C/EBPβ pathway was blocked (i.e. lacked 
expression of genes associated with the M2 macrophage phenotype), the tissue which formed 
within the site of tissue remodeling was highly fibrotic and associated with a decrease in 
myofiber size, which was in direct contrast to control mice which exhibited full recovery of the 
injured muscle.  Representative images of muscle morphology from this study are shown in 
Figure 5.  This shows the importance of the M2 macrophage phenotype in promoting a 
constructive tissue remodeling type response following skeletal muscle injury. 
  39 
 
Figure 5.  Muscle tissue remodeling following cardiotoxin injection in normal (C57BL6 – A,C,E) and 
CREB-C/EBPβ (B, D, F) mice at 2 (A, B), 5 (C, D), and 10 days (E, F) post-injection.  Myofibers with 
eosinophil cytoplasm indicated by arrowheads.  Myofibers with decreased size were observed at 10 days in 
the knockout mice (arrows).  Modified from (149) with permission from National Academy of Sciences, USA. 
 
In this dissertation, concepts of macrophage M1/M2 phenotype are applied to the study of 
tissue remodeling following the implantation of extracellular matrix scaffold materials in an 
abdominal wall musculature defect model to determine whether differences in the phenotype of 
the macrophage population which responds following ECM scaffold implantation may be, in 
part, a predictor of the downstream tissue remodeling outcome. 
1.4 CENTRAL HYPOTHESIS 
The central hypothesis of this dissertation is that methods used in the production ECM scaffolds 
have distinct effects upon the characteristics of the resultant scaffold, and that these 
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characteristics play an important role in determining the ways in which the scaffold materials 
interact with cells both in vitro and in vivo, and that ECM scaffold-macrophage interactions play 
an important role in determining the ability of ECM scaffolds to promote constructive tissue 
remodeling.  
1.5 SPECIFIC AIMS 
Aim 1:  To determine the effects of tissue source and chemical cross-linking upon the structure 
and composition of ECM scaffold materials, and to show that these characteristics have effects 
upon patterns of cell behavior in vitro. 
 
Aim 2:  To determine the effects of the presence of a cellular component within an extracellular 
matrix scaffold and the use of carbodiimide during scaffold production upon the capacity of 
extracellular matrix scaffolds to elicit a constructive tissue remodeling versus encapsulation or 
scar tissue type remodeling response in model of rat abdominal wall musculature reconstruction. 
Sub-Aim:  To determine whether the host remodeling response to one ECM scaffold 
material affects the outcome of the host remodeling response to a second material implanted 
concurrently in the same animal. 
 
Aim 3:  To show that extracellular matrix scaffolds are capable of altering the default host 
macrophage response following implantation, and that the modulation of the host macrophage 
response is related to the ability of the scaffold to promote the constructive versus encapsulation 
or scar tissue type remodeling responses observed in Aim 2. 
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Sub-Aim:  To evaluate the effects of polarized macrophages upon the in vitro behavior 
of other cell types. 
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2.0  SPECIFIC AIM 1: EFFECTS OF TISSUE SOURCE AND CHEMICAL CROSS-
LINKING UPON EXTRACELLULAR MATRIX SCAFFOLDS 
2.1 BACKGROUND 
The extracellular matrix (ECM) is composed of the secreted molecules produced by the resident 
cells of each tissue or organ.  Thus, the composition and three-dimensional ultrastructure of the 
ECM is highly related to cell phenotype and the required functions of the tissue or organ from 
which it is derived.  The exact composition of the ECM is dependant on a number of factors that 
influence resident cell phenotype including mechanical forces, biochemical milieu, oxygen 
requirements, pH, and gene expression patterns, among others.  The ECM, in turn, influences the 
phenotype, migration, and proliferation of its resident cells, and serves as a medium for signal 
transfer between cells (2-5).  For these reasons, the ECM is considered to be in a state of 
dynamic reciprocity (3) with the cells which reside within it and to play an important role in 
normal tissue and organ morphogenesis (6).  
For these same reasons, biologic scaffolds composed of ECM have been investigated as 
inductive templates for functional tissue reconstruction in a number of anatomic locations 
including the lower urinary tract, skin, musculotendinous tissues, dura mater, esophagus and 
cardiovascular structures in both preclinical animal studies and in human clinical applications 
(51, 150-159).  ECM scaffolds prepared from different tissue sources or prepared using different 
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methods have been shown to have distinctive effects upon cell adhesion patterns (1, 160, 161), 
the ability to support and maintain a differentiated cell phenotype (2, 162, 163), oxygen 
diffusivity (68), and water permeability (164, 165).  It is unknown whether the bulk (or average) 
composition of the ECM, the surface chemistry, or the ultrastructural morphology, especially the 
surface ultrastructure, plays a greater role in determining the phenotype of the cells with which it 
comes into contact. 
The process of host tissue remodeling following implantation of a biologically derived 
scaffold is dependant upon the immediate and subsequent events that occur at the surface of the 
material following in vivo implantation.  The surface topography and ligand landscape of the 
scaffold material will determine the host molecules that bind and the type and behavior of cells 
that mediate the host response.  The production of biologic scaffolds composed of ECM requires 
the use of processing methods that decellularize and terminally sterilize the material (67).  These 
methods can affect the composition, ultrastructure, mechanical properties, and surface 
topography of the resulting scaffold, thus potentially affecting the host response associated with 
its use (67).  Similarly, chemical cross-linking is a method used in the production of many 
commercially available ECM scaffolds that may affect the surface characteristics of the resulting 
material as well as alter the host response following implantation (69, 166). Therefore a 
comprehensive understanding of surface characteristics and their effects upon cellular behavior 
both in vitro and in vivo is essential for the design of intelligent scaffolds for specific clinical 
applications. 
The objectives of the studies presented in this section were fourfold: (1) to determine and 
compare by scanning electron microscopy (SEM) and time of flight secondary ion mass 
spectrometry (ToF-SIMS) the ultrastructure and molecular composition of the surfaces of 
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extracellular matrix (ECM) scaffolds derived from porcine UBM, SIS, and liver (LECM); (2) to 
determine the effects of two commonly used methods of chemical cross-linking (carbodiimide 
and glutaraldehyde) upon the surface characteristics of one of these ECM scaffold materials, 
specifically UBM; (3) to determine the presence of an intact basement membrane complex on the 
surfaces of three types of ECM scaffold described above; and (4) to determine the effects of the 
ECM scaffold surface characteristics upon the in vitro growth of NIH 3T3 fibroblasts, human 
microvascular endothelial cells (HMECs), and embryonic rat spinal cord neurons. 
2.2 METHODS 
2.2.1 Preparation of Extracellular Matrix Scaffold Materials 
The ECM materials for this study were harvested and prepared using methods previously 
described (80, 167-169).  The urinary bladder, small intestine and liver were harvested from 
market weight pigs (approximately 110-120 kg) immediately after sacrifice.  
2.2.1.1 Urinary Bladder Matrix 
 Excess adipose tissue and collagenous connective tissue were removed from the outside 
of the bladder with scissors.  The urothelial cells were removed by soaking the bladder tissue in 
1.0 N saline.   Intraluminal water pressure was used to expand and stretch the bladder to facilitate 
the removal of the muscle layer and the tunica submucosa.  The apex of the bladder was removed 
using scissors.  The bladder was then bisected on one side from the opening to the apical region, 
forming a rectangular shaped sheet.  The luminal side of the bladder was placed downward and 
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the tunica serosa, tunica muscularis externa, tunica submucosa, and the muscularis mucosa were 
removed by mechanical delamination.  The remaining tissue was then soaked in phosphate 
buffered saline (PBS, pH 7.4) and represented UBM (21). 
2.2.1.2 Small Intestinal Submucosa 
 The jejunum of the porcine intestine was isolated and the mesentery removed by sharp 
dissection.  The lumen of the isolated segment of jejunum was then flushed with running tap 
water for 2-5 minutes.  The intestine was then split longitudinally and mechanically delaminated 
to remove the luminal portions of tunica mucosa including the majority of the lamina propria and 
the entirety of the tunica muscularis externa and serosa.  The remaining tunica submucosa and 
the basilar layers of the tunica mucosa, specifically the muscularis mucosa and stratum 
compactum, represented SIS (22, 80). 
2.2.1.3 Liver Extracellular Matrix 
 The four lobes of the porcine liver were separated using a scalpel and then trimmed to a 
uniform shape.  The liver lobes were allowed to freeze completely at -80°C for at least 24 hours.  
The frozen lobes were cut into 5 mm slices using a commercial meat slicer.  Because the 
structure of liver tissue is complex and does not exhibit a layered structure, it was not possible to 
mechanically delaminate the desired tissue layers as in the case of intestinal and urinary bladder 
scaffolds.  Instead, the liver slices were chemically treated to remove undesired content.  The 
slices were placed in deionized (DI) water and shaken vigorously for 30 minutes at room 
temperature.  This process was repeated with clean DI water for a total of three rinses.  The slices 
were then massaged to hasten the lysis of hepatocytes and the removal of cell remnants, and then 
were placed in a container of 0.02% trypsin / 0.05% EDTA at 37°C for one hour.  The solution 
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was decanted, the slices rinsed in DI water, and the massaging was repeated.  The liver slices 
were then placed back on the shaker at room temperature for one hour in 3% Triton X-100. The 
water rinses and massaging process were then repeated as necessary to lyse and remove any 
remaining cellular elements.  The slices were then placed in 4% sodium deoxycholic acid for one 
hour on a shaker and then rinsed in water.  The remaining decellularized connective tissue matrix 
was referred to as LECM (41). 
2.2.1.4 Disinfection and Cell Lysis 
 Following removal of the appropriate tissue layers and bulk cellular contents from the 
three organs as described above, the remaining tissue was treated with a 0.1% peracetic acid/4% 
ethanol solution for two hours at room temperature on a shaker (170).  Traces of peracetic acid 
were removed and the pH was returned to approximately 7.4 by rinsing the ECM at room 
temperature, with shaking, in PBS one time, then in water twice, and then again in PBS one time. 
Each rinse lasted 15 minutes. Samples to be examined by time of flight secondary ion mass 
spectrometry were subjected to three additional 1-hour long water rinses and one overnight water 
rinse to remove as much of the residual contamination which might affect ToF-SIMS data 
collection (e.g., Na, K, Si, PDMS) remaining from the production process as possible. The 
resulting decellularized and disinfected ECM scaffolds were then lyophilized prior to any cross-
linking or sterilization treatments as described below. 
2.2.1.5 Cross-linking of Urinary Bladder Matrix 
 Scaffolds composed of UBM were cross-linked by immersion in solutions of either 
carbodiimide (10 mM; CDI-UBM) or glutaraldehyde (0.625%; GLUT-UBM) for 8-10 hours at 
room temperature. The cross-linked scaffolds were subjected to three separate 1 hour water 
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washes as well as an overnight water wash to remove any residual cross-linking solution or 
contamination that may have remained following the cross-linking process. 
2.2.1.6 Terminal Sterilization 
 The resulting decellularized and disinfected ECM scaffolds were terminally sterilized by 
exposure to ethylene oxide gas for 16 hours.   
2.2.2 Characterization of Extracellular Matrix Scaffolds 
2.2.2.1 Scanning Electron Microscopy 
 
 Samples to be utilized in the characterization of ultrastructure were dehydrated by 
sequential immersion in 30, 50, 70, 90, and 100 percent ethanol. The immersion in 100 percent 
ethanol was repeated three times. Residual ethanol in the samples was exchanged with 
hexamethyldisilazane (HMDS) and then the samples were allowed to air dry. Samples were 
attached to aluminum specimen mounting stubs and sputter coated with gold palladium alloy. 
The samples were then analyzed using a JEOL 6330F field emission gun SEM with an 
accelerating voltage of 3 kV. 
2.2.2.2 Time of Flight Secondary Ion Mass Spectrometry 
 
 ToF-SIMS is an analytically sensitive surface technique that can be used to create a 
detailed mass spectrum of the outermost 10-20 Å of a sample (171).  ToF-SIMS is performed by 
bombarding the surface of the sample with a beam of primary ions and then measuring the 
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intensities of the individual masses of the positive and negative secondary ions emitted (Figure 
7A and B).  Analysis of the type and amount of secondary ions generated can provide important 
information about the material from which they were emitted including the composition, 
structure, orientation and spatial distribution of the molecules on the surface (Figure 7B). 
 
Figure 6.  (A) A schematic drawing of the secondary ion emission process initiated by the impact of a 
primary ion. Extensive fragmentation occurs near the collision site producing mainly atomic particles. Away 
from the point of impact collisions become less energetic resulting in the emission of larger molecular 
fragments.  (B) Schematic drawing of a SIMS instrument with a TOF analyzer. The primary ion source, 
sample, and flight tube are kept under ultrahigh vacuum. The mass of the detected ions is determined by the 
flight time of the ion between the extractor and the detector. The reflectron helps compensate for energy and 
angular dispersion that can occur during the emission process.  Reprinted from (171) with permission from 
Elsevier. 
In the present study, ToF-SIMS spectra were acquired on an ION-TOF ToF.SIMS 5-100 
spectrometer using an 25 keV Bi+ ion source in the pulsed mode, at a pulse width of 
approximately 2 ns based on the hydrogen peak width, to enhance mass resolution of the spectra. 
Spectra were acquired for both positive and negative secondary ions over a mass range of mass 
to charge ratio (m/z) = 0 to 700. The primary ion current was 0.8 pA. Secondary ions of a given 
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polarity were extracted and detected using a reflectron time-of-flight mass analyzer. Spectra 
were acquired using an analysis area of 0.005-0.01 mm2. Positive ion spectra were mass 
calibrated using the CH3+, C2H3+, and C3H5+ peaks. Negative ion spectra were not considered in 
this study as they lacked characteristic peaks. Mass calibration errors were kept below 10 ppm. 
Mass resolution (m/Dm) for a typical spectrum was 3000 - 7000 at m/z = 27.   
Multivariate analysis was conducted by selecting peak sets from the samples analyzed by 
ToF-SIMS. The selected peaks were then normalized to the total ion intensity of all peaks 
selected to account for fluctuations in secondary ion yield between different spectra.  Principal 
components analysis (PCA) was then employed to analyze the positive ToF-SIMS data using a 
Matlab based algorhithm.  All spectra were mean-centered before running PCA. PCA was used 
to determine the linear combination of peaks that captured the highest degree of variation in a 
dataset (172). 
2.2.2.3 Immunolabeling  
 Immunolabeling was performed using the Vectastain advin-biotin peroxidase (ABC) 
method.  Tissues were frozen in optimal cutting temperature solution and sectioned on a cryostat 
at 8μm and placed on slides. The cryosections were thawed to room temperature, fixed in 
acetone for five minutes at room temperature, rinsed in PBS, treated with 0.3% hydrogen 
peroxide in methanol at room temperature for 30 minutes to quench endogenous peroxidase 
activity, rinsed in PBS, and then incubated in 1.5% serum for 30 minutes in a 37°C humidified 
chamber to block binding of antibodies to nonspecific proteins. Serum for blocking was horse 
serum or rabbit serum, depending on the host species of the secondary antibody. Following 
incubation in blocking serum, sections were incubated in primary antibody in a 37°C humidified 
chamber for 30 minutes and then rinsed in PBS. Sections were then incubated in the appropriate 
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secondary antibody for 30 minutes in a humidified 37oC chamber and again rinsed in PBS.  
Sections were then incubated in Vectastain ABC reagent for 30 minutes in a humidified 37oC 
chamber, rinsed 3 times in PBS for a total of five minutes, incubated in 4% diaminobenzadine 
(DAB) substrate solution at room temperature while being viewed on a microscope until slides 
showed the desired darkness of antigen labeling.  Finally slides were rinsed in DI water to stop 
the development of the DAB substrate prior to coverslipping.  Each PBS rinse in the protocol 
was for 5 minutes at room temperature, replacing the PBS 3 times, with occasional agitation.   
The primary antibodies used were rabbit anti-human laminin at 1:100, rabbit anti-human 
collagen  IV at 1:200, and mouse anti-human collagen  VII, which was used undiluted. All 
primary antibodies cross-reacted with porcine tissue.  The secondary antibodies used were 
biotinylated goat anti-rabbit IgG at 1:200 and biotinylated horse anti-mouse IgG at 1:200.     
For collagen IV staining, formalin fixed paraffin embedded tissue samples were 
sectioned, dewaxed and treated as the frozen sections, beginning with the hydrogen peroxide 
step. 
2.2.3 Cell Culture on Extracellular Matrix Scaffolds 
2.2.3.1 NIH 3T3 Mouse Fibroblasts 
 NIH 3T3 fibroblasts were cultivated in Dulbecco's modified eagle medium (DMEM) 
containing 10% fetal bovine serum. Cells were grown at 37oC in a 5% CO2/95% air humidified 
incubator, and were harvested for seeding when they were approximately 70-80% confluent. All 
scaffolds were placed in 100mm cell culture dishes, one sample per dish, and stainless steel 
tissue culture rings with inner diameters of 1.5 cm were placed on the scaffolds. Pressure was 
applied to create a seal and to hold the sheets of ECM on the bottom of the Petri dish.  The 
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scaffolds were incubated in 1mL of the appropriate media at 37°C and 5% CO2 for 
approximately 15 minutes prior to cell seeding, at which point the media was removed just 
before adding the cells.  Cells were trypsinized, counted and placed on the ECM scaffolds within 
the tissue culture rings at concentrations of either 0.5X106 or 1X106 cells per ring.  Growth 
media was added to the cell culture dishes and dishes were incubated at 37oC and 5% CO2. After 
4 hours, two-thirds of the media was replaced with fresh media.  After four additional hours at 
37°C and 5% CO2, the stainless steel rings were removed.  The cells were grown on the scaffolds 
for 10 days at 37°C and 5% CO2.  
2.2.3.2 Human Microvascular Endothelial Cells 
 HMECs were cultivated in MCDB-131 medium containing 10% fetal bovine serum, 
2mM L-glutamine, 100 units/ml penicillin/100 ug/ml streptomycin, and 1 ug/ml hydrocortisone.  
Cells were grown at 37°C in 5% CO2/95% air humidified incubator, and were harvested for 
seeding when they were approximately 70-80% confluent. The same cell seeding procedure 
described above for NIH 3T3 cells was used for the culture of HMEC cells upon ECM scaffolds. 
2.2.3.3 Histologic Staining 
 After the 10-day growth period, ECM scaffolds seeded with either NIH 3T3 cells or 
HMECs were placed in 10% neutral buffered formalin, embedded in paraffin, and then sectioned 
and stained with hematoxylin and eosin prior to being viewed under a light microscope. 
2.2.3.4 Primary Rat Embryonic Spinal Cord Neurons 
 Spinal cord neurons were isolated from embryonic day 14 Sprague–Dawley rat pups. 
Spinal cords were isolated under a dissection microscope and placed in cold Hank’s buffered salt 
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solution (HBSS) without Ca2+ and Mg2+, minced into pieces approximately 0.5 mm2 in size and 
enzymatically dissociated in 2 ml 0.25% trypsin solution containing 0.05% collagenase L1 at 37° 
C for 20 min. Cell digestion was inhibited by adding 2 ml SBTI-DNAse solution (0.52 mg/ml 
soybean trypsin inhibitor, 3.0 mg/ml BSA, 0.04 mg/ml bovine pancreas DNAse). The cell 
suspension was gently mixed with a Pasteur pipette and centrifuged at 800 × g for 5 min. The 
resulting pellet was then re-suspended in plating medium and gently mixed. The plating medium 
consisted of 20% horse serum, 2 mM L-glutamine, 5 ml HBSS without Ca2+ and Mg2+ and 9.8ml 
DMEM.  
Single sheets of UBM were cut with a 1.5 cm diameter circular punch and sterilized to 
create discs for use in cell culture experiments. Using sterile stainless steel rings to anchor the 
UBM discs, spinal cord neurons were seeded on the abluminal surface of the discs in plating 
medium at a plating density of 3 × 105 cells/cm2 and allowed to adhere for 4 h in culture 
conditions of 5% CO2 and 37 °C in a humidified environment. After 4 h, the medium was 
exchanged with 1 ml serum-free culture medium containing Neurobasal-A, 1× B27 supplement 
and 1 mM Glutamax. The cells were maintained in a humidified 5% CO2 atmosphere at 37°C, 
with 50% of the culture medium changed every 4 days. Cells were seeded at the same 
concentration on poly-L-lysine-coated coverslips (12.5 μg/ml in H2O) as a control. 
2.2.3.5 Immunolabeling  
Rat primary spinal cord neurons seeded on control coverslips were maintained in culture 
for 5 days and were then washed three times with PBS warmed to 37°C, fixed with 4% 
formaldehyde at 37°C for 15 min and incubated in permeablization buffer (0.5% Triton X) for 15 
min at room temperature. All antibodies were diluted in a modified PBS solution (0.3 M NaCl 
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PBS, 0.3% Triton X). All primary antibodies were diluted to a working dilution of 1:100 in PBS 
and incubated overnight at 4°C.  All secondary antibodies, also at a working dilution of 1:100, 
were incubated for 1 h at 37°C.  After each stage of antibody incubation, the samples were gently 
washed three times for 5 min in PBS. Samples were examined using antibodies against β-tubulin 
III and GFAP and appropriate secondary antibodies, FITC-conjugated goat anti-mouse IgG and 
TRITC-conjugated goat anti-rabbit IgG, respectively. All samples were mounted in Vectashield 
mounting medium containing 4',6-diamidino-2-phenylindole (a nuclear stain, DAPI) prior to 
being viewed under a fluorescence microscope. 
UBM cell-seeded discs were harvested after 5 days and fixed with 10% neutral buffered 
formalin for 24 h. Sections of the discs were trimmed, embedded in paraffin and then cut in into 
5 μm thick sections. All sections were deparaffinized by immersion in a xylenes and a graded 
series of ethanol before being immersed in permeablization buffer (0.5% Triton X) for 15 min at 
room temperature. Sections were then triple-stained as described above for samples grown on 
coverslips. 
2.2.3.6 Scanning Electron Microscopy 
 ECM scaffolds seeded with primary spinal cord neurons were fixed for 2 h with 2.5% 
glutaraldehyde. After three 15 min washes in PBS, the samples were dehydrated through a 
graded series of ethanol washes, followed by chemical drying with 100% HMDS overnight. 
Samples were sputter-coated with a 4 nm thick layer of gold-palladium alloy and then examined 
using a JEM 6335F field emission gun SEM with an excitation voltage of 4 kV. 
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2.3 RESULTS 
2.3.1 Characterization of Extracellular Matrix Scaffolds 
2.3.1.1 Scanning Electron Microscopy 
 Scanning electron micrographs showed morphological and structural differences between 
the luminal and abluminal sides of SIS and UBM but not LECM, which did not appear to possess 
a distinct sidedness.  In brief, a network of collagen, reticular fibers, and elastic fibers with 
varying diameters ranging from submicron to micron scale were observed on the abluminal sides 
of SIS and UBM while the luminal sides were characterized by a relatively smooth surface 
comprised of tightly compacted fibers in the case of SIS or a smooth surface characteristic of a 
basement membrane structure in the case of UBM.  This is in contrast with LECM, which 
consisted of a dense meshwork of predominantly submicron fibers throughout the entirety of the 
material. The inter-fiber distance on the abluminal sides of SIS and UBM was observed to be 
greater than the distance between the fibers present in LECM.  Furthermore, on the abluminal 
sides of SIS and UBM, smaller fibers characteristic of reticular and elastic fibers (173) were 
found to be interlaced with the larger bundles of collagen I, creating a more porous extracellular 
matrix microenvironment compared to that observed in LECM.  Representative SEM images of 
the surfaces of the non-cross-linked UBM, SIS, and LECM scaffolds are shown in Figure 7 and a 
cross sectional view of the same scaffolds is shown in Figure 8. 
The CDI-UBM demonstrated distinct structural differences in the arrangement of 
collagen fibers from those observed for GLUT-UBM and non-cross-linked UBM.  Fibers on the 
abluminal side of the CDI-UBM appeared to coalesce to form a more dense, compact mesh of 
collagen with smaller pore sizes compared to non-cross-linked UBM and GLUT-UBM.  The 
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abluminal side of GLUT-UBM showed thicker bundles of collagen than were found in UBM; 
however, GLUT-UBM maintained a similar pore size to that observed on the abluminal side of 
non-cross-linked UBM.  Fewer individual reticular and elastic fibers were observed in both CDI-
UBM and GLUT-UBM than were observed in non-cross-linked UBM.  The luminal sides of 
both CDI-UBM and GLUT-UBM exhibited a more fibrous surface topography as compared to 
non-cross-linked UBM.  Representative SEM images of the surfaces of the cross-linked UBM 
scaffolds are shown in Figure 9. 
 
 
 
 Figure 7. SEM images of the luminal surface of SIS (A), the abluminal surface of SIS (B), the luminal 
surface of UBM (C), the abluminal surface of UBM (D), and the surface of LECM (E).  All images are 2500X 
magnification and scale bar = 10 µm.  Reprinted from (174) with permission from Elsevier. 
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 Figure 8. SEM showing a cross sectional view of UBM, SIS, and LECM scaffolds. The presence of a 
smooth surface ultrastructure which is consistent with a basement membrane (arrow) and underlying 
connective tissue of the tunica propria (arrowhead) was observed in UBM (A).  SIS (B) and LECM (C) do not 
contain a smooth surface ultrastructure which is consistent with non-basement membrane surfaces.  (400X).  
Reprinted from (1) with permission from Elsevier. 
 
 
 Figure 9. SEM images of the luminal surface of CDI-UBM (A), the abluminal surface of CDI-UBM 
(B), the luminal surface of GLUT-UBM (C), and the abluminal surface of GLUT-UBM.  All images are 
2500X magnification and scale bar = 10 µm.  Reprinted from (174) with permission from Elsevier. 
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2.3.1.2 Time of Flight Secondary Ion Mass Spectrometry 
 In all of the samples investigated, the majority of the total ion yield was observed in the 
mass (m/z) 0-150 range with the exception of large peaks at m/z 166.06, 184.07, and 224.11, 
which were observed in the SIS and UBM as well as the cross-linked UBM samples but not the 
LECM samples.  Representative positive ion spectra from the abluminal and luminal sides of the 
SIS and UBM samples along with spectra from the single sided LECM samples are shown in 
Figure 10.  Figure 11 shows representative positive ion spectra for the luminal and abluminal 
sides of the CDI-UBM and GLUT-UBM samples. 
 
 Figure 10. Representative positive ion spectra from the luminal surface of SIS (A), the abluminal 
surface of SIS (B), the luminal surface of UBM (C), the abluminal surface of UBM (D), and the surface of 
LECM (E).  Reprinted from (174) with permission from Elsevier. 
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 Figure 11. Representative positive ion spectra from the luminal surface of CDI-UBM (A), the 
abluminal surface of CDI-UBM (B), the luminal surface of GLUT-UBM (C), and the abluminal surface of 
GLUT-UBM. Reprinted from (174) with permission from Elsevier. 
 
The peak list used for PCA (Table 3) in the present study is a slightly abbreviated version 
of a previously published peak list (175, 176).  This list is comprised of peaks characteristic of 
unique amino acid mass fragmentation patterns created from model extracellular matrix protein 
surfaces analyzed with ToF-SIMS (175). All PCA data is presented with 95% confidence 
intervals (176). 
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 Table 3. Positive Ion Fragment List for Multivariate Analysis with Amino Acids Adapted from 
Previous Work. (175, 176) Reprinted from (174) with permission from Elsevier. 
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Figure 12a shows principal component (PC) 1 vs. PC 2 for the non-cross-linked UBM, 
SIS, and LECM samples.  Distinct differences were observed between the LECM samples and 
the luminal and abluminal surfaces of UBM and SIS.  These differences were predominantly 
observed in PC 1, which accounted for 60% of the statistical separation of the total variance 
between all samples.  It was observed that the peaks at m/z 30.036 (CH4N), 59.048 (CH5N3), and 
68.068 (C4H6N) accounted for the majority of the loading on the LECM side of the PC 1 axis 
while peaks at m/z 72.088 (C4H10N), 115.059 (C4H7N2O2), and 117.074 (C5H9OS) accounted for 
the majority of the loading on the side of the PC 1 axis attributed to the UBM and SIS samples 
(Figure 12b).  
It was further observed that PC 2, which accounts for 18% of the total sample variance, 
was predominantly associated with differences between the luminal and abluminal surfaces of 
the UBM and SIS samples.  More specifically, clear sample separation is seen in Figure 12a 
between the abluminal and the luminal surfaces of UBM.  More overlap of the data in PC2 was 
observed in the luminal and abluminal surfaces of SIS than was observed for the UBM samples 
making clear differentiation of the peaks associated with each SIS surface difficult (Figure 12b). 
To better assess differences in the spectra taken from the luminal and abluminal sides of 
UBM, PCA was performed on ToF-SIMS data taken from only the luminal and abluminal sides 
of UBM (i.e. data from SIS or LECM was not included).  The scores and loadings for this 
comparison can be seen in Figure 13.  Only PC 1 is shown as PC 2 for the abluminal and luminal 
sides of UBM did not capture discernable trends in the data (Figure 13a).  It was observed that 
PC 1, which accounted for 47% of the total sample variance, was associated with differences 
between the luminal and abluminal surfaces of UBM.  Peaks at m/z 73.070 (C2H7N3), 115.059 
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(C4H7N2O2), and 117.074 (C5H9OS) were observed to account for the majority of the loading on 
the portion of the PC 1 axis associated with the luminal surface of UBM, while peaks at m/z 
44.052 (C2H6N), 55.020 (C3H3O), and 72.088 (C4H10N) accounted for the majority of the loading 
associated with the abluminal surface of UBM (Figure 13b). A similar analysis was performed 
for the abluminal and luminal surfaces of SIS; however, distinct peaks were not distinguishable 
due to overlap in the PCA data affiliated with the SIS surfaces (data not shown). 
For the analysis of the differences between the surfaces of cross-linked and non-cross-
linked UBM samples, spectra obtained from the CDI and GLUT treated UBM samples were 
compared to those obtained from the non-cross-linked samples used above.  Overlapping of the 
data was observed in the PCA analysis when performed on the luminal and abluminal surfaces of 
UBM, CDI-UBM, and GLUT-UBM together.  However, more distinct trends were observed 
when the luminal sides of UBM, CDI-UBM, and GLUT-UBM were examined separately.  The 
scores and loadings for this analysis are shown in Figure 14.   
In Figure 14a, separation associated with the non-cross-linked samples as compared to 
the two cross-linked samples can be observed.  PC 1, which captures 51% of the total variance, 
can be used to clearly differentiate the CDI cross-linked sample from the non-cross-linked 
sample while there is some overlap of the glutaraldehyde cross-linked sample with non-cross-
linked UBM surface.  In PC 2, which captures 30% of the variance, the samples are not 
statistically distinct, but the graphical locations of the 95% confidence intervals suggest that 
differences may exist and further characterization of these distinctions could be done in future 
work.  A similar analysis was performed on the abluminal sides of UBM, CDI-UBM, and 
GLUT-UBM, but the comparisons are not included as trends were difficult to extract due to 
overlapping loadings. 
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 Figure 12. Principal component scores and loadings for UBM, SIS, and LECM samples.  (A) PC1 vs. 
PC2 scores plot for the luminal surface of UBM (UL; circle), the abluminal surface of UBM (UA; diamond), 
the luminal surface of SIS (SL; cross), the abluminal surface of SIS (SA; asterisk), and the surface of LECM 
(LS; x).  All results are presented with 95% confidence interval (35).  (B)  Loadings for PC1.  (C)  Loadings 
for PC2.  Peaks with loadings greater than 0.1 are labeled with their respective ion. Reprinted from (174) 
with permission from Elsevier. 
  63 
 
 
 
 
 
 Figure 13. Principal component 1 scores and loadings for the luminal surface of UBM (UL; circle) 
and the abluminal surface of UBM (UA; x).  Only PC1 is presented.  All results are presented with 95% 
confidence interval (35).  (B)  Loadings for PC1.  Peaks with loadings greater than 0.1 are labeled with their 
respective ion. Reprinted from (174) with permission from Elsevier. 
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 Figure 14. Principal component scores and loadings for the luminal sides of UBM, UBM-CDI (ULxC) 
and UBM-GLUT (ULxG) samples.  (A) PC1 vs. PC2 scores plot for the luminal surface of UBM (circle), the 
luminal surface of UBM-GLUT (diamond), and the luminal surface of UBM-CDI (cross).  All results are 
presented with 95% confidence interval (35).  (B)  Loadings for PC1.  (C)  Loadings for PC2.  Peaks with 
loadings greater than 0.1 are labeled with their respective ion. Reprinted from (174) with permission from 
Elsevier. 
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2.3.1.3 Immunolabeling 
 
Positive staining for collagen IV (Figure 15) was observed in the vasculature of all of the 
scaffold materials examined in this study. For the UBM scaffold material, collagen IV staining 
was also localized at the surface of the tissue in a contiguous pattern consistent with the presence 
of a basement membrane complex. There was dense positive staining for collagen IV also noted 
near the surface of SIS consistent with the stratum compactum layer of this ECM.    Positive 
staining for laminin (Figure 16) was localized to the vasculature of all scaffold materials 
examined and in a contiguous pattern at the surface of UBM material. UBM was the only ECM 
that stained positive for collagen VII (Figure 17).  Positive staining for collagen VII in UBM was 
localized with the collagen IV and laminin on the luminal surface of the tissue, consistent with 
the presence of an intact basement membrane complex. 
 
 
 
  
 Figure 15. Immunoperoxidase staining showed the presence of collagen IV in UBM (A), SIS (B) and 
LECM (C) (40X).  Scale bar = 100 µm. Reprinted from (1) with permission from Liebert Publishing. 
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2.3.2 In Vitro Cell Behavior and Phenotype 
2.3.2.1 NIH 3T3 Fibroblasts and HMECs 
 NIH 3T3 cells invaded below the surface and extended into the underlying connective 
tissues when seeded on UBS, SIS and LECM and when seeded on the abluminal surface of 
UBM.  However, NIH 3T3 cells formed confluent layers on, but did not invade, the luminal 
 Figure 16. Immunoperoxidase staining showed the presence of laminin in UBM (A), SIS (B) and 
LECM (C) (40X). Scale bar = 100 µm. Reprinted from (1) with permission from Liebert Publishing. 
 
Figure 17. Immunoperoxidase staining showed the presence of collagen VII in UBM (A), SIS (B) and 
LECM (C) (40X). Scale bar = 100 µm. Reprinted from (1) with permission from Liebert Publishing. 
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(basement membrane containing) surface of the UBM. The same growth patterns were observed 
when either a concentration of 0.5 X 10^6 or 1 X 10^6 cells was used as the cell seeding density. 
The characteristic patterns of growth of NIH 3T3 when seeded on the abluminal and on the 
luminal surfaces of UBM as well as SIS and LECM scaffolds are illustrated in Figure 15. 
Patterns of cell growth for HMECs were the same as those listed above for NIH 3T3 fibroblasts.  
 
 
 
 
Figure 18. H&E staining of cell seeded UBM showing that NIH 3T3 cells (A) were not able to invade 
below the luminal surface of UBM, but were able to invade the abluminal side (B). Staining also showed that 
NIH 3T3 had an invasive pattern of growth when seeded on SIS (C) and LECM (D). Scale bar = 100 µm.  (40X). 
Reprinted from (1) with permission from Liebert Publishing. 
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2.3.2.2 Primary Rat Embryonic Spinal Cord Neurons 
 Approximately 90% of cells isolated from the spinal cord tissue of embryonic Sprague 
Dawley rat pups and grown on control coverslips were positively labeled for the neuron-specific 
cytoskeletal marker β-tubulin-III and were therefore classified as neurons (Figure 19).  
 
 Figure 19. Immunofluorescent staining of cells seeded on poly-L-lysine control coverslips after 5 days 
in culture. β-tubulin III (green), glial fibrillary acidic protein (GFAP) (red) and DAPI (blue). Scale bar = 100 
µm. Reprinted from (134) with permission from John Wiley and Sons. 
 
These same cells were seeded onto the luminal and abluminal surfaces of UBM.  Investigation 
by SEM showed that cells which were seeded onto the luminal side of UBM scaffolds were few 
in number and exhibited a rounded appearance with under developed cellular processes (Figure 
20).  Cellular debris was also observed.  Cells which were seeded onto the abluminal side of the 
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UBM scaffold were more numerous and were also observed to attach to the collagen fibrils of 
the UBM scaffold both at the surface and within collagen meshwork (Figure 21).  Cellular 
processes were observed both interacting with the collagen fibers of the ECM scaffold and 
spanning the spaces between fibers.   
 
 
 
 
 
 
 Figure 20.  SEM images of embryonic spinal cord neurons cultured on the luminal surface of UBM 
for 5 days.  (A = 700x, B = 6500x). 
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 Figure 21.  SEM images of embryonic spinal cord neurons culture on the abluminal surface of UBM 
for 5 days.  Arrowheads in image A denote the collagen fibers of the UBM scaffold.  Smaller arrows in image 
A denote cells attached to the scaffold material (700x).  Image B shows a higher magnification of the area 
denoted in image a by the white box (1700x).  Large arrowheads in image B denote cells growing beneath the 
surface of the scaffold and smaller arrows denote cellular processes spanning the collagen fibers of the UBM 
scaffold.  Image C shows cells growing within the UBM scaffold at high magnification (4300x).  Large arrows 
denote cellular processes interacting with the collagen fibers of the UBM scaffold and smaller arrows denote 
cellular processes spanning spaces within the scaffold.  Image D shows a high magnification example of cells 
growing on the outer fibers of the UBM scaffold.  Small arrows denote cellular processes spanning collagen 
fibers. 
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 To confirm that the cells and corresponding cell processes attached to the abluminal 
surface of the UBM scaffold were neurons, sections were labeled for β-tubulin-III and glial 
marker GFAP. Cells seeded on the scaffold surface stained positive for both cytoskeletal markers 
(β-tubulin-III and GFAP; Figure 23).  
 
 
 Figure 22. Immunofluorescent images of cells seeded on the abluminal surface of the UBM scaffolds 
(A and C).   Immunofluorescent images of seeded sections stained with secondary antibodies only (B and D, 
inset). Arrows indicate cellular processes seen spanning pores of the ECM scaffold material.  β-tubulin III 
(green), glial fibrillary acidic protein (GFAP) (red) and DAPI (blue).  Scale bars = 50 μm. (40X) 
2.4 DISCUSSION 
In tissue engineering and regenerative medicine applications, the cells that participate in 
the processes of tissue reconstruction require “instruction” for proliferation, morphogenesis, and 
differentiation.  The sources of this “instruction” are the cellular microenvironment and the 
scaffold or matrix surfaces with which these cells interact.  Factors known to influence the 
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outcome of cell-scaffold interactions include surface topography (18, 177-180), 
hydrophilicity/hydrophobicity (181-184), ligand presence and presentation (58, 185-189), and 
mechanical properties (190-194), among others.  Further, the success of a given cell-scaffold 
combination may be highly dependant on the type of cell being examined.  Therefore, it is 
essential to characterize and to consider the surface of a scaffold as well as its effects upon cell 
phenotype when designing a strategy to facilitate the reconstruction of complex three-
dimensional tissues and organs.  
Scaffolds composed of single purified ECM components as well as scaffolds composed 
of intact ECM have been investigated in a large number of in vitro and in vivo tissue engineering 
and regenerative medicine applications with varying degrees of success.  The advantage of using 
intact acellular ECM as a scaffold for cell growth or reconstructive tissue remodeling as opposed 
to the individual components of the ECM includes the presence of all the ECM constituents in 
the same relative amounts as exist in nature and in an ultrastructure similar to that of native 
ECM. It remains unclear, however, whether the molecular composition or the ultrastructure of 
these scaffolds plays a greater role in determining the outcome of the interaction of cells with the 
scaffold material.  Likely, it is the diverse combination of both the structural and the functional 
components present within ECM scaffolds that accounts for the success of ECM based materials 
in multiple organ systems. 
The studies presented here examined the ultrastructural and compositional characteristics 
of the surfaces of porcine ECM scaffolds harvested from three different anatomical locations: (1) 
urinary bladder, (2) small intestine, and (3) liver.  SEM showed that the ECM derived from each 
of the three anatomical locations possessed a distinct ultrastructure.  Further evaluation of these 
same scaffolds using ToF-SIMS showed that that UBM and SIS had more similar surface 
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compositions when compared to each other than when compared to LECM.  There is evidence 
that these differences, which appear to be related to the tissue source from which an ECM 
scaffold is derived, may play a role in modulating or maintaining the phenotype of cells that have 
been seeded into the matrix (1, 41, 163, 195).  A recent study investigated the ability of the same 
three porcine derived ECM scaffolds that were used in the present study to maintain the 
phenotype of a hepatic sinusoidal endothelial cell population during in vitro cell culture (163).  
The results showed that the LECM scaffolds were capable of maintaining the specialized 
endothelial cell phenotype in culture both to a greater degree and for a longer duration than were 
the UBM or SIS scaffolds. 
In the present study, it was also observed that certain ECM scaffolds (UBM and SIS) 
exhibited distinct ultrastructural differences depending on the sidedness (i.e. luminal versus 
abluminal) of the scaffold while others exhibited an ultrastructure that was more homogeneous 
throughout (LECM).  Evaluation of the scaffolds by ToF-SIMS showed that UBM exhibited 
significant differences in the composition of the luminal and abluminal surfaces, while SIS 
exhibited overlapping composition of the luminal and abluminal surfaces.   
These results parallel the results of the immunolabeling studies which showed that UBM, 
but not SIS or LECM, scaffolds possessed an intact basement membrane on its luminal surface, 
although all three of the scaffolds evaluated did show basement membrane proteins present at 
sites where vascular structures existed beneath the surface of the materials. The presence of the 
surface basement membrane on UBM prevented both HMEC and NIH 3T3 fibroblasts from 
invading the luminal side of the UBM scaffold and this basement membrane served as a 
substrate for confluent layered growth of these cells.  Differences in the behavior of primary 
spinal cord neurons seeded onto either the luminal or abluminal sides of UBM scaffolds were 
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also observed.  Those cells which were seeded on the luminal side displayed a rounded 
morphology and did not extend cellular processes while those cells which were seeded onto the 
abluminal side were more numerous and extended numerous cellular processes.  It is unknown 
whether the differences observed were due to differences in the molecular composition or the 
ultrastructure of the surface, both of which are well known to play a role the maintenance of 
neuronal cell phenotype. 
Chemical cross-linking is a process commonly used in the production of ECM scaffolds 
to slow or prevent degradation of the resultant scaffold, to inhibit the recognition of surface 
epitope by the host, and to provide improved mechanical properties for load bearing applications.  
The present study examined the effects of chemical cross-linking upon the surface characteristics 
of the urinary bladder derived extracellular matrix scaffold.  It was observed that chemical cross-
linking caused changes in the ultrastructure of both the luminal and abluminal sides of UBM. 
However, chemical cross-linking appeared to cause only minimal changes in the molecular 
composition of the scaffold surface as observed by ToF-SIMS.  It is logical to assume that cross-
linking may alter the presentation and conformation of ligands on the surface of an ECM 
scaffold, thus altering ligand-receptor interactions which may be important in determining the 
outcome of cell-scaffold interactions; however, it was not possible to fully assess these changes 
in the present study.  Further characterization of the surface of cross-linked ECM scaffolds by 
ToF-SIMS and other methods may provide insights into the effects of cross-linking upon the 
cellular response.  The in vivo response to non-cross-linked and carbodiimide cross-linked ECM 
scaffolds is examined in the section which follows. 
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The studies presented in the following sections of this dissertation will examine the 
effects of cross-linking upon the host tissue remodeling and macrophage responses to ECM 
scaffolds following implantation. 
2.5 CONCLUSIONS 
The results of the present study demonstrated that each surface of an ECM scaffold is associated 
with distinct ultrastructural and compositional characteristics and that these surface 
characteristics are dependant on both the anatomic location from which the material is derived as 
well as the methods used in its production (i.e. decellularization and chemical cross-linking).  
These characteristics were shown to affect patterns of in vitro cell behavior.  It is likely that a 
complex combination of the structural and functional components of the ECM scaffolds 
investigated was responsible for the cellular behavior observed.  The effects of chemical cross-
linking upon the in vivo response to ECM scaffolds will be further investigated in the sections 
which follow. 
It was also demonstrated that ToF-SIMS is a highly sensitive method for the detection 
and differentiation of the molecular composition of the outermost surface of an ECM scaffold.  
Further, ToF-SIMS may represent a method for future identification of previously unknown 
surface species as well as for the prediction of cell-scaffold interactions and subsequent 
remodeling events. Finally, the richness of molecular detail in the ToF-SIMS spectra suggests 
that ToF-SIMS may be useful for quality control of commercialized ECM-based regenerative 
scaffold products and for standardization of these scaffolds. 
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2.6 LIMITATIONS AND FUTURE DIRECTIONS 
ToF-SIMS as a tool for studying the surface of protein based materials is recent concept, and the 
present study represents the first attempt to use ToF-SIMS as a tool for compositional analysis 
and differentiation of the surfaces of highly complex ECM based scaffolds.  In the present study, 
ToF-SIMS was capable of identifying differences in the compositions of the various surfaces 
investigated and the results obtained paralleled those of obtained in the immunolabeling studies.  
There are, however, a number of limitations in the application of ToF-SIMS to the analysis of the 
surface of a biologically derived material. 
Due to the inherent mass range limitation of ToF-SIMS, it is not possible to assess whole 
proteins or peptide sequences.  Rather, the method relies on analysis of mass fragmentation 
patterns.  Previous studies have shown successful correlations between such fragmentation 
patterns and protein surfaces (175, 176).  In one such study, known amino acid mass 
fragmentation patterns generated from ToF-SIMS were compared to the mass spectra obtained 
for extracellular matrix proteins remaining on a polyNIPAM surface following the removal of 
cultured bovine aortic endothelial cells.  The mass spectra obtained for single purified ECM 
components adsorbed onto the polyNIPAM surface were the reference spectra for the present 
study (175).  The results showed that ToF-SIMS was capable of detecting protein fragment 
fingerprints for laminin, fibronectin, and collagen within the film remaining on the culture 
surface by comparing the protein remnants to single protein film controls.  A slightly variant 
version of this peak list was utilized for this study (Table 3).   
In the present study, the complexity of the surfaces makes it difficult to report a one-to-
one correlation between fragment and implied protein association.  Therefore, it is likely more 
useful to report the data obtained as a list of prominent fragments as opposed to suggesting that 
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the fragments indicate specific proteins.  The complicated surface milieu of these materials and 
the relative lack of data on specific fragmentation patterns of many purified ECM components 
justify this approach.  On the other hand, this approach suggests that identification of unknown 
molecules may be achievable.  This possibility for the unique identification of surface structures 
and features was part of the original hypothesis that was the impetus for this study. Traditional 
antibody-based immunolabeling requires prior knowledge of the surface proteins as a 
prerequisite for their identification.  In the present approach, the potential to identify molecules 
both expected and unexpected exists, aiding in the creation of a unique picture of the material 
surface chemistry and functionality on a molecular level.   
In addition to using amino acid mass fragmentation peaks identified in the studies 
relating ToF-SIMS spectra to protein films, spectra taken from the surfaces in this study were 
cross-examined with previously published lipid peak lists (196).  The identification of large 
peaks at m/z 166.06, 184.07, and 224.11 in the spectra for SIS and UBM as well as cross-linked 
UBM indicates lipid structures and likely cell membrane components.  Interestingly, these peaks 
were not observed to the same extent in the LECM scaffolds.  This may be due to the different 
methods used for the decellularization of the SIS/UBM and LECM in this study.  The existence 
of peaks found in the high mass region was not limited to the large peaks mentioned above.  Low 
intensity lipid peaks were identified throughout the high mass region that matched previously 
published lipid work.  However, the focus of this work was to create a fingerprint of the protein 
remnants and future work will be necessary to more completely characterize the lipid fragments 
observed here.   
Finally, it should be noted that the studies presented here are a continuation of several 
studies intended to characterize the surfaces of ECM scaffolds and their effects upon cell 
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phenotype (1, 68, 163, 195).  The present studies sought only to characterize the ultrastructure 
and molecular composition of the surfaces of ECM scaffolds.  Further work will be required 
relate the data shown here to cell behavior both in vitro and in vivo.  Previous studies have used 
methods such as partial least squares regression to relate data to subsequent in vitro cell culture 
observations (197).  Similar studies could be performed to compare the present data to the 
morphologic or phenotypic profiles of cells cultured on ECM scaffolds or following in vivo 
implantation. 
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3.0  SPECIFIC AIM 2: EFFECTS OF CELLULAR COMPONENTS AND CROSS-
LINKING UPON THE CAPACITY OF AN EXTRACELLULAR MATRIX SCAFFOLD 
TO PROMOTE CONSTRUCTIVE TISSUE REMODELING 
3.1 BACKGROUND 
The success of ECM scaffolds in tissue engineering and regenerative medicine 
applications may be attributed in large part to their ability to modulate the default mechanisms of 
tissue repair.  In general, the response following implantation of an acellular non-chemically 
cross-linked ECM scaffold has been described as “constructive tissue remodeling”.  That is, 
ECM scaffolds are capable of inducing the formation of new tissue structures that are arranged in 
a spatially appropriate pattern for the tissue of interest.  This is in direct contrast to the default 
mechanisms of mammalian response to tissue injury, which involve inflammation and scarring.  
An example of an application in which constructive tissue remodeling was observed following 
implantation of an ECM scaffold material is provided in detail in Appendix A of this 
dissertation.  Briefly, an acellular non-cross-linked ECM scaffold composed of UBM was used 
to reconstruct the temporomandibular joint meniscus following either unilateral or bilateral 
meniscectomy in a canine model.  The scaffold material was seen to degrade rapidly and was 
replaced by new tissue which both grossly and microscopically resembled the native meniscus.  
The remodeled tissue consisted not only of the fibrocartilaginous tissue and scant vasculature 
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which comprise the bulk of the meniscus, but also the muscular attachments at the periphery of 
the meniscus.  These results show that a single ECM scaffold composed only of UBM was able 
to promote the formation of multiple tissue types including fibrocartilage, muscle, connective 
tissue, and vasculature, which were arranged into an appropriate tissue specific architecture.  
Biomechanical and biochemical testing was performed on the remodeled tissues, showing that 
both the composition and the mechanical properties of the remodeled tissue were approaching 
that of native tissue.   
ECM scaffolds such as the ones described above, and such as those used in the studies 
presented in this dissertation, are produced by the removal of cellular components (i.e. 
decellularization) prior to their use in tissue engineering and regenerative medicine applications 
(67).  The removal of the cellular component provides a substrate which is ostensibly free of 
antigenic cellular epitope, leaving only ECM components which have been shown to be highly 
conserved across species (7).  However, a number of studies have shown that potentially 
antigenic substances such as the α-Gal epitope and DNA remain in ECM scaffolds following the 
decellularization process (95, 198).  The presence of these molecules in small quantities, 
however, does not appear to affect the ability of ECM scaffolds to promote constructive tissue 
remodeling (92, 199). The effects of larger quantities of cellular components remaining within an 
ECM scaffold and the effects of viable cells upon the remodeling outcome associated with their 
use is unclear.  Some studies have shown improved tissue remodeling outcomes when site 
appropriate autologous cells are either seeded onto the ECM scaffold prior to implantation or 
placed in contact with the scaffold in-situ (27, 31, 39).  However, the survival and fate of such a 
cellular component during the remodeling process and the effects of cell death upon the tissue 
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remodeling response following in vivo implantation is largely unknown and remains an 
important question in the fields of tissue engineering and regenerative medicine as a whole. 
A number of studies have utilized chemical cross-linking during the processing and 
production of ECM based scaffold materials as a method to mask cellular epitope which may 
remain within a scaffold material, either due to the use of intact (i.e. not decellularized) tissues or 
due to inefficient decellularization.  While chemical cross-linking may mask cellular epitope 
present at the surface of the scaffold material, its effects upon the ability of the material to 
function in the long-term have not always been positive (69). Other strategies utilize cross-
linking in applications where increased mechanical properties or slowed degradation of the 
scaffold material is desirable.  While the use of cross-linking does serve a purpose in some 
applications (i.e those requiring the scaffold to remain without degradation or loss of mechanical 
properties over long periods of time), it was shown in the previous chapter that cross-linking 
causes changes in scaffold architecture and surface composition which may affect the host 
remodeling response following implantation. 
The objectives of the studies presented in this section were two fold: (1) to determine the 
effects of the presence of a cellular component and the use of carbodiimide cross-linking during 
scaffold production upon the capacity of extracellular matrix scaffolds to elicit constructive 
tissue remodeling versus encapsulation or scar tissue formation in a well described model of rat 
abdominal wall musculature reconstruction, and (2) to determine whether the host tissue 
remodeling response to one ECM scaffold material affects the outcome of the host tissue 
remodeling response to a second material implanted concurrently in the same animal. 
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3.2 METHODS 
3.2.1 Overview 
The present studies were split into two separate in vivo studies.  In the first study, a unilateral 
model of rat abdominal wall defect repair was used to evaluate the effects of the presence of 
viable intact cells or cellular components within a test article upon its ability to promote 
constructive tissue remodeling.  A qualitative histomorphologic analysis was performed, as was 
immunolabeling for evidence of innervation within the remodeled tissue.  In the second study, a 
bilateral model of rat abdominal wall defect repair was used to evaluate the effects of chemical 
cross-linking with carbodiimide upon the ability of an ECM test article to promote constructive 
tissue remodeling.  The use of a bilateral defect model also allowed for the comparison of 
remodeling responses when two different test articles were implanted concurrently within the 
same animal.  In the second study, a qualitative histomorphologic analysis was again performed.  
Staining with Herovici’s Polychrome was also performed in order to evaluate the type and 
maturity of the collagen within the remodeling site to assess differences the quality of the tissue 
being deposited following implantation of each test article.  Finally, quantitative real time PCR 
was performed to examine the expression of four matrix metalloproteinases (MMP 2, 3, 7, and 
9), to examine differences in the remodeling process associated with each test article. 
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3.2.2 Preparation of Extracellular Matrix Scaffolds 
3.2.2.1 Rat Body Wall Muscle Extracellular Matrix 
 The rat body wall tissue for this study was harvested from Sprague-Dawley rats of 
approximately 200-500g immediately following sacrifice and frozen at -80 ºC.  The tissue 
consisted of all three muscle layers of the ventral abdominal wall without the overlying skin.  
The body wall tissue was thawed in PBS at room temperature before being placed in 0.02% 
trypsin/0.05% EDTA at room temperature for 2 h on a shaker.  Following soaking in 
trypsin/EDTA, the body wall tissue was washed in PBS on a shaker for 1 h.  The body wall 
tissue was then placed in 3% (v/v) Triton X-100  at room temperature on an orbital shaker for 2 
h.  The Triton X-100 treated samples were then washed in water.  Following the water wash, the 
body wall tissue was placed in 4% (w/v) deoxycholic acid for 2 h at room temperature on an 
orbital shaker and then washed in water.  The tissue was then treated with a 0.1% peracetic 
acid/4% ethanol solution for 2 h at room temperature on a shaker to further decellularize and 
disinfect the tissue.  The peracetic acid solution was decanted and the pH of the material was 
returned to approximately 7.4 by rinsing in PBS at room temperature, with shaking, then in water 
twice, and then again in PBS. Each rinse lasted 15 min. The remaining tissue consisted of 
acellular allogeneic rat body wall ECM (rat body wall ECM).  The absence of cell nuclei in this 
test article was confirmed by DAPI staining (Figure 23a).  
The rats used in this study were an outbred strain.  As the tissue for the rat body wall 
ECM was both harvested and implanted into the same outbred rat strain, the intra-strain 
transplants performed in this study were indeed allografts and cannot be considered isografts. 
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3.2.2.2 Cellular and Acellular Urinary Bladder Matrix 
 The porcine bladders for this study were harvested and prepared using methods 
previously described.  The urinary bladders were harvested from market weight pigs of 
approximately 260 pounds immediately following sacrifice. Two different constructs were 
prepared from the urinary bladder: 1) cellular xenogeneic bladder tissue, and 2) and acellular 
xenogeneic bladder ECM. 
Excess adipose tissue and collagenous connective tissue were removed from the exterior 
of the bladder using scissors and the urothelial cells were removed by soaking the bladder tissue 
in water. The apex of the bladder was then removed and a full thickness cut from the neck of the 
bladder to the apical opening was made to create a rectangular-shaped sheet. The tunica serosa, 
tunica muscularis externa, tunica submucosa, and the majority of the muscularis mucosa were 
removed by mechanical delamination of the abluminal side of the bladder, leaving the basement 
membrane, tunica propria, and the resident cells intact.  The remaining tissue was soaked in PBS 
and represented cellular urinary bladder matrix (cUBM). 
A portion of the cellular urinary bladder matrix prepared as described above was 
subjected to the 0.1% peracetic acid/4% ethanol treatment as described for the acellular allograft.  
The peracetic acid treated material consisted of only the basement membrane and tunica propria 
without the resident cells and represented acellular urinary bladder matrix (UBM).  The presence 
or absence of cell nuclei in the cUBM and UBM test articles was confirmed by DAPI staining 
(Figure 23b and 23c). 
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 Figure 23. DAPI staining confirms removal of cell nuclei in the rat body wall ECM (A), maintenance of cell 
nuclei in the cUBM (B), and removal of cell nuclei in the UBM (C).  The cellular autograft test article is not shown as it 
was replaced immediately following defect creation in the sterile setting of the operating room.  Scale bar = 100 µm  
(20X).  Reproduced from (100) with permission from Elsevier. 
3.2.2.3 Preparation of Four Layer Constructs 
 Single sheets of the cUBM and UBM tissue had insufficient strength to serve as a body 
wall replacement device in the rat model.  Therefore, multilaminate (4-layer) sheets were 
constructed.  In brief, four hydrated sheets of either the cUBM or the UBM were placed on top of 
one another, each at 90° orientations to the adjacent layers to create a device with isotropic 
mechanical properties.  The constructs were then placed into plastic pouches and attached to a 
vacuum pump (Leybold, Export, PA) with a condensate trap inline. The constructs were 
subjected to a vacuum of 28 inches Hg until dried, leaving a multilaminate construct. 
3.2.2.4 Chemical Cross-linking 
 Four-layer scaffolds composed of UBM were cross-linked by immersion in solutions of 
carbodiimide (10 mM; CDI-UBM) for 8-10 hours at room temperature. The cross-linked 
scaffolds were then subjected to three separate 1 hour water washes as well as an overnight water 
wash to remove any residual cross-linking solution that may have remained following the cross-
linking process. 
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3.2.2.5 Terminal Sterilization 
 The rat body wall ECM, cUBM, UBM, and CDI-UBM were terminally sterilized using 
ethylene oxide gas.  The cellular autografts required no terminal sterilization as they were 
harvested in sterile fashion and replaced during the surgical procedure. 
3.2.3 Rat Abdominal Wall Defect Model 
Female Sprague-Dawley rats, age 8-12 weeks, were purchased from Charles River Laboratories 
(Wilmington, MA).  The rats were housed individually in shoebox cages. Room temperature was 
maintained at 68-76 ºC and the rats were fed Purina Iso Pro throughout the study period.  Cage 
bedding was changed at least once per week. All animals were examined by a veterinarian prior 
to surgery and were determined to be in good health. 
3.2.3.1 Unilateral Defect Surgical Procedure 
 Sixty-four Sprague-Dawley rats were randomly divided into four separate groups of 
sixteen each.  Each rat was subjected to the surgical procedure listed below and one of the four 
test articles listed in Table 4 was implanted in each animal.  The treatment groups were the 
subdivided into four groups of four each that were sacrificed and explanted at 3, 7, 14, or 28 days 
post surgery (n=5 for each test article at each time point). 
A previously described abdominal wall defect model was used (69, 82).  Each rat was 
anesthetized and maintained at a surgical plane of anesthesia with 2% isoflurane in oxygen. The 
surgical site was prepared in sterile fashion using a betadine (providone-iodine) solution 
followed by placement of sterile drapes. A ventral midline incision was made and the adjacent 
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subcutis bluntly dissected to expose the ventral lateral abdominal wall including the 
musculotendinous junction of the oblique musculature. 
 A 1 cm x 1 cm defect was created in the exposed musculature, leaving the underlying 
peritoneum and transversalus fascia and the overlying skin intact.  The defects were then 
repaired with one of the test articles listed in Table 4.  The autologous tissue test article was 
harvested from the defect site and then replaced immediately thereafter in the sterile setting of 
the operating room.  Each implant was sutured to the adjacent abdominal wall with 4-0 Prolene 
non-absorbable suture at each corner to secure the test article and to allow for identification of 
the device boundaries at the time of euthanasia and explantation.  A minimal amount of suture 
material was used to avoid eliciting a host response to the suture that would obscure the host 
response to the test article.  The skin was closed using absorbable 4-0 Vicryl suture.  The animals 
were recovered from anesthesia on a heating pad and allowed normal activity and diet for the 
remainder of the study period 
Each rat received Buprinex (buprenorphine hydrochloride, 0.02 mg) postoperatively as 
needed for discomfort as evidenced by failure to eat, drink, or resume normal activity.  
Gentamicin was given subcutaneously (2 mg) postoperatively and once daily for an additional 
three days.  The animals were monitored daily for signs of infection or inflammation at the 
surgical site.  All animals survived the surgical procedure and their predetermined study period 
without complications. 
An example of a device following placement in the unilateral body wall defect model is 
provided in Figure 24a. 
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 Table 4.  Test articles implanted in the unilateral body wall defect model. 
Test Article Composition Graft Origin 
Autologous Rat Body Wall Autologous ECM + Autologous Cells Rat Body Wall 
Rat Body Wall ECM Allogenic ECM without cells Rat Body Wall 
Cellular UBM Xenogeneic ECM + Xenogeneic Cells Porcine Urinary Bladder 
Acellular UBM Xenogeneic ECM without cells Porcine Urinary Bladder 
 
3.2.3.2 Bilateral Defect Surgical Procedure 
 Thirty Sprague-Dawley rats were randomly divided into three separate groups of 10 each.  
Each rat was subjected to the surgical procedure listed below and two of the three test articles 
listed in Table 5 were implanted in each animal, one on each side of the ventral midline.  The 
treatment groups were the subdivided into five groups of two each that were sacrificed and 
explanted at 1, 3, 7, 14, or 28 days post surgery (n=2 for each combination of test articles and 
n=4 for each individual test article at each time point). 
The surgical procedure used to create the bilateral defect utilized in the present study was 
similar to the procedure described above, except that two incisions were made either side of the 
ventral midline.  Two defects of the abdominal wall musculature were then created beneath the 
incisions on either side of the ventral midline as described above.  The defects encompassed of 
the same tissue structures described above (removal of the internal and external oblique muscles) 
and were repaired using the same procedure as described for the bilateral model.  Defects in the 
bilateral rat body wall model were repaired with combinations of the three test articles listed in 
Table 5.  Post-surgical care was the same as described above for the unilateral defect model. 
All animals survived the surgical procedure and the post surgical study period with no 
complications. 
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An example of two devices inserted in the bilateral body wall defect model is given in 
Figure 24b. 
 
 Table 5.  Test articles implanted in the bilateral body wall defect model. 
Test Article Composition Graft Origin 
Autologous Rat Body Wall Autologous ECM + Autologous Cells Rat Body Wall 
Acellular UBM Xenogeneic ECM without cells Porcine Urinary Bladder 
Cross-linked Acellular UBM Xenogeneic ECM without cells + Carbodiimide Porcine Urinary Bladder 
 
 
Figure 24.  Photomicrographs of the unilateral (A) and bilateral (B) surgical defect models.    
3.2.4 Characterization of the Host Tissue Remodeling Response 
3.2.4.1 Sample Collection 
 On the predetermined sacrifice date, each animal was anesthetized using isoflurane (5% 
in oxygen) and then euthanized by intracardiac injection of potassium chloride to induce cardiac 
arrest.  The grafts were explanted with a small amount (approximately 2 mm) of the surrounding 
native tissue.  Tissue was fixed in 10% neutral buffered formalin and then embedded in paraffin.  
The other half of each specimen was preserved in RNAlater for RNA extraction. 
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3.2.4.2 Histologic Staining 
The explanted wound site specimens were fixed in formalin and embedded in paraffin 
prior to being cut into 6 µm thick sections and mounted on glass slides.  The specimens were 
deparaffinized with xylenes followed by exposure to a graded series of ethanol solutions (100-
70%).  Sections were stained with Masson’s trichrome (unilateral defect model) or H&E 
(bilateral defect model) for morphological assessment.  Selected slides from the bilateral defect 
model were also stained with Herovici’s Polychrome stain, a stain which allows for 
differentiation of newly synthesized (type III) and mature collagen (type I).  The slides were then 
dehydrated using the reverse of the deparaffinization treatment described above prior to 
coverslipping. 
A qualitative analysis of the histological morphology of each specimen was performed by 
a pathologist and a trained investigator.  The analysis included an assessment of the intensity and 
type of cellular infiltration, the presence and extent of vascularity, and the organization of host 
tissue within and around the wound site.  The suture sites were avoided in the morphologic 
evaluation. 
3.2.4.3 Immunolabeling for Evidence of Innervation 
 Paraffin-embedded specimens from the unilateral defect study studies were cut into 6 μm 
thick sections and mounted onto glass slides. The specimens were deparaffinized by treatment 
with xylenes and exposure to a graded series of ethanol solutions (100–70%). Following 
deparaffinization, the slides were placed in citrate antigen retrieval buffer (10 mM citric acid 
monohydrate, pH 6.0) at 95 – 100 ◦ C for 20 min. The buffer was allowed to cool to room 
temperature on ice and the slides were washed twice in Tris-buffered saline/Tween 20 solution, 
pH 7.4, and twice in PBS. The sections were then incubated in 2% normal horse serum  for 1 h at 
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room temperature in a humidified chamber to inhibit non-specific binding of the primary 
antibody. Following incubation in blocking serum, the sections were incubated in primary 
antibody in a humidified chamber at 4°C overnight. Each tissue specimen was exposed to 
antibodies to the light chain of neurofilament, to a marker that localizes to the growth cones of 
regenerating neurons (GAP43) or to a marker that is known to localize to Schwann cells in the 
peripheral nervous system following injury (GFAP). Following overnight incubation, the slides 
were washed three times in PBS. The sections were then incubated in a solution of 3% H2O2 in 
methanol for 30 min at room temperature to quench any endogenous peroxidase activity. 
Following H2O2 treatment, the slides were washed three times in PBS and incubated in 
secondary antibody for 30 min in a humidified chamber at room temperature prior to three more 
washes in PBS. The sections were then incubated in Vectastain ABC  reagent for 30 min in a 
humidified 37°C chamber, rinsed three times in PBS and incubated in 4% DAB substrate 
solution at room temperature until the slides showed the desired staining affinity. Finally, the 
slides were rinsed in water to stop the development of the DAB substrate and counterstained 
using Harris’s acidified hematoxylin stain. The slides were then dehydrated using the reverse of 
the deparaffinization treatment described above and then coverslipped. Each PBS rinse in the 
protocol was for 3 minutes at room temperature, with occasional agitation. 
Anti-neurofilament antibody was used at a concentration of 1:100. Anti-GAP43 was used 
at a concentration of 1:250.  Anti-GFAP antibody was used at a concentration of 1:500.  
Corresponding secondary antibodies were used at a concentration of 1:100  for biotinylated anti-
mouse IgG and 1:200 for biotinylated anti-rabbit IgG (PK-4001, Vector Labs). All antibodies 
were diluted in filtered PBS, pH 7.4. Native rat abdominal wall was used as positive control 
tissue samples for staining. 
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3.2.4.4 Quantitative Real Time Polymerase Chain Reaction 
 Total RNA was isolated from the explanted tissues from the bilateral defect model using 
TRI-Reagent according to the manufacturer’s instructions.  The isolated RNA was then purified 
using an RNAeasy Mini Kit and a vacuum system.  cDNA was synthesized from 1 μg of total 
RNA in a volume of 20 µL using a iScript cDNA synthesis kit according to the manufacturer’s 
instructions.   
Quantitative real-time PCR was then performed using primers specific for four different 
MMPs (MMP2, 3, 7, 9).  Primers were custom designed using Primer-BLAST (NCBI, 
http://www.ncbi.nlm.nih.gov/tools/primer-blast/; Table 6).  Primers for housekeeping genes were 
purchased as part of a housekeeping gene primer kit, and housekeeping gene expression was 
used to normalize reactions.  1 µL of cDNA was mixed with the appropriate primers and 2X 
SYBR Green Master Mix in a total volume of 25 µL.  All reactions were performed in triplicate 
and were monitored using an iQ5 Real-Time Detection System.  
Relative expression of the MMP genes as compared to the housekeeping gene was 
calculated using the 2-(∆Ct) method (200, 201).  The difference between the value of the threshold 
cycle (∆Ct) for the gene of interest (GOI) and the value of the threshold cycle for the 
housekeeping gene (HSKG) was calculated for each specimen as follows: 
 
 
∆CtGOI = CtGOI − CtHSKG  
 
Fold increase or decrease in gene expression compared to native abdominal wall muscle 
for each sample type was then calculated using the following equation: 
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Fold Expression =
Mean ∆CtGOI Sample
Mean ∆CtGOI Native
 
 
Table 6.  Primers used for MMP gene expression analysis of bilateral body wall samples. 
Gene Forward Primer (5' -> 3') Reverse Primer (5' -> 3') 
MMP2 AAGAGGCCTGGTTACCCTGT AAGTAGCACCTGGGAGGGAT 
MMP3 ACCCCACTCACATTCTCCAG ATGAGCCAAGACCATTCCAG 
MMP7 CGGAGATGCTCACTTTGACA TGGGAACAGAAGAGTGACCC 
MMP9 TAATAAACACGGATCCCCCA GGTCAGAACCGACCCTACAA 
3.2.5 Statistical Methods 
A two way analysis of variance was performed on the gene expression data obtained as part of 
the bilateral defect model to determine statistical significance of the factors of type of scaffold 
(autograft, CDI-UBM, and UBM) and the factor of days (1, 3, 7, 14, and 28 days).  For the gene 
expression analysis, the variables analyzed were MMP2, 3, 7, and 9 expression.  Because the 
distributions of these variables were strongly skewed, log-transformed values were used for the 
statistical analysis and results were transformed back to the original scale for presentation.  This 
transformation corresponds to using geometric means in place of arithmetic means.  The Tukey 
multiple comparison procedure was then employed to determine which pairs of levels of factors 
were significantly different when a main effect was statistically significant.  Additional student’s 
t-tests were used to determine whether there were statistically significant differences within 
scaffold groups which were related to the contralateral implant.  A p-value of p<0.05 was used to 
determine statistical significance. 
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3.3 RESULTS 
3.3.1 Unilateral Defect Model 
3.3.1.1 Histopathologic Findings 
 The host response to the autologous body wall tissue test article showed necrosis of the 
skeletal muscle which was apparent as early as the three day post surgery time point.  
Neutrophils and mononuclear cells were present within the wound site at day 3 and showed a 
marked increase in number at 7 days post surgery (Figure 25a).   By day 14, the cell population 
was decreased in number, the necrotic muscle fibers were decreased in size, and there was 
deposition of neomatrix at the site of remodeling.  By day 28, dense partially organized 
connective tissue consistent with scar tissue and a small population of randomly distributed 
mononuclear cells were present within the remodeled site (Figure 25b). 
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Figure 25. (A) Histologic appearance of the autograft tissue test article at 7 days post surgery.  Necrotic skeletal 
muscle (brackets), early neomatrix deposition (arrows), neutrophils, and macrophages were present.  (B) Histologic 
appearance of the autograft tissue test article at 28 days post surgery.  Autograft muscle tissue has been completely 
resorbed and replaced by dense poorly organized connective tissue (bracket), adipose tissue (arrows), and a small number 
of randomly distributed macrophages.  Red staining tissue bundles at the bottom of the images represent the underlying 
transversalis muscle.  Scale bar = 100 µm. (Masson’s Trichrome, 20X).  Reproduced from (100) with permission from 
Elsevier. 
 
The host response to the acellular allogeneic rat body ECM test article was characterized 
by a dense cellular infiltrate of equal numbers of neutrophils and mononuclear cells at day 3.  
Angiogenesis was also observed at 3 days post surgery and remained a feature of the remodeling 
wound site throughout the study period. The cellular infiltrate increased in number and was 
primarily composed of mononuclear cells on day 7 accompanied by a small amount of neomatrix 
deposition, especially at the periphery of the implant (Figure 26a).  By day 14, the rat body wall 
ECM material was still discernable, but was diffusely and uniformly infiltrated with host 
mononuclear cells that were embedded within new ECM.  By day 28, the rat body wall ECM 
material was no longer visible and was replaced by moderately well organized collagenous and 
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adipose tissue containing blood vessels, a small number of randomly dispersed mononuclear 
cells, and small islands of skeletal myoblasts growing in from the periphery (Figure 26b). 
 
Figure 26.  (A) Histologic appearance of the rat body wall ECM at 7 days post-surgery.  A dense cell population 
consisting of primarily macrophages was present.  New blood vessels (asterisks) and neo-matrix (blue staining) deposition 
were also present.  (B) Histologic appearance of the rat body wall ECM at 28 days post surgery.  The rat body wall ECM 
was no longer discernable and was replaced by moderately well organized collagenous tissue, containing blood vessels 
(asterisks), islands of skeletal myoblasts (arrows) and a small number of randomly distributed mononuclear cells.  Red 
staining tissue bundles at the bottom of the images represent the underlying transversalis muscle. Scale bar = 100 µm. 
(Masson’s Trichrome, 20X).  Reproduced from (100) with permission from Elsevier. 
 
The host response to the cellular xenogeneic cUBM test article was characterized by a 
dense accumulation of neutrophils with a lesser number of mononuclear cells at day 3.  
Maximum cellularity occurred at 7 days (Figure 27a) with extension of the inflammatory 
response into the surrounding normal tissue.  The multilaminate device was still visible at day 14 
and neomatrix could be identified.  The cellular infiltrate at day 14 was characterized by a 
mixture of mononuclear cells and a lesser number of neutrophils.  By day 28, the implant was no 
longer visible, and there was an accumulation of dense, poorly organized collagenous connective 
tissue and a small amount of adipose tissue including a randomly distributed population of 
mononuclear cells (Figure 27b). 
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Figure 27.  (A) Histologic appearance of the cUBM at 7 days post surgery.  The cUBM (blue staining) 
appeared minimally degraded at 7 days post surgery.  A dense population of both neutrophils and 
mononuclear cells were present in the operative site; however, there was minimal invasion of the cells into the 
cUBM.  (B) Histologic appearance of the cUBM at 28 days post surgery.  The cUBM was no longer 
discernable at 28 days and was replaced with dense poorly organized collagenous connective tissue (dark blue 
staining, bracket), a small amount of adipose tissue (arrows), and a randomly distributed population of 
mononuclear cells.  The red staining tissue bundles at the bottom of the image represent the underlying 
transversalis muscle. Scale bar = 100 µm. (Masson’s Trichrome, 20X).  Reproduced from (100) with permission 
from Elsevier. 
 
The host response to the acellular xenogeneic UBM test article was characterized by a 
dense infiltration of both neutrophils and mononuclear cells that surrounded the implant and 
separated the individual layers of the multilaminate device at 3 days post surgery.  Angiogenesis 
was prominent as early as 3 days post surgery and remained a prominent feature of the host 
response throughout the 28 day study period.  Degradation of the UBM was most obvious at 7 
and 14 days post surgery at which times there was a uniformly distributed population of 
mononuclear cells accompanied by neomatrix and a notable absence of neutrophils (Figure 28a).  
By day 28, the implant was no longer visible and was replaced by organized host connective 
  98 
tissue.  Fibroblasts, blood vessels, aligned collagen, and small islands of skeletal myoblasts 
growing in from the periphery were observed at the site of remodeling (Figure 28b). 
 
Figure 28.  (A) Histologic appearance of the UBM at 7 days post surgery.  A dense cellular infiltrate 
consisting of mostly mononuclear cells was seen surrounding and within (arrows) the layers of the UBM (blue 
staining, bracket) at 7 days post surgery.  (B) Histologic appearance of the UBM at 28 days post surgery.  The 
UBM was no longer discernable by 28 days post surgery and was replaced by fibroblasts, blood vessels 
(asterisks), aligned collagen and small islands of skeletal myoblasts (arrows).  The red staining tissue bundles 
at the bottom of the image represent the underlying transversalis muscle. Scale bar = 100 µm. (Masson’s 
trichrome, 20X).  Reproduced from (100) with permission from Elsevier. 
 
The temporal and spatial infiltration of host cells and the degradation of the scaffold 
material was very similar between the acellular allogeneic body wall ECM and the acellular 
xenogeneic ECM test groups. 
3.3.1.2 Evidence of Innervation  
 Following unilateral abdominal wall repair in the rodent model, the UBM scaffold 
showed progressive remodeling with time. Histological examination showed a mixture of 
skeletal muscle cells and organized collagenous connective tissue at the site of UBM placement 
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at day 28. No positive labeling for neurons or Schwann cells was present at days 3, 7 and 14. At 
day 28, positive labeling for neurons was observed in the remodeled UBM scaffold adjacent to 
the leading edge of growth of the adjacent native external oblique muscle. Nerves were localized 
to regions of neo-muscular growth. Positive labeling for GAP-43 confirmed that these nerves 
were actively growing (202-204). Positive labeling for Schwann cells co-localized with positive 
labeling for nerves within the pockets of neo-muscular growth (Figure 29). The specificity of 
neurofilament, GFAP and GAP-43 stains was confirmed via staining of nerve in native rat 
abdominal wall muscle. 
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Figure 29.  Histological images of remodeled UBM 28 days after repair of a 1 cm × 1 cm defect in the 
rat abdominal wall, with specific staining for (A) neurofilament, (B) GAP43 and (C) GFAP. Specificity of 
staining was confirmed by primary delete negative controls for (D) neurofilament, (E) GAP43 and (F) GFAP. 
Positive control staining was confirmed in native rat abdominal wall muscle for (G) neurofilament, (H) 
GAP43 and (I) GFAP. All scale bars are 75 μm.  Reprinted from (134) with permission from John Wiley and 
Sons. 
3.3.2 Bilateral Defect Model 
3.3.2.1 Histopathologic Findings 
 In the bilateral model, the host response to the autologous tissue test article consisted of 
necrotic skeletal muscle and a dense infiltration of mononuclear cells with some neutrophils at 
the one day post-implantation time point.  This was followed by a progression of tissue 
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remodeling which was similar to that observed for the autograft test article in the unilateral 
model (Figure 30a and b).  Briefly, the host response was characterized by necrosis of the 
majority of the skeletal muscle tissue accompanied by an angiogenic response and the deposition 
of abundant neo-matrix with time.  Evidence of survival of some of the autograft muscle fibers 
was observed.  By 28 days post-implantation, the remodeling site was characterized by the 
necrosis of most of the graft material with few islands of skeletal muscle remaining, minimal 
vascularity, deposition of a layer of dense collagenous connective tissue, and a reduction in the 
number of inflammatory cells present within the wound site as compared to earlier time points 
(Figure 30c and d).  A qualitatively similar histologic response and tissue remodeling outcome 
was observed for autograft tissues that were implanted in the same animal as non-cross-linked 
UBM (Figure 30a and c) and cross-linked UBM (Figure 30b and d) test articles. 
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Figure 30.  (A, B) Histologic appearance of the autologous tissue test article at 7 days post-implantation 
(A, B).  Necrotic skeletal muscle (brackets), early neo-matrix deposition (arrow), and a dense infiltration of 
macrophages were observed. (C, D) Histologic appearance of the autologous tissue test article at 28 days post-
implantation.  Autograft tissue has been resorbed and has been replaced with dense collagenous connective tissue 
(brackets), and a small number of spindle shaped cells.  Pink tissue at bottom of images is native muscle  tissue.  A 
and C are autologous tissue test articles implanted with contralateral implantation of UBM.  B and D are 
autologous tissue test articles implanted with contralateral implantation of CDI-UBM.  Scale bar = 100 µm.  
(Hematoxylin and eosin, 20X) 
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The host response to the carbodiimide cross-linked UBM test article was characterized by 
an accumulation of primarily neutrophils at the surface of the scaffold material at early time 
points.  Some necrotic muscle fibers were observed at within the superficial layer of the native 
host muscle tissue.  By three days post-implantation, the majority of the cells within the wound 
site were neutrophils with a lesser number of mononuclear cells within the remodeling site.  At 
the three day time point, few of the cells within the remodeling site were seen to be interacting 
with the surface of the cross-linked test article.  By seven days post-implantation, the neutrophil 
population had changed to a population consisting of predominantly mononuclear cells, few of 
which were observed to have infiltrated the surface of the test article (Figure 31a and b).  
Angiogenesis and areas of neo-matrix deposition were observed in the tissues adjacent to the test 
article.  By 14 days post-implantation a more defined connective tissue layer was observed 
surrounding the test article and a small degree of cellular infiltration was observed at the 
periphery of the test article.  The cells within the remodeling site were predominantly 
mononuclear with a number of foreign body giant cells observed at the superficial surface of the 
test article.  By 28 days the site of remodeling was characterized by little to no evidence of 
infiltration of the scaffold material with mononuclear cells, the formation of an increasingly 
dense layer of disorganized collagenous connective tissue at the host-test article interface, and a 
significant foreign body giant cell response at the superficial surface of the test article (Figure 
31c and d).  Again, no qualitative differences in the course of tissue remodeling were observed 
for those test articles which were implanted with non-cross-linked UBM (Figure 31a and c) or 
autologous tissue test articles (Figure 31b and d). 
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Figure 31.  (A, B)  Histologic appearance of CDI-UBM at 7 days post-implantation.  The test article is 
visible (brackets) and no infiltration of mononuclear cells was observed.  (C, D)  Histologic appearance of the CDI-
UBM test article at 28 days post-implantation.  The test article is still clearly visible (brackets) and a foreign body 
giant cell response is observed at the superficial surface of the implant (arrows).  Deposition of dense, poorly 
organized connective tissue was observed at the host-material interface (block arrow). Pink tissue at bottom of 
images is native muscle tissue. A and C are CDI-UBM test articles implanted with contralateral implantation of 
UBM.  B and D are CDI-UBM test articles implanted with contralateral implantation of autologous tissue. Scale bar 
= 100 µm.  (Hematoxylin and eosin, 20x). 
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The host response to the non-cross-linked UBM test article was similar to that observed 
in the unilateral body wall study.  The host response at one day post-implantation was 
characterized by the accumulation of neutrophils at the surface of the test article, with a small 
number of cells infiltrating into the interior of the test article.  By three days post-implantation 
the cellular population was predominantly composed of neutrophils with a lesser number of 
mononuclear cells observed, mostly at the periphery of the test article.  More obvious infiltration 
of neutrophils into the test article was observed than at one day post-implantation.  By seven 
days post-implantation, significant disruption of the architecture of the UBM test article was 
observed and cellular infiltration was observed throughout the full thickness of the test article 
(Figure 32a and b).  The cells within the remodeling site and infiltrating the scaffold were 
predominantly mononuclear in nature.  Angiogenesis was observed mainly at the periphery of 
the implant with a smaller number of vessels within the test article itself.  Neo-matrix deposition 
was also observed, predominantly at the periphery of the test article with lesser amounts of neo-
matrix deposition observed within the UBM test article.  By 14 days post-implantation, the 
remodeling site was characterized by extensive degradation of the test article accompanied by 
robust deposition of neo-matrix within the remodeling site.  The cellular population at the 14 day 
time point was almost exclusively mononuclear with few multinucleated cells observed.  It was 
not clear whether these cells represented foreign body giant cells, early muscle cells, or satellite 
cells.  By 28 days post-implantation the scaffold material was not distinguishable in histologic 
sections, except for a small amount of scaffold material which was distinguishable in one sample 
(Figure 32c and d).  The rapid degradation of the scaffold material was accompanied by a 
marked decrease in cellularity, scattered islands of muscle tissue located largely at the periphery 
of the scaffold material, and partially organized connective tissue within the site of remodeling.  
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Again, no qualitative differences in the outcome of tissue remodeling were observed to occur 
when the UBM test article was implanted with either the autologous tissue test article (Figure 
32a and c) or the CDI-UBM (Figure 232b and d) test articles. 
 
 
Figure 32.  (A, B)  Histologic appearance of UBM at 7 days post-implantation.  A dense infiltration of 
mononuclear cells is observed within and surrounding the layers of the UBM test article (brackets).  (C, D)  
Histologic appearance of the UBM test article at 28 days post-implantation.  The test article was largely 
degraded and was replace with newly deposited extracellular matrix, fewer mononuclear cells and some 
spindle shaped cells, and small islands of skeletal muscle at the periphery of the implantation site (arrows).  
In one sample (D), a small amount of the test article was observed (bracket). Pink tissue at bottom of images 
is native muscle tissue. A and C are UBM test articles implanted with contralateral implantation of 
autologous tissue.  B and D are UBM test articles implanted with contralateral implantation of CDI-UBM 
tissue. Scale bar = 100 µm. (Hematoxylin and eosin, 20x). 
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3.3.2.2 Herovici’s Polychrome Staining 
Herovici’s polychrome allows for the identification of immature (type III; blue) collagen 
and mature (type I; dark purple/pink) collagen.  Each test article type was investigated at 7 
(early) and 28 day (late) time points for the type and maturity of collagen deposited.  Each test 
article was associated with a qualitatively different pattern of immature and mature collagen 
deposition (Figure 33).  The autologous tissue test article showed deposition of immature 
collagen within the implant site and between the necrotic skeletal muscle bundles of the autograft 
at 7 days.  By 28 days, the necrotic bundles of skeletal muscle were no longer visible and were 
replaced by a dense layer of mature collagenous connective tissue surrounded by immature 
collagen.  The CDI-UBM test article was visible at 7 days and the intact scaffold material 
remaining within the site of implantation was characterized by predominantly mature collagen 
type I.  The surrounding tissue was characterized by the deposition of immature collagen.  By 28 
days, the test article was still present within the remodeling site and again stained positive for 
mature collagen.  The surrounding implant site was characterized by the deposition of mostly 
immature collagen and with a small band of more mature encapsulating collagen at the implant 
surface.  At 7 days the UBM test article was partially degraded and appeared to be composed of 
a mixture of mature and immature collagen.  Immature collagen was observed within the layers 
of the degrading UBM test article.  By 28 days, the UBM test article was largely degraded and 
the implant site was characterized by the deposition of mature collagen intermixed with a smaller 
amount of immature collagen throughout the site of implantation. 
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Figure 33.  Herovici staining of autologous tissue (A, D), CDI-UBM (B, E), and UBM (C, F) test 
articles at  7 (A, B, C) and 28 (D, E, F) days post-implantation.  Brackets indicate visible remnants of test 
articles and arrow indicates dense layer of mature collagen deposition.  Light blue staining is indicative of 
immature collagen (type III) deposition, purple/pink staining is indicative of mature collagen (type I) 
deposition, yellow staining indicates muscle bundles.  Scale Bar = 200 µm.  (Herovici’s Polychrome, 10x). 
3.3.2.3 MMP Gene Expression Analysis 
MMP expression was evaluated by real-time quantitative PCR.  With few exceptions, 
increased expression of all genes examined (MMP2, 3, 7, and 9) was observed in all samples as 
compared to native tissue.  An increase in MMP2 expression (Figure 34a) was observed for all 
remodeling test articles between 1 and 7 days post-implantation, with similar expression levels 
for all test articles at the 1 and 3 day time points.  At 7 days the autologous test article exhibited 
higher expression of MMP2 than did UBM or CDI-UBM; however, the results were not 
statistically significant.  MMP2 expression decreased between 7 and 14 days, with all test articles 
expressing similar levels of MMP2 at 14 days post-implantation.  By 28 Days MMP2 expression 
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was slightly elevated in the autologous tissue and CDI-UBM test articles as compared to native 
tissue.  However, MMP2 levels in the UBM test article were seen to increase between 14 and 28 
days post-implantation, again this result was not statistically significant.  No significant 
interactions between scaffold type and time point were found.   
MMP3 expression levels (Figure 34b) were elevated in all test articles as compared to 
native tissue, with the exception of UBM at 1 day post-implantation.  Levels in autologous tissue 
test articles were elevated at 1 day post-implantation as compared to CDI-UBM and UBM test 
articles, although not statistically significant.  Levels in all test articles decreased from 3 days to 
7 days, then increased at 14 days.  By 28 days post-implantation levels had decreased as 
compared to 14 days, however were elevated as compared to native tissue.  No significant 
interactions between scaffold type and time were found 
MMP7 expression levels (Figure 34c) were found to be slightly elevated at early time 
points (1 and 3 days post-implantation) in all scaffold materials.  At 7 days post-implantation, 
MMP7 expression was significantly higher in the CDI-UBM test article, while levels remained 
only slightly elevated in the autologous tissue and UBM test articles.  At 14 days both the CDI-
UBM and UBM test articles were found to have statistically significant elevated MMP7 
expression as compared to the autologous tissue test article, which dropped below the level 
found in native tissue.  By 28 days post-implantation, MMP7 levels were elevated as compared 
to native tissue in the autologous and CDI-UBM test articles, with higher levels observed for the 
UBM test article, although not statistically significant.  Only scaffold type was found to be a 
statistically significant factor (F=5.2451, p<0.01). Statistically significant differences in MMP7 
expression between scaffold types were observed at 7, and 14 days post-implantation. 
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MMP9 expression levels (Figure 34d) were found to be elevated in all scaffold types 
throughout the study period as compared to native tissue.  At 1 day post-implantation, both the 
CDI-UBM and UBM test articles showed statistically significant higher expression of MMP9 
than the autologous tissue test article.  Expression levels were seen to decrease at 3 and 7 days 
post-implantation, and increase at 14 and 28 days post-implantation.  The largest increase was 
observed in the UBM test articles and was highest at 28 days, although not statistically 
significant. No significant interactions between scaffold type and time were found.  Both 
scaffold type (F=7.9702, p<0.001) and time (F=7.8561, p<0.01) were found to be statistically 
significant factors. Statistically significant differences in MMP9 expression between scaffold 
types were observed at 1, 7, and 14 days post-implantation. 
Statistically significant differences were found for MMP2 (at 3 days) and MMP7 (at 28 
days) expression for autologous tissue which was implanted concurrently with either UBM or 
CDI-UBM test articles.  However, these differences were few and no distinct pattern was 
observed. 
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Figure 34.  MMP gene expression compared to expression in native tissues for samples from the 
bilateral defect study. (A) MMP2 expression was not shown to have statistically significant relationships with 
scaffold type or time. (B)  MMP 3 expression was not shown to have statistically significant relationships with 
scaffold type or time.  (C)  Scaffold type was found to be a statistically significant (F=5.2451, p=<0.01) factor 
in MMP7 expression with statistically significant differences observed at 7, and 14 days post implantation. 
(D)  MMP9 expression showed the most significant differences for all MMP genes investigated.  Both scaffold 
type and time were found to be significant factors (F=7.9702, p=<0.001 and F=7.8561, p<0.01, respectively).  
3.4 DISCUSSION 
 
The results of the present studies show that each of the implanted test articles was associated 
with a distinct tissue remodeling outcome.  In both the unilateral and bilateral body wall models, 
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the implantation of autograft tissue resulted in necrosis of the skeletal muscle and replacement 
with dense, mature collagenous connective tissue within the remodeling site.  Implantation of 
UBM, both in the unilateral and bilateral body wall defect models, resulted in early stages of 
constructive tissue remodeling (i.e. innervated islands of skeletal muscle, angiogenesis, and 
deposition of mature, well organized collagen).  In contrast, UBM that contained a cellular 
component or was chemically cross-linked with carbodiimide resulted in either degradation of 
the scaffold material resulting in deposition of a dense layer of poorly organized collagenous 
connective tissue or a foreign body reaction and encapsulation, respectively.  Herovici’s 
polychrome staining showed that the composition of the tissues deposited within the remodeling 
site were different for the autograft, CDI-UBM, and UBM groups and MMP gene expression 
analysis showed that there were significant differences in MMP expression between scaffold 
materials.  Most notably, UBM test articles appeared to have increased MMP expression as 
compared to other test articles occurring between the 14 and 28 day time points.  Although, not 
necessarily statistically significant, this change in MMP expression also coincided with the most 
noticeable differences in the histologic response. 
These results show that, despite a response which is histologically similar at early time 
points (1 to 7 days post-implantation) in the tissue remodeling process, the outcome of the tissue 
remodeling process is distinctly different at later time points (14 days and beyond).  In each case, 
however, a large population of mononuclear cells was observed starting at 3 days post-
implantation and continued to persist to varying degrees throughout the course of the study 
period.  A robust mononuclear cell response has been observed following the implantation of 
ECM scaffold materials in a wide variety of applications (85).  This response, although it often 
results in constructive tissue remodeling, has been characterized by some as chronic 
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inflammation.  However, as the results of the present study show, this response does not 
necessarily result in the deposition of granulation tissue, a foreign body response, or the 
deposition of collagenous connective tissue within the site of remodeling.  Rather, the response 
resolves and results in what can be described as constructive tissue remodeling. This would 
suggest that, although the majority of the cells present in the early stages of remodeling are 
polymorphonuclear and mononuclear in nature, there may be phenotypic differences which are 
dependant on the nature of the scaffold implanted and that these differences may be predictive of 
the tissue remodeling outcome.   
The present studies also showed that the presence of cellular material within an ECM 
scaffold prior to implantation led to inability of the ECM scaffold material to promote 
constructive tissue remodeling.  This is not surprising in the case of large amounts of xenogeneic 
cellular components, which may be recognized by the host immune system and elicit host 
immune response following implantation. Porcine cells express such cell associated epitope as α-
Gal, which is known to play a role in transplant rejection in humans (88, 89).  Other molecules, 
including those associated with cell death, have also been shown to have potent 
immunomodulatory effects (205, 206).  These cell death associated molecules, termed damage 
associated molecular pattern molecules (DAMPs), include extracellular DNA, high mobility 
group box 1, S100, and heat shock proteins among numerous others.  In general, these molecules 
are recognized by pattern recognition receptors on cells of the innate immune system.  Therefore, 
it is logical to assume that large amounts of these molecules resulting from inefficient removal 
during processing or due to cellular death upon implantation may have detrimental effects upon 
the ability of ECM scaffold materials to promote a constructive tissue remodeling response.  
DAMPs including HMGB1, S100, and multiple heat shock proteins have been shown to be 
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present within ECM scaffold materials (unpublished data), even those which have been 
efficiently decellularized.  The presence of these molecules within decellularized matrices is 
logical when one considers that most decellularization processes include cell lysis.  However, the 
amounts of these molecules which remain following decellularization has not been shown to 
have detrimental effects upon tissue remodeling. 
The present studies also show that the presence of autologous cellular components within 
a test article may prevent constructive tissue remodeling.  In the present study, healthy 
autologous tissue harvested during the creation of the surgical defect was re-implanted within 
minutes of defect creation.  Tissue remodeling, however, resulted in necrosis of the cellular 
component and deposition of dense mature collagenous scar tissue.  The process of muscle 
necrosis is well understood, and the results in the present study are not surprising.  Likely, 
disruption of the vascular supply leads to necrosis of the skeletal muscle tissue, causing a pro-
inflammatory tissue response which results in the deposition of collagenous connective tissue. 
The fate and contribution of seeded cells in tissue engineering is a subject which has not been 
well addressed.  While cells may have positive paracrine effects following implantation, it is not 
clear that seeded cells participate in constructive tissue remodeling in the long-term. However, if 
one thinks of autologous tissue as a target for tissue engineering approaches to muscular 
reconstruction, the results of the present study may suggest that seeding of a scaffold with 
autologous cells, even if viable and arranged in a tissue-specific three dimensional architecture 
with a vascular network, prior to implantation may not promote constructive tissue remodeling. 
The exact mechanisms by which non-cross-linked ECM scaffolds are capable of 
modulating the host tissue response towards constructive tissue remodeling are not fully 
understood; however, the results presented here clearly show that chemical cross-linking has 
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detrimental effects upon this ability.  Similar results were observed in a study which investigated 
the short (2 days) and long-term (up to 112 days) host tissue remodeling responses elicited by 5 
commercially available ECM based scaffold materials commonly used for rotator cuff repair 
(69).  Results showed that constructive tissue remodeling occurred in those ECM scaffolds which 
were not chemically cross-linked.  This was in contrast to materials which were chemically 
cross-linked, which elicited a chronic foreign body response similar to that observed in the 
present study.  As was shown in the previous studies, chemical cross-linking changes both the 
ultrastructure and, to a smaller degree, the composition of the surface of ECM scaffold materials.  
Therefore, it is logical to assume that interactions between the surface of the material and the 
cells which participate in the host tissue remodeling response may be responsible for determining 
the downstream tissue remodeling outcome associated with the implantation of ECM scaffold 
materials. 
In the present studies, it was also observed that the host tissue remodeling response to one 
test article did not appear to affect the host tissue remodeling of another scaffold material 
implanted concurrently within the same animal.  These results suggest that scaffold remodeling 
is a localized phenomenon which occurs at the site of implantation.  Likely this is a result of 
cellular interactions with the surface of the material. 
3.5 CONCLUSIONS 
Despite a similar histologic response at early time points in the remodeling process (up to 7 days 
post-implantation), the outcomes observed following the implantation of each scaffold type were 
distinct.  The present study showed that the presence of a cellular component within an 
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extracellular matrix scaffold impaired the ability of the scaffold material to support constructive 
tissue remodeling.  It was observed that those test articles that contained a cellular component, 
even viable autologous cells, resulted in the deposition of dense connective tissue and/or 
scarring.  Those test articles that did not contain a cellular component, however, were observed 
to result in a more constructive type remodeling response including the formation of islands of 
new skeletal muscle within organized, mature collagen.  Chemical crosslinking was also shown 
to affect the ability of and ECM scaffold material to promote constructive tissue remodeling.  
Scaffolds which were crosslinked resulted encapsulation of the material within increasingly 
dense collagenous connective tissue with no signs of constructive tissue remodeling.  Lastly, the 
remodeling of one ECM scaffold material did not appear affect the remodeling of a second ECM 
scaffold material implanted in the same animal, suggesting that ECM scaffold remodeling is a 
localized and not a systemic phenomenon.  The results of these studies demonstrate the 
importance of the methods used in ECM scaffold production and an understanding of how 
scaffold characteristics affect downstream tissue remodeling.  The section which follows will 
investigate differences in the phenotype of the macrophages which participate in the response to 
each of the materials described above and their role in determining the downstream tissue 
remodeling outcome associated with their implantation. 
3.6 LIMITATIONS AND FUTURE DIRECTIONS 
The present study utilized a rat abdominal wall musculature defect model to investigate the host 
tissue remodeling response to ECM scaffold materials.  This model has been used to successfully 
evaluate the ability of a wide variety of ECM scaffold materials to promote constructive tissue 
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remodeling (44, 69, 133).  In the present study, ECM materials derived from two separate tissue 
sources were investigated.  Implantation of both acellular rat body wall ECM (allogeneic source) 
and acellular ECM derived from porcine urinary bladder (xenogeneic source) were observed to 
result in early signs of constructive tissue remodeling of the abdominal wall musculature.  
However, due to the short time period utilized in the present study, it was not possible to 
determine if the source of the ECM scaffold material would have affected the long-term outcome 
of tissue remodeling and the functionality of the remodeled muscle tissue.  A number of in vitro 
studies have shown that ECM derived from tissue-specific sources may be better for the support 
of specialized cell populations derived from the same tissue (207-209).  However, the effects of 
tissue, or species, specific ECM scaffolds has not been well investigated in vivo.  
 The effects of both viable autologous cells and xenogeneic cellular components were 
investigated.  In both cases, tissue remodeling resulted in the deposition of dense collagenous 
connective tissue with no signs of constructive tissue remodeling.  The exact mechanism by 
which cellular components affect tissue remodeling in the case of ECM based scaffold materials 
has not been fully elucidated, but likely includes pro-inflammatory responses to cellular 
components such as DNA and DAMPs.  Previous studies have shown that ECM scaffold 
materials contain small amounts of DNA, α-Gal, and DAMPs, even when intact nuclei are not 
present in histologic sections.  Despite the presence of these molecules, acellular non-cross-
linked ECM scaffold materials are capable of eliciting an immune response which does not 
appear to affect the ability of the material to promote constructive tissue remodeling.  In the 
present study, it was shown that large amounts of cellular material, even viable autologous cells, 
affected the ability of the scaffold to remodel.  Thus, there may be a threshold for potentially 
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immunogenic molecules, beyond which the ability of an ECM scaffold to promote constructive 
tissue remodeling is impaired.  Further studies are needed to determine this threshold. 
 The present study examined the effects of one commonly used method of chemical cross-
linking.  In the previous chapter, both glutaraldehyde and carbodiimide cross-linking were shown 
to affect the surface ultrastructure and, to a lesser degree, the surface composition of UBM.  A 
variety of other chemical cross-linking methods are available and may result in a different tissue 
response than was observed in the present studies.  In particular, genipin, a cross-linking agent 
derived from gardenia, has been shown to have anti-inflammatory properties (210-212).  Cross-
linking of ECM scaffolds with genipin may result in a more constructive host tissue remodeling 
response than was observed with the carbodiimide cross-linked ECM scaffolds used in the 
present study.  Additionally, in the present study, the mechanisms by which cross-linking 
inhibited constructive tissue remodeling were unclear.  The inability of the ECM scaffold 
material to degrade may have prevented the release of bioactive matricryptic peptides which 
have been shown to have antibacterial, and chemotactic properties in previous studies.  
Alternatively, cross-linking, as was suggested in the studies presented previously, may have 
altered the presentation of ligands on the surface of the material.  Differences in surface 
chemistry may have also resulted the adsorption of a different repertoire of proteins following 
implantation and contact with blood.  It is also possible that the observed differences were due to 
inability of the macrophage population participating in the host response to degrade or 
phagocytose the material within the site of tissue remodeling resulting in the formation of foreign 
body giant cells and encapsulation. 
 Finally, the results of the present studies suggest that the tissue remodeling response to 
one test article was not affected by the implantation of a second test article implanted 
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concurrently within the same animal.  This suggests that the remodeling of an ECM scaffold 
material is a localized phenomenon.  However, as the data presented as part of the above studies 
was largely qualitative and study populations were small (n=2 for each combination of scaffolds, 
and n=4 for each scaffold type), additional work may be necessary to detect smaller differences 
in the tissue remodeling outcome which may not be readily observed through histologic staining 
alone.  However, it is clear that the implantation of either autologous tissue or CDI-UBM did not 
significantly inhibit constructive tissue remodeling of UBM.  And, conversely, that the 
implantation of UBM did not result in constructive tissue remodeling of autologous tissue or 
CDI-UBM.  The studies which follow will investigate the host response to each of the scaffolds 
implanted as part of these studies and quantitatively assess differences in the host macrophage 
response which may occur as a result of the implantation of two ECM scaffold materials within 
the same animal. 
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4.0  SPECIFIC AIM 3: EXTRACELLULAR MATRIX SCAFFOLDS ALTER THE 
DEFAULT HOST MACROPHAGE RESPONSE  
4.1 BACKGROUND 
The extracellular matrix (ECM) represents the secreted products, both structural and functional, 
of the resident cells of each tissue and organ.  The composition and ultrastructure of the ECM is 
determined by factors that influence the phenotype of its resident cells including mechanical 
forces, biochemical milieu, oxygen requirements, pH and inherent gene expression patterns, 
among others.  In turn, the ECM influences cell attachment, migration, proliferation and three-
dimensional organization, serving as an “information highway” between cells (3-5).  For these 
reasons, multiple forms of allogeneic and xenogeneic ECM from sources such as small intestine, 
urinary bladder, and skin have been investigated as biologic scaffolds for tissue reconstruction in 
both preclinical studies and human clinical applications (213).  
Macrophages are a heterogeneous subset of the mononuclear cell population (139, 142-
144, 146) involved in the host response to implanted materials.  Macrophages are generally 
activated in response to tissue damage or infection, causing an increase in the production of 
cytokines, chemokines, and other inflammatory molecules to which they are exposed (141, 143, 
144).  Recently, macrophage phenotype has been characterized based on distinct functional 
properties, surface markers, and the cytokine profile of the microenvironment (141, 143, 146).  
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Polarized macrophages are referred to as either M1 or M2 cells, mimicking the Th1/Th2 
nomenclature (143).  However, M1 and M2 represent extremes along a continuum that includes 
multiple macrophage phenotypes (M1, M2a, M2b and M2c).  M1, classically activated pro-
inflammatory, macrophages are known to be induced by IFN-γ alone or in combination with 
LPS, TNF and GM-CSF.  In general, M1 activated macrophages express IL-12high, IL-23high, IL-
10low; metabolize arginine, produce high levels of inducible nitric oxide synthase (iNOS); secrete 
toxic reactive oxygen and nitric oxygen intermediates and inflammatory cytokines such as IL-1β, 
IL-6, and TNF; and are inducer and effector cells in Th1 type inflammatory responses.  In 
contrast, M2, alternatively activated, macrophages are induced by exposure to a variety of 
signals including the cytokines IL-4, IL-13, and IL-10, immune complexes, and glucocorticoid or 
secosteroid (vitamin D3) hormones.  M2 activated macrophages express IL-12low, IL-23low, and 
IL-10high; have high levels of scavenger, mannose, and galactose receptors; produce arginase in 
the place of arginine, subsequently producing ornithine and polyamines; are involved in 
polarized Th2 reactions; and possess the ability to facilitate tissue repair and regeneration. 
Macrophages are a plastic cell population capable of sequentially changing their 
polarization in response to local stimuli during the process of wound healing (214-216).  The 
macrophages participating in the host response to an implanted material are exposed to multiple 
stimuli including cytokines and effector molecules secreted by cells including other macrophages 
that are participating in the host response, microbial agents, epitope associated with the 
implanted biomaterial, and the degradation products of the biomaterial, among others.  
Therefore, it is logical to assume that the host macrophage response after implantation of a 
biomaterial is modulated via “cross-talk” between macrophages and the other cells involved in 
the host response as well as factors within the local microenvironment.  The effects of 
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macrophage phenotype upon the tissue remodeling outcome following the implantation of a 
biomaterial are largely unknown, but recognition of the predominant phenotypic profile of the 
macrophages which participate in the host response to an implanted material may provide a tool 
by which a constructive and functional tissue remodeling outcome can be predicted and/or 
promoted. 
The objectives of the present studies were three fold: (1) to shown that extracellular 
matrix scaffolds are capable of altering the default host macrophage response following 
implantation, (2) to show that modulation of the host macrophage response is related to the 
ability scaffold to promote the constructive versus encapsulation or scar tissue type remodeling 
responses observed in Aim 2, and (3) to evaluate the effects of polarized macrophages upon the 
in vitro behavior of other cell types in vitro. 
4.2 METHODS 
4.2.1 Evaluation of Macrophage Phenotype in Explanted Extracellular Matrix Scaffolds 
The samples evaluated in the present studies were the same samples examined in the studies 
presented as part of Aim 2 above.  The evaluation methods used for immunolabeling and 
quantification of macrophage phenotype in samples from the unilateral model and samples from 
the bilateral model differ in some respects which are listed below. 
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4.2.1.1 Sample Collection 
 On the predetermined sacrifice date, each animal was anesthetized using isoflurane (5% 
in oxygen) and then euthanized by intracardiac injection of potassium chloride to induce cardiac 
arrest.  The grafts were explanted with a small amount (approximately 2 mm) of the surrounding 
native tissue.  One half of the tissue was fixed in 10% neutral buffered formalin and then 
embedded in paraffin.  The other half of each specimen was preserved in RNAlater (Ambion, 
Austin, TX) for RNA extraction. 
4.2.1.2 Immunolabeling 
(a) Unilateral Model 
 Immunolabeling was performed on consecutive 6 µm sections of each specimen in order 
to assess the macrophage phenotype within and surrounding the implant wound site.  Following 
deparaffinization, the slides were placed in citrate antigen retrieval buffer (10mM citric acid 
monohydrate, pH 6.0, Spectrum) which was then brought to a boil (95-100ºC) for 20 min.  The 
buffer was allowed to cool and the slides were then washed twice in TRIS buffered saline/Tween 
20 (Trizma Base, Sigma; Tween 20, Sigma) solution (pH 7.4) and twice in PBS.  The sections 
were incubated in 1.5% normal horse serum (Vector) for 1 h at room temperature in a humidified 
chamber to inhibit non-specific binding of the primary antibody.  Following incubation in 
blocking serum, the sections were incubated in primary antibody in a humidified chamber at 4°C 
overnight.  Each tissue specimen was exposed to antibodies to a pan-macrophage marker 
(CD68), an M1 phenotype marker (CCR7), and an M2 phenotype marker (CD163).  Following 
the overnight incubation, the slides were washed three times in PBS.  Sections were then 
incubated in a solution of 3% H2O2 in methanol for 30 min at room temperature to quench 
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endogenous peroxidase activity.  Following H2O2 treatment, the slides were washed three times 
in PBS prior to incubation in secondary antibody for 30 min in a humidified chamber, at either 
room temperature (CD68) or 37°C (CD163, CCR7), and then subjected to three more washes in 
PBS.  The sections were then incubated in Vectastain ABC (Elite ABC kit, Vector) reagent for 
30 min in a humidified 37°C chamber, rinsed 3 times in PBS, and incubated in 4% DAB 
substrate solution (Vector) at room temperature.  The slides were rinsed in water to stop the 
development of the DAB substrate and counterstained using Harris hematoxylin stain (Thermo 
Electron Corporation-Shandon, Pittsburgh, PA).  The slides were then dehydrated using the 
reverse of the deparaffinization treatment described above prior to coverslipping.  Each PBS 
rinse in the protocol was for 3 minutes at room temperature, with occasional agitation. 
The primary antibodies used were mouse anti-rat CD68 (Serotec, Raleigh, NC) at a 
dilution of 1:50, rabbit anti-CCR7 (Cell Applications, San Diego, CA) at a dilution of 1:100, and 
mouse anti-rat CD163 (Serotec) at a dilution of 1:50. The secondary antibodies used were 
biotinylated horse anti-mouse IgG (Vector, CD68 and CD163) at a dilution of 1:50 and goat anti-
rabbit IgG (Vector, CCR7) at a dilution of 1:100.  All antibodies were diluted in filtered PBS 
(pH 7.4).   
Representative images of the immunolabeling for each surface marker at 7 days post 
implantation are shown in Figure 35. 
The immunostained slides were examined and imaged by a blinded investigator using a 
Nikon e600 microscope.  The images were then evaluated quantitatively in a blinded fashion by 
two independent investigators.  Quantitative analysis was performed by counting the number of 
immunopositive cells in six matched microscope fields at 40X magnification.  Cell counts from 
negative controls (no primary antibody) were subtracted from the cell counts of the test articles 
  125 
and the percentage of M1 and M2 macrophages was determined by dividing the number of 
CCR7+ (M1) and CD163+ (M2) cells by the number of CD68+ (pan-macrophage) cells in each 
field.  A ratio of the percentage of M1 cells to M2 cells was also calculated for each field as 
follows: 
 
M1 : M2 =
Percent M1 Cells
Percent M2 Cells
 
 The ratioa were then plotted on a log scale such that values grater than 1.0 were 
representative of the predominance of M1 cells among those cells staining positive for either M1 
or M2 surface markers.  Conversely, a value of less than 1.0 was representative of a 
predominance of M2 cells. 
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Figure 35. Representative images of immunohistochemical staining for CD68, CD163, and CCR7 in 
the cellular autograft and acellular allograft test articles at 7 days post surgery.  Scale bar = 100 µm (40X).  
Reproduced from (100) with permission from Elsevier. 
(b) Bilateral Model 
Immunofluorescence was utilized in place of immunoperoxidase methods in the bilateral 
study in order to allow for the evaluation of both the phenotype of the macrophages participating 
in the host response and their temporal and spatial distribution throughout the site of remodeling.  
As the analysis was performed using immunofluorescent triple labeling, which required the use 
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of rat-specific primary antibodies from three different species, the antibodies and markers used 
for macrophage polarization analysis in the bilateral study were somewhat different from those 
used in the unilateral defect study due to the commercial availability of antibodies which react 
with rat markers at the time the study was performed. 
Immunolabeling was performed on 6 μm sections.  Following deparaffinization, the 
slides were placed in citrate antigen retrieval buffer (10 mm citric acid monohydrate, pH 6.0) 
which was then brought to a boil (95–100 °C) for 20 min. The buffer was allowed to cool and the 
slides were then washed twice in TRIS buffered saline/Tween 20 (Trizma Base, Sigma; Tween 
20, Sigma) solution (pH 7.4) and twice in PBS. The sections were incubated in 2% normal horse 
serum, 1% BSA, 0.1% Triton X-100, and 0.1% Tween 20 in PBS (pH 7.4) for 1 h at room 
temperature in a humidified chamber to inhibit non-specific binding of the primary antibody. 
Following incubation in blocking serum, the sections were incubated in primary antibodies in a 
humidified chamber at 4 °C overnight. Each tissue specimen was exposed to antibodies to a pan-
macrophage marker (CD68), an M1 macrophage phenotype marker (CCR7), and an M2 
macrophage phenotype marker (CD206). Following the overnight incubation, the slides were 
washed three times in PBS prior to incubation in fluorescently labeled secondary antibodies for 
one hour in a humidified chamber at room temperature, and then subjected to three more washes 
in PBS. Slides were then exposed to a DRAQ5 nuclear stain for 30 minutes at 37°C prior to 
being washed three times in PBS.  The slides were then coverslipped using aqueous mounting 
media prior to visualization under a fluorescent microscope. Each PBS rinse in the protocol was 
for 3 min at room temperature, with occasional agitation. 
The primary antibodies used were mouse anti-CD68 (Serotec) at a dilution of 1:50, rabbit 
anti-CCR7 (Epitomics) at a dilution of 1:200, and goat anti-CD206 (Santa Cruz) at a dilution of 
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1:50. The secondary antibodies used were AlexaFluor donkey anti-mouse IgG (350 nm) at a 
dilution of 1:25, donkey anti-rabbit IgG (568 nm) at a dilution of 1:100 and donkey anti-goat IgG 
(488 nm) at a dilution of 1:100. All antibodies were diluted in blocking serum as described 
above. 
The immunolabeled slides were examined and imaged by a blinded investigator using a 
Nikon e600 microscope.  The images were then evaluated quantitatively in a blinded fashion by 
a separate independent investigator.  Quantitative analysis was performed by selecting three 
areas of approximately 90 x 60 µm at the surface of the test article and encompassing the 2-3 cell 
layers closest to the test article surface from within a high power microscope field (40x 
magnification).  The number of cells labeled positively for each marker within the three boxes 
was then counted and summed for each image.  The mean of the sums for all three high power 
images was then calculated for each sample.  Examples of immunolabeling of UBM and CDI-
UBM at 14 days post-implantation are provided in Figures 32 and 33. 
A ratio of the percentage of M1 cells to M2 cells was also calculated for each field as 
follows: 
 
M1 : M2 =
Number M1 Cells
Number M2 Cells
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Figure 36. Example of immunolabeling in UBM at 14 days post-implantation.  (A) 40x magnification 
image of immunolabeling.  Red labeling is CD68 (pan-macrophage); orange labeling is CCR7 (M1); green 
labeling is CD206 (M2); blue labeling is nuclei (DRAQ5).  (B)  Three areas of 90 µm x 60 µm at the surface of 
the test article were randomly selected from each high power image.  (C, D, E)  The number of CD68+ (C), 
CCR7+ (D), and CD206+ (E) within each box were counted and summed for each image.  Reproduced from 
(100) with permission from Elsevier. 
4.2.1.3 Quantitative Real Time Polymerase Chain Reaction 
(a) Unilateral Model 
 Total RNA was isolated from the explanted tissues using TRI-Reagent (Molecular 
Research Center Inc., Cincinnati, OH) according to the manufacturer’s instructions.  The isolated 
RNA was then purified using an RNAeasy Mini Kit (Qiagen, Valencia, CA) and a vacuum 
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system (Qiagen).  cDNA was synthesized from 1 μg of total RNA in a volume of 20 µL using a 
Superscript RT III kit (Invitrogen, Carlsbad, CA) according to the manufacturer’s instructions.   
Quantitative real-time PCR was then performed using primers specific for genes known 
to be strong indicators of either an M1 (inducible nitric oxide synthase, iNOS) or an M2 
(arginase, ARG) type macrophage response.  Both primers were custom designed using Beacon 
Designer 7.2 primer design software (PREMIER Biosoft International, Palo Alto, CA) (Table 7). 
Primers for housekeeping genes were purchased as part of a housekeeping gene primer kit (Rat 
Housekeeping Gene Primer Set, Real Time Primers, LLC, Elkins Park, PA), and housekeeping 
gene expression was used to normalize reactions.  1 µL of cDNA was mixed with the appropriate 
primers and 2X SYBR Green Master Mix (BioRad, Hercules, CA) in a total volume of 25 µL.  
All reactions were performed in triplicate and were monitored using an iQ5 Real-Time Detection 
System (BioRad).  
Relative expression of the M1 and M2 genes was calculated using the 2-(∆Ct) method (200, 
201).  The difference between the value of the threshold cycle for the gene of interest and the 
value of the threshold cycle for the housekeeping gene (∆Ct) was calculated for each specimen as 
follows: 
 
∆CtGOI = CtGOI − CtHSKG   
Expression relative to the housekeeping gene was then expressed as 
 
2−(∆Ct ).  The relative 
expression of M1 and M2 genes in each specimen was then compared using the following 
equation: 
 
2−(∆CtM 1 )
2−(∆CtM 2 )
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Values were then plotted on a log scale such that values greater than 1.0 represented a 
predominance of iNOS gene expression and values less than 1.0 represented a predominance of 
ARG gene expression.   
It should be noted that fold expression as compared to native muscle tissue was not 
calculated for samples harvested in the unilateral model as native tissue was not collected. 
 
Table 7.  Primers used for M1 and M2 gene expression analysis of unilateral body wall samples. 
Gene Forward Primer (5' -> 3') Reverse Primer (5' -> 3') 
iNOS GAGACGCACAGGCAGAGG CAGGCACACGCAATGATGG 
Arginase CATATCTGCCAAGGACATCG GGTCTCTTCCATCACTTTGC 
 
(b) Bilateral Model 
Real time PCR was also performed on the samples from the bilateral defect model.  
However, for the bilateral defect model an expanded panel of M1 (iNOS, CXCL10, IL1β, IL6, 
IL12B) and M2 (Arg, IL1r-a, IL-10, E-Cadherin) gene markers was used (Table 8). Primers were 
designed using Primer-BLAST (NCBI, http://www.ncbi.nlm.nih.gov/tools/primer-blast/) and 
cDNA was synthesized using an iScript cDNA synthesis kit (BioRad).  All other methods 
remained the same as those described for gene expression analysis in samples harvested from the 
bilateral defect model in Section 3.2.4.4 above. 
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Table 8.  Primers used for M1 and M2 gene expression analysis of bilateral body wall samples. 
Gene Forward Primer (5' -> 3') Reverse Primer (5' -> 3') 
M1 Genes   
iNOS CACCTTGGAGTTCACCCAGT ACCACTCGTACTTGGGATGC 
CXCL10 GCTTATTGAAAGCGGTGAGC GGGTAAAGGGAGGTGGAGAG 
IL-1 GCAGCTATGGCAACTGTCCCTGA TGGACAGCCCAAGTCAAGGGCT 
IL-6 TCTCGAGCCCACCAGGAACGA AGGGAAGGCAGTGGCTGTCA 
IL-12 TGCCATGGTTTTGCTGGTGTCT AGGGTCACCGTTTCTCCAGGGG 
M2 Genes   
Arg AGCGCCTTTCTCTAAGGGAC ACAGACCGTGGGTTCTTCAC 
IL1r-a TCTACCGCCATGGTCTGCTTCC TCTACCGCCATGGTCTGCTTCC 
IL-10 GAGTGAAGACCAGCAAAGGC TTGTCCAGCTGGTCCTTCTT 
CDH1 ACACAGTAGTGCCTGGGCCCTT CGCAGCTTGCATAGTGGTCCCA 
 
4.2.2 Evaluation of Chemotaxis Towards Macrophage Conditioned Medias 
4.2.2.1 RAW 264.7 Mouse Macrophage Culture 
 RAW 264.7 macrophages were cultivated in Dulbecco's minimal essential medium 
containing 10% fetal bovine serum and 1% penicillin/streptomycin.  Cells were grown at 37oC in 
5% CO2/95% air, and were split when they were approximately 80% confluent.  Macrophages 
were passaged once following thawing and then allowed to reach 80% confluence.  Cells were 
then removed from the cell culture flask using a rubber cell scraper and re-suspended at a 
concentration of 1 x 106 cells/mL of cell culture media.   
 Macrophages were then subjected to one of three well-described polarization protocols as 
follows prior to being placed into a 6 well cell culture plate at a concentration of 2 x 106 
cells/well (2 mL/well).  M0 (un-polarized) macrophages were cultured in DMEM with 10% fetal 
bovine serum.  M1 macrophages were cultured in DMEM with 10% fetal bovine serum 
supplemented with 20 ng/mL IFN-γ and 100 ng/mL LPS.  M2 macrophages were cultured in 
DMEM with 10% fetal bovine serum supplemented with 20 ng/mL IL-4.  Macrophages were 
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cultured in polarization media for 24 hours post-plating.  Following the 24 hour polarization 
period, the polarization media was aspirated from all wells and the cells were rinsed once using 
37oC PBS and once using 37oC serum free DMEM.  Following rinsing, 2 mL of serum free 
DMEM was placed in each well and the polarized macrophages were allowed to condition the 
media for 4, 8, 12, and 24 hours.  At each specified time point, the conditioned media was 
removed from each plate and stored at -80oC until use in the Boyden chamber chemotaxis assay 
described below. 
4.2.2.2 Effects of Macrophage Polarization Upon Cell Chemotaxis  
(a) C2C12 Mouse Myoblast Culture 
 C2C12 mouse myoblasts were cultivated in Dulbecco's minimal essential medium 
containing 10% fetal bovine serum and 1% penicillin/streptomycin.  Cells were grown at 37oC in 
5% CO2/95% air, and were harvested for Boyden chamber analysis when they were 
approximately 80% confluent. 
(b) MG-71 Pericyte Culture 
 MG-71 pericytes (217) were cultivated in Dulbecco's minimal essential containing 20% 
fetal bovine serum and 1% penicillin/streptomycin.  Cells were grown at 37oC in 5% CO2/95% 
air, and were harvested for Boyden chamber analysis when they were approximately 80% 
confluent. 
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(c) Boyden Chamber Assay 
Migration of C2C12 myoblasts and MG71 pericytes towards macrophage-conditioned 
medias was investigated using a Boyden chamber assay.  C2C12 myoblasts and MG71 pericytes 
were placed into starvation media (DMEM with 0.5% heat-inactivated fetal calf serum) in a 37oC 
in 5% CO2/95% air incubator for 16 hours prior to use in the Boyden chamber assay.  Cells were 
then trypsinized and re-suspended in serum free media and incubated in a conical tube for 1 hour 
in suspension in a humidified 95% air/5% CO2 incubator.  Polycarbonate chemotaxis filters with 
a pore size of 8μm were coated with 0.05 mg/mL collagen type I.  Macrophage conditioned 
medias (M0, M1, and M2) as well as positive (media + 10% fetal calf serum) and negative 
(serum free media) control medias were added to the lower wells of a Neuro Probe 48-well micro 
chemotaxis chamber.  The collagen coated chemotaxis filter was then placed over top of the 
macrophage conditioned media and 50,000 cells were added to each of the upper wells of the 
chemotaxis chamber.  Cells were then allowed to migrate across the chemotaxis filter for 3 hours 
in a 37ºC humidified 95% air/5% CO2 incubator.  Following the 3 hour migration period, non-
migrating cells on the upper side of the filter were removed with a rubber scraper and migrating 
cells on the underside of the filter were stained with DiffQuick prior to imaging under a bright 
field microscope.  Images of three 20x fields corresponding to the top left, top right, and bottom 
center side of each well were taken for each well.  The number of cells in each image was 
counted and an average for each well was determined.  Each sample was tested in quadruplicate 
and the mean number of migrated cells for each of the macrophage-conditioned medias was 
determined.  Each experiment was repeated at least twice and the results reported are the 
combined average for all assays performed. 
  135 
4.2.3 Statistical Methods 
 A two way analysis of variance (ANOVA) was performed on the immunolabeling 
quantification data and the gene expression data obtained as part of the unilateral and bilateral 
defect models to determine statistical significance of the factors of type of scaffold (unilateral: 
autograft, rat body wall ECM, cUBM, UBM; bilateral: autograft, CDI-UBM, UBM) and the 
factor of days (unilateral: 3, 7, 14, and 28 days; bilateral:1, 3, 7, 14, and 28 days).  For the 
immunolabeling data, the variables analyzed were the percentage of M1 and M2 cells (unilateral) 
or the number of M0, M1 and M2 cells (bilateral).  For the gene expression data, the variables 
analyzed were the expressions of the genes listed in Tables 7 (unilateral) and 8 (bilateral).  
Because the distributions of these variables were strongly skewed, log-transformed values were 
used for the statistical analysis and results were transformed back to the original scale for 
presentation.  This transformation corresponds to using geometric means in place of arithmetic 
means.  The Tukey multiple comparison procedure was then employed to determine which pairs 
of levels of factors were significantly different when a main effect was statistically significant. 
Additional student’s t-tests were used to determine whether there were statistically significant 
differences within scaffold groups which were related to the contralateral implant Results of the 
Boyden chamber assays were evaluated using a students T-test.  A p-value of p<0.05 was used to 
determine statistical significance. 
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4.3 RESULTS 
4.3.1 Macrophage Response Following Implantation of Extracellular Matrix Scaffolds 
4.3.1.1 Immunolabeling 
(a) Unilateral Model 
 The results of the immunolabeling evaluation showed that mononuclear macrophages 
(CD68+) were present in all four of the test article implantation sites at each of the time points 
investigated throughout the study period. 
A quantitative analysis of the phenotype of the macrophages present in the remodeling 
cellular autograft tissue test article showed that the polarized macrophages (those expressing 
either CCR7 or CD163) present in the remodeling cellular autograft were predominantly CCR7+ 
(M1) at 3, 7, 14, and 28 days post implantation (Figure 37A).  Conversely, the macrophages 
present in the remodeling rat body wall ECM test article were predominantly CD163+ (M2) at 3, 
7, 14, and 28 days (Figure 37B).  The macrophages present in the remodeling cUBM were 
observed to be predominantly CCR7+ at 3, and 7 days post implantation, with a mixed 
CCR7+/CD163+ population at 14 days followed by a predominantly CCR7+ population 
thereafter (Figure 37C). The macrophages present in the UBM were observed to be 
predominantly CD163+ at 3 days post surgery with a mixed CCR7+/CD163+ thereafter (Figure 
37D). 
It was observed that the patterns of macrophage polarization were similar for the cellular 
autograft and cUBM test articles, which elicited a CCR7:CD163 ratio that was skewed towards 
the CCR7+ phenotype at most of the time points examined during the present study.  In contrast, 
  137 
the acellular test articles elicited a CCR7:CD163 ratio that was skewed towards the CD163+ 
phenotype at most of the time points throughout the study period.  Figure 37 shows the 
phenotypic profile of the macrophages responding to each test article at each time point as well 
as the ratio of M1 to M2 cells in each test article. 
No significant interactions between scaffold type and time point were found.  For percent 
of M1 cells, both scaffold type and time were statistically significant (F=2.93, P<0.05 and 
F=5.26, P<0.003, respectively).  For percent of M2 cells only scaffold type was found to be 
statistically significant (F=17.22, P<0.0001).  For M1, there was a statistically significant 
difference between the mean at 7 and 14 days and the mean at 21 days; the mean for acellular 
body wall was significantly different from the mean for autologous body wall.  For M2, all pairs 
of scaffold type means exhibited statistically significant differences with the exception of cellular 
UBM versus autologous body wall. 
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Figure 37. Percentage macrophage polarization at 3, 7, 14, and 28 days post implantation of cellular autograft 
(A), rat body wall ECM (B), cUBM (D), or UBM (E). All values are presented as mean ± SEM. For percent of M1 cells, 
scaffold type and time were statistically significant (F=2.93, P<0.05 and F=5.26, P<0.003).  For percent of M2 cells, 
scaffold type was statistically significant (F=17.22, P<0.0001).  Ratio of the percentage of CCR7+:CD163+ macrophages 
present in the remodeling cellular autograft and rat body wall ECM (C) as well as the remodeling cUBM and UBM (F) at 
3, 7, 14, and 28 days post implantation.  Values above 1.0 are indicative of an M1 type response while values less than 1.0 
are indicative of an M2 type response.  Reproduced from (100) with permission from Elsevier. 
 
(b) Bilateral Model 
As in the unilateral body wall model, immunolabeling showed that there were CD68+ 
cells present within the sites of remodeling associated with all test articles at all of the time 
points examined.   
Immunofluorescent labeling was used in the bilateral defect study, allowing not only for 
quantification of the phenotype of the macrophages within the sites of remodeling, but also for 
the evaluation of the spatial distribution CCR7+ (M1) and CD206+ (M2) macrophages 
throughout the site of remodeling.  Few CD68+ cells were observed in remodeling site 
associated with any test article at 1 day post-implantation.  As was observed in the histologic 
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assessment in the previous section, the cells present at 1 day post-implantation were 
predominantly neutrophils.  By three days post-implantation, the autologous test article was 
characterized by a predominance of CCR7+ cells and a smaller number of CD206+ cells 
throughout the area of the necrotic skeletal muscle (Figure 38a).  A similar response was 
observed at seven days post implantation.  By 14 days post-implantation, the number of CCR7+ 
cells within the site of remodeling was decreased and the number of CD206+ cells had increased 
from the 7 day time point (Figure 38b).  CCR7+ cells were found to be located predominantly 
within the area of necrosis, with CD206+ cells present within the superficial border of the site of 
remodeling as well as within the underlying native muscular tissue.  By 28 days post-
implantation the number of both CCR7+ and CD206+ cells was greatly decreased as compared 
to other time points (Figure 38c).  The CDI-UBM test article was characterized by a strong 
CCR7+ macrophage response at all time points, especially at the interface between the test 
article and the host muscular tissue and at the superficial surface of the test article.  Few 
macrophages of either CCR7+ or CD206+ phenotype were send to invade the scaffold material.  
At 3 days post-implantation, predominantly CCR7+ macrophages were observed within the site 
of remodeling with few cells interacting with the surface of the material (Figure 38d).  A small 
number of CD206+ cells were observed at the periphery of the site of remodeling and within the 
native musculature.  A similar response was observed at 7 days post-implantation.  However, in 
contrast to day 3, CCR7+ macrophages were observed to be present at the surface of the 
material.  By 14 days a strongly polarized CCR7+ response was observed at the surface of the 
implanted material (Figure 38e).  This response coincided with the start of the foreign body giant 
cell response observed in the histologic analysis in the previous section.  Multinucleate giant 
cells were observed and stained positive for CCR7+ markers.  CD206+ macrophages were 
  140 
present within the site of remodeling, however were only found at the periphery and within areas 
encapsulating collagenous tissue deposition.  A similar distribution of cells was observed within 
the site of remodeling at 28 days post-implantation, with fewer CD206+ cells observed within 
the encapsulating layer (Figure 38f).  The UBM test article was characterized by a similar 
macrophage response as was observed for the CDI-UBM test article at 3 days post-implantation 
(Figure 38g).  By 7 days post-implantation, a mixed population of both CCR7+ and CD206+ 
cells was seen invading between the layers of the scaffold material and the number of CD206+ 
cells was higher than at 1 or 3 days.    By 14 days, the number of CD206+ macrophages began to 
decrease.  However, both CCR7+ and CD206+ macrophages were observed throughout the 
scaffold material (Figure 38h).  By 28 days, the number of both CCR7+ and CD206+ cells was 
decreased with a mixed population observed within the middle of the site of remodeling and a 
predominance of CD206+ macrophages at the interface with the native musculature as well as at 
the periphery of the remodeling site  (Figure 38i).  Figure 38 shows the macrophage response to 
each test articles at early (3 days), middle (14 days), and late stages (28 days) of the remodeling 
process. 
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The number of each type of macrophage observed at the surface of each scaffold material 
was quantified for each time point and a ratio of CCR7+:CD206+ cells was calculated.  Figure 
39 shows the counts of the number of macrophages staining positive for each surface marker as 
well as the CCR7+:CD206+ ratio for each scaffold material.  For M0 cells, time was shown to be 
a statistically significant factor (F=4.5623, p=<0.04), and significant interactions between time 
and scaffold material were found (F=4.5330, p<0.02).  Statistically significant differences were 
observed at the 14 and 28 day time points.  For M1 cells, neither scaffold type or time were 
found to be statistically significant, however statistically significant interactions between 
Figure 38. Immunolabeled images of macrophage response to the autograft tissue test article 
(A-C), the CDI-UBM test article (D_F) and the UBM test article (G-I).  Images shown are from 3 day 
(A,D,G), 14 day (B,E,H) and 28 day (C,F,I) post-implantation time points.  Orange=CCR7 (M1), 
Green=CD206 (M2), Blue=DRAQ5 (nuclei).  Image magnification = 10X, scale bar = 100 µm.  
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scaffold type and time were found to exist (F=6.1341, p<0.004).  Statistically significant 
differences between scaffold type were observed at the 28 day time point.  For M2 cells, only 
scaffold type was found to be a statistically significant factor (F=7.9981, p<0.001).  Statistically 
significant differences between scaffold types were observed at 28 days post-implantation.  For 
M1:M2 ratio, material was found to be a statistically significant factor (F=13.7723, p<0.0001) 
and significant interactions were found between scaffold type and time (F=6.8027, p<0.003).  
Statistically significant differences in the M1:M2 ratio between scaffold materials was observed 
at 1, 14, and 28 days post implantation.  
 
 
 
 
 
 
 
 
  143 
 
 
 
Figure 39.  Average number of CD68+ (pan-macrophage, A) in each 40X field.  Time was found to be 
a significant factor (F=4.5623, p<0.04), and a significant interaction was found between time and scaffold type 
(F=4.533, p<0.02).  Statistically significant differences were observed at 14 and 28 days post-implantation. 
Average number of CCR7+ (M1, B) cell per 40X field.  Significant interactions between time and scaffold 
were found (F=6.1341, P<0.004).  Statistically significant differences were observed at 28 days.  Average 
number of CD206+ (M2, C) cells in each 40x field.  Scaffold type was found to be a significant factor 
(F=7.9981, p<0.001).  Statistically significant differences were observed at 28 days.  Average ratio of M1 to 
M2 cells present within each 40x field (D).  Both scaffold type was found to be statistically significant factor 
(F= 13.7723, P<0.0001) and significant interactions between time and material were observed (F=13.7723, 
p<0.003).  Statistically significant differences between test articles were observed at 1, 14, and 28 days.  All 
data is presented as mean ± SEM.  White bar is autologous tissue, grey bar is CDI-UBM, black bar is UBM. 
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4.3.1.2 Gene Expression 
(a) Unilateral Model 
 Varying levels of iNOS (M1) and ARG (M2) gene expression were observed in all test 
articles throughout the course of the study.  However, expression levels in the cellular test 
articles were higher than expression levels in the acellular test articles for both of the genes 
examined at all time points with the exception of the 3 day time point in the rat body wall ECM 
test article.  The fold difference in gene expression between the cellular and acellular scaffolds 
ranged from 5.45 to 1904.91 depending on the time point and gene. Interestingly, it was 
observed that the fold increase in iNOS expression was larger than the fold increase in ARG 
expression in the cellular test articles at all time points.   
The expression of iNOS versus ARG was also compared in each individual test article.  
There was a mix of iNOS and ARG gene expression in the cellular autograft group, with a ratio 
of iNOS:ARG that was skewed towards iNOS expression at all time points with the exception of 
14 days (Figure 40A).  A mix of iNOS and ARG gene expression was also observed in the 
acellular allograft test article group (Figure 40B).  However, in the rat body wall ECM group the 
ratio of iNOS:ARG was skewed towards ARG gene expression at all time points (Figure 40C).  
Similarly, the cUBM group exhibited mixed iNOS and ARG gene expression with a skewing of 
the iNOS:ARG ratio towards iNOS expression at 3, 7, and 14 days post surgery changing to 
ARG gene expression at day 28 while the UBM group exhibited a iNOS:ARG ratio that was 
skewed towards ARG gene expression at all of the time points investigated (Figure 40D, 40E, 
40F).  
The gene expression profiles in both of the acellular test articles were similar with an 
increasing predominance of ARG expression from 3 to 14 days and a slight decrease at 28 days.  
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Conversely, in the cellular test articles, the gene expression ratio was skewed towards the 
expression of CCR7 at most of the time points investigated in this study.  Figure 40 shows the 
gene expression levels as well as the iNOS:ARG expression ratio in each of the test articles. 
No significant interactions between scaffold type and time point were found.  For M1 
gene expression, both scaffold type and time were statistically significant (F=2.98, P=<0.05 and 
F=21.11, P=<0.0001, respectively).  For M2 gene expression, only scaffold type was found to be 
statistically significant (F=44.33, P<0.0001). For M1, expression was found to be significantly 
higher at 28 days than at 3 days. For both iNOS and ARG, the expression in the cellular test 
articles was significantly higher than in the acellular test articles. 
 
 
Figure 40. Gene expression relative to housekeeping gene at 3, 7, 14, and 28 days post implantation of cellular 
autograft (A), rat body wall ECM (B), cUBM (D), UBM (E).  All values are presented as mean ± SEM.  For iNOS 
expression, scaffold type and time were statistically significant (F=21.11, P<0.0001 and F=2.98, P<0.05).  For arginase 
expression, scaffold type was statistically significant (F=44.33, P<0.0001).  Ratio of iNOS:arginase expression in the 
remodeling cellular autograft and rat body wall ECM (C) as well as the remodeling cUBM and UBM (F) at 3, 7, 14, and 
28 days post implantation.  Values above 1.0 are indicative of a predominance of iNOS expression while values less than 
1.0 are indicative of a predominance of arginase expression.  Reproduced from (100) with permission from Elsevier. 
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(b) Bilateral Model 
Varying levels were observed for both the M1 (iNOS, CXCL10, IL1β, IL6 and IL12) and 
M2 (ARG, IL1receptor antagonist, IL10, and E-Cadherin) genes examined in this study.  iNOS 
levels were observed to be greatly increased as compared to native tissue at the one day time 
point, especially in the CDI-UBM test article.  Levels were also observed to be elevated to a 
lesser degree in the UBM test article.  Expression of iNOS decreased at 3 and 7 days, but 
remained elevated as compared to native tissue.  At 14 days the expression of iNOS was shown 
to increase in the autologous tissue test article, but not in the CDI-UBM or UBM test articles.  
By 28 days, iNOS expression remained elevated in the CDI-UBM and UBM test articles, but 
expression in the autologous tissue test article had dropped below the level observed for native 
tissues.  Time was found to be a significant factor in iNOS expression (F=14.751, p<0.0005), 
and no interactions were found between scaffold type and time.  Statistically significant 
differences in expression between test articles were found at 1 and 7 days post-implantation. 
CXCL10 Expression was shown to increase from one to three days in all test articles 
examined. Levels in UBM and AT test articles continued to increase until 7 days and decrease at 
14 days; however, levels in the CDI-UBM test article decreased steadily from 3 to 14 days.  At 
14 days expression in all test articles was similar, but elevated as compared to native tissue.  
Increased expression was seen for the UBM and CDI-UBM test articles, however a slight 
decrease was observed for the autologous tissue test article.  Time was found to be a statistically 
significant factor (F=4.6570, p<0.04), and no interactions between scaffold type and time were 
found.  No statistically significant differences in CXCL10 expression between scaffold types 
were observed at any time point. 
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IL1β expression showed the largest number of statistically significant differences of any 
of the M1 genes investigated.  At 1 day, increased expression was observed in the CDI-UBM test 
article and UBM test article as compared to the autologous tissue test article, which while 
elevated as compared to native tissue, remained relatively steady throughout.  Expression in the 
UBM test article was found to be slightly higher than was observed for the autologous tissue or 
CDI-UBM test articles at 3 days post implantation.  Expression in all samples was seen to remain 
relatively steady thereafter.  Material was found to be a statistically significant factor (F=3.4206, 
p<0.05).  Statistically significant differences in expression between test articles was observed at 
1 and 3 days post-implantation. 
IL6 expression was slightly elevated in all samples as compared to native tissue.  
Expression remained relatively steady with the exception of an increase in expression in the 
UBM test article at 3 days post-implantation.  Neither time nor scaffold type were found to be 
significant factors and no interactions between scaffold type and time were found. 
IL12 expression was elevated in all test articles as compared to native tissue throughout 
the study period.  Expression was increased in all test articles at the 7 day time point, however 
the results were not statistically significant.  Levels were seen to decrease thereafter, with the 
exception of a small increase in expression in the UBM test article at 28 days. Neither time nor 
scaffold type were found to be significant factors and no interactions between scaffold type and 
time were found. 
As with MMP expression in Aim 2, small differences were observed within groups for 
implantation with a different contralateral material.  However, again as in Aim 2, these instances 
were few and did not occur in any discernable pattern.  Figure 41 shows M1 gene expression for 
each scaffold type at each of the time points investigated in the study. 
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Figure 41.  M1 gene expression.  (A) Expression of iNOS. Time was found to be a significant factor 
(F=14.751, p<0.0005).  Significant differences between scaffold materials were observed at 1 and 3 days. (B)  
Expression of CXCL10. Time was found to be a significant factor (F=4.6570, p<0.04).  Significant differences 
between scaffold materials were not observed at any time point. (C) Expression of IL1β. Scaffold material 
was found to be a significant factor (F=3.4206, p<0.05).  Significant differences between scaffold materials 
were observed at 1 and 3 days. (D) Expression of IL6. Neither scaffold material or time was found to be a 
significant factor.  Significant differences between scaffold materials were not observed. (E) Expression of 
IL12. Neither scaffold material or time was found to be a significant factor.  Significant differences between 
scaffold materials were not observed. 
 
 
  149 
ARG levels were observed to be greatly increased as compared to native tissue at the one 
day time point, especially in the CDI-UBM and UBM test articles.  Levels were also observed to 
be elevated to a lesser degree in the autograft test article.  Expression of ARG decreased at 3 and 
7 days, but remained elevated as compared to native tissue.  At 14 days the expression of ARG 
was to be similar for all test articles.  At 28 days, ARG expression in the CDI and UBM test 
articles was seen to increase, but expression in the autologous tissue test article remained at 
similar levels to those observed at earlier time points.  Both time and material were found to be a 
significant factors in ARG expression (F=10.9215, p<0.002 and F=4.0982, p<0.03, respectively), 
and no interactions were found between scaffold type and time.  Statistically significant 
differences in expression between test articles were found at 1, 3 and 7 days post-implantation. 
IL1ra expression showed the largest number of statistically significant differences of any 
of the M2 genes investigated.  At 1 day, increased expression was observed in the CDI-UBM test 
article and UBM test article as compared to the autologous tissue test article, which while 
elevated as compared to native tissue, remained relatively steady throughout.  By 3 days 
expression in the CDI-UBM test article were seen to drop to levels similar to those observed for 
autologous tissue.  CDI-UBM did not increase significantly thereafter.  UBM test articles 
showed a more gradual decrease from 1 to 14 days, and an increase at 28 days. Both material and 
time were found to be a statistically significant factors (F=11.8361, p<0.0001 and F=8.3442, 
P<0.006, respectively).  Statistically significant differences in expression between test articles 
was observed at 1, 3, 7 and 14 days post-implantation. 
IL10 expression was elevated in all samples as compared to native tissue from one to 14 
days post-implantation.  Expression was then observed to increase at 28 days for the UBM and 
CDI-UBM test articles with a greater increase in the UBM test article.  Neither time nor scaffold 
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type were found to be significant factors and no interactions between scaffold type and time were 
found. 
E-Cadherin expression was elevated in all test articles as compared to native tissue 
throughout the study period.  Expression was increased in all test articles at the 3 day time point, 
however the results were not statistically significant.  Levels were seen to decrease at 7 days, and 
then increase at 14 days. Levels were decreased at 28 days, however were still elevated as 
compared to native tissues. Neither time nor scaffold type were found to be significant factors 
and no interactions between scaffold type and time were found. 
Again, small differences were observed within groups for implantation with a different 
contralateral material.  However, again, these instances were few and did not occur in any 
discernable pattern.  Figure 42 shows M2 gene expression for each scaffold type at each of the 
time points investigated in the study. 
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Figure 42. M2 gene expression.  (A) Expression of ARG. .  Both time and material were found to be a 
significant factors in ARG expression (F=10.9215, p<0.002 and F=4.0982, p<0.03, respectively), and no 
interactions were found between scaffold type and time.  Statistically significant differences in expression 
between test articles were found at 1, 3 and 7 days post-implantation. (B)  Expression of IL1ra. Both material 
and time were found to be a statistically significant factors (F=11.8361, p<0.0001 and F=8.3442, P<0.006, 
respectively).  Statistically significant differences in expression between test articles was observed at 1, 3, 7 
and 14 days post-implantation. (C) Expression of IL10. Neither time nor scaffold type were found to be 
significant factors and no interactions between scaffold type and time were found. (D) Expression of E-
Cadherin. Neither scaffold material or time was found to be a significant factor.  Significant differences 
between scaffold materials were not observed.  
4.3.2 In Vitro Effects of Macrophage Phenotype Upon Cell Chemotaxis 
4.3.2.1 C2C12 Myoblasts 
The number of myoblasts which migrated in the Boyden chamber assay were quantified 
for medias conditioned by M0, M1 and M2 macrophages at varying time points (4, 8, 12, and 24 
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hours).  Results showed that myoblast migration which was similar for media from cultures of all 
macrophage types harvested at 4 hours.  Results from medias harvested at 8, 12, and 24 hours 
show that both M0 and M2 conditioned medias caused greater myoblast migration than did M1 
conditioned media.  However, all media types were observed to cause migration which was 
greater than or equal to that of the positive control at 8 hours.  M1 conditioned media caused 
migration which was less than the positive control at 12 and 24 hours.  The greatest migration 
response was seen in 8 hour conditioned medias from M0 and M2 cells.  No significant 
differences were found between M0 and M2 conditioned medias at any time point.  Statistically 
significant differences were found for the M0 and M2 groups as compared to the M1 medias 
harvested at 8, 12, and 24 hours. 
 
Figure 43. C2C12 myoblast migration towards culture supernatants from M0, M1, and M2 
macrophages at 4, 8, 12, and 24 hours post-implantation.  White bar represents M0 supernatants, grey bar 
represents M1 supernatants, and black bar represents M2 supernatants.  * denotes statistical significance, 
p<0.05. 
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4.3.2.2 MG-71 Pericytes 
Similar to the results obtained for C2C12 cells, no differences in pericyte migration were 
observed at the 4 hour time point for any of the conditioned medias.  At 8 hours it was shown 
that both M0 and M2 cells caused migration of pericytes which was statistically greater than was 
observed for M1 cells.  A similar result was seen for media conditioned for 12 or 24 hours.  The 
greatest pericyte migration response for any of the conditioned medias was observed for medias 
which were conditioned for 24 hours.  M2 conditioned media was observed to cause statistically 
greater migration of pericytes than was M0 conditioned media when harvested at 8, 12, and 24 
hours. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 44. MG-71 pericyte migration towards culture supernatants from M0, M1, and M2 
macrophages at 4, 8, 12, and 24 hours post-implantation.  White bar represents M0 supernatants, grey bar 
represents M1 supernatants, and black bar represents M2 supernatants.  * denotes statistical significance as 
compared to M0, p<0.05.  ** denotes statistical significance as compared to both M0 and M1, p<0.05. 
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4.4 DISCUSSION 
The present study examined the effects of the presence of a cellular component within a scaffold 
derived from extracellular matrix or chemical crosslinking used in its production upon the 
polarization of the macrophages participating in the host response following implantation.  The 
study also examined the relationship between macrophage polarization and the host tissue 
remodeling events until 28 days post-implantation.  The results of the study indicate that the 
presence of a cellular component or the use of chemical crosslinking shifts the macrophage 
polarization profile towards a more M1, pro-inflammatory phenotype and is associated with a 
more pro-inflammatory gene expression profile.  Further, the results of this study suggest that 
macrophage polarization is indeed linked to tissue remodeling following implantation of a 
biologic scaffold. 
The mechanisms by which mammals respond to whole organ transplantation are 
reasonably well understood.  Immune recognition of xenogeneic and allogeneic cellular antigens 
occurs followed by the production of pro-inflammatory mediators, cytotoxcicity, and resultant 
organ rejection.  The mechanisms of the host immune response to acellular biologic scaffolds 
composed of ECM, either allogeneic or xenogeneic, are neither as well studied nor as well 
understood.  The preparation of an ECM scaffold for regenerative medicine applications involves 
decellularization of the tissue or organ from which the ECM is harvested (67).  The removal of 
cellular components produces a markedly different type of ‘tissue graft’ than is typically 
presented with autogenous, allogenous, or xenogeneic whole organ grafts.   
An ECM scaffold consists primarily of the ECM constituent molecules, many of which 
are known to be highly conserved across species, thus mitigating many of the adverse 
components of the immune response (7, 86).  Studies have shown, however, shown that both 
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DNA fragments and, in the case of porcine derived ECM scaffolds, Galactosyl-α(1,3)galactose 
(Gal) epitope are present within ECM scaffolds following the decellularization process (95, 198).  
The amount of Gal epitope (a molecule known to cause hyper acute rejection in xenotransplants 
(218, 219)) present within porcine derived ECM scaffolds was found to be insufficient to cause 
the activation of complement in human plasma (198). Furthermore, despite the presence of these 
cellular components, many of which are well known for their ability to initiate a host 
inflammatory/immune response, ECM scaffolds have been shown to elicit constructive tissue 
remodeling.  The decellularization methods used to process ECM scaffolds may alter these 
molecules such that they can no longer negatively influence the host response or there may be a 
threshold amount required to alter the host response to an ECM scaffold.   
As was shown in Aim 2, and as has been shown elsewhere, the host response following 
the implantation of an ECM scaffold that has not been chemically cross-linked or seeded with 
cells is characterized by an immediate and intense neutrophil and mononuclear cell infiltration 
followed by a shift to primarily mononuclear cells within 72 hours (69, 82).  Rapid degradation 
of the ECM scaffold is followed by replacement with organized, site appropriate functional host 
tissue (69, 82, 98).  Interestingly, although the host response involves a large infiltration of 
mononuclear cells, an event conventionally associated with inflammation, there is a lack of the 
usual cytotoxic mediators of inflammation and graft rejection, with resultant formation of a 
polarized type 2 T lymphocyte (Th2) response (86).   
A number of studies have shown differences and, in some cases, improvements in tissue 
remodeling outcomes when a cellular component has been placed in contact with an ECM 
scaffolds during or prior to implantation (27, 31, 39).  However, the effect of these cells upon the 
resultant host response remains an open question.  A recent study investigated differences in 
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remodeling of ECM based bioscaffolds with and without cells in a primate model, finding that 
the presence of cellular content was associated with increased levels of pro-inflammatory 
cytokines, increased macrophage activation, and a poor remodeling outcome (220).  In the 
present study, it was observed that the presence of a cellular component, either xenogeneic or 
autologous, altered the host response toward an M1 phenotype compared to the phenotype that 
was observed with an acellular ECM scaffold alone.   
The previous studies, and those published elsewhere, have demonstrated that there were 
temporal and spatial distribution differences in the neutrophil and mononuclear cell populations 
that participate in the host response to an implanted ECM scaffold depending on the origin of the 
ECM as well as the methods used to process the scaffold, and that these differences were related 
to the downstream tissue remodeling outcome (69).   Further investigation these same scaffold 
materials in the present studies showed that test articles which were chemically cross-linked did 
not show any significant degradation during the study period following implantation, resulted in 
a more M1 type macrophage response, and resulted in a host response that was characterized by 
chronic inflammation.  Conversely, non-cross-linked test articles degraded rapidly following 
implantation, elicited a more M2 type response, and resulted in constructive tissue remodeling of 
the abdominal wall including organized collagenous connective tissue, islands of skeletal 
muscle, and blood vessels (96).  It is clear from these studies that the phenotype of mononuclear 
macrophages that participate in the host response to implanted biologic scaffold materials plays 
an important role in determining the extent of a constructive tissue remodeling outcome versus 
destructive, scar tissue outcome.  
In vitro work performed in the present studies showed that the culture supernatants from 
all macrophage populations (M0, M1, and M2) were capable of promoting the chemotaxis of 
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progenitor cell populations (C2C12 and MG-71 pericytes).  However, the degree of chemotaxis 
was shown to differ depending on the cell population investigated.  In general, M0 and M2 
macrophages were shown to promote greater chemotaxis than did M1 cells.  These results 
parallel those shown in another study which investigated the ability of M1 and M2 macrophages 
to recruit a mesangioblast population (221).  The study showed that the mechanism of 
chemotaxis was different for M1 and M2 cells.  The effects of M0, M1, and M2 effector 
molecules upon the phenotype and survival of the recruited progenitor cell populations in the 
long term remains unclear.  
4.5 CONCLUSIONS 
The present study showed that the presence of a cellular component within an extracellular 
matrix scaffold or the use of chemical cross-liking in scaffold production modulates the 
phenotype of the macrophages participating in the host response following implantation.  It was 
observed that those test articles that contained a cellular component, even an autologous cellular 
component, elicited a more M1 type macrophage response and resulted in the deposition of 
dense connective tissue and/or scarring.  A distinct macrophage response was elicited by those 
test articles which were chemically cross-linked; however, chemical cross-linking was also 
shown to result in a more M1 (or less M2) type macrophage response.  Those test articles that 
did not contain a cellular component and were not chemically cross-linked, however, were 
observed to elicit a more M2 type macrophage response and resulted in a more constructive type 
remodeling response.  It was also observed that the macrophage response to one test article did 
not appear to affect the macrophage response to a second material implanted concurrently within 
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the same animal.  Lastly, in vitro results suggest that M0, M1, and M2 macrophages have distinct 
paracrine effects upon other cell populations, in this case the chemotaxis of progenitor cell 
populations, further suggesting distinct roles for macrophage subpopulations in tissue 
remodeling. 
4.6 LIMITATIONS AND FUTURE DIRECTIONS 
There were several limitations in the present study.  A limited number of surface markers were 
utilized for the characterization of the M1/M2 profile of the macrophages participating in the 
host response.  The choice of markers was mainly due to the limited availability of antibodies 
specific for M1 and M2 markers in the rat model.  It is also recognized that species variations do 
exist.  The markers chosen for this study are known to be highly indicative of M1 or M2 
polarization in multiple animal and human models.  Multiple studies have shown that CCR7 is 
highly expressed on M1 polarized cells and that CD163 and CD206 are highly indicative of M2 
type anti-inflammatory polarization (141, 222).  A limited number of gene expression markers 
were also used in this study.  However, iNOS and arginase expression, used in the unilateral and 
bilateral studies, are widely viewed as markers of M1 and M2 polarization, respectively.  In the 
bilateral study an expanded set of markers were examined however, the greatest statistically 
significant differences were observed for IL1β and IL1ra.  Additional studies exploring the ways 
in which ECM scaffolds are capable of modulating the IL1 expression pathway may yield 
insights into the role of M1 and M2 macrophages in the response to ECM scaffold materials and 
the ability of ECM scaffolds to promote constructive tissue remodeling. 
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In the present study, a population of CD68+ macrophages was observed within the 
wound site, some of which did not stain positive for either M1 or M2 surface markers.  These 
cells may have only just arrived at the site of remodeling and, thus, might not yet have been 
stimulated to undergo activation or polarization towards an M1 or M2 phenotype.  Macrophages 
that have not yet been polarized towards an M1 or M2 phenotype would not express markers 
indicative of polarization. Therefore, it is logical to expect that the percentages of CCR7+ and 
CD163+ cells would not sum to 100%.  Perhaps more importantly, it is presently not known 
what percentage of M1 or M2 cells is required to influence the formation of a scar tissue or 
constructive tissue remodeling response, respectively (i.e. a threshold effect).  It is hypothesized 
that the ratio of M1:M2 cells may be more important than the absolute number of cells.  There is 
clearly a correlation of the M1:M2 ratio to remodeling outcome in the present study.   
Similarly, in the bilateral body wall study, cells expressing various combinations of 
CD68, CCR7 and CD206 were observed, but not quantified.  It is possible that a percentage of 
the macrophages participating in the host response to ECM scaffolds may not express a fully 
polarized M1 or M2 phenotype. A recent study showed that cells within the site of ECM 
mediated tissue remodeling expressed both macrophage and primitive stem cell markers and 
could be differentiated along all three lineages, suggesting a potentially unique role for 
macrophages in ECM scaffold remodeling (223).  Other studies have shown that myeloid to 
mesenchymal transition is possible for cells responding to an implanted material, again 
suggesting potentially unrecognized roles for macrophages in tissue remodeling (224). 
Additional studies to determine the exact phenotype of the cells observed within sites of ECM 
mediated remodeling are warranted and will provide additional information on the mechanisms 
by which ECM scaffolds are capable of promoting constructive tissue remodeling. 
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In vitro studies showed that M0, M1, and M2 macrophages were capable of causing the 
chemotaxis of progenitor cell populations.  While the recruitment of muscle and vascular 
progenitor cells to sites of ECM remodeling have been shown in previous studies (225), the role 
of macrophages in promoting the observed recruitment of progenitor cells in vivo is not yet clear.  
Additional studies are needed to determine if in vivo macrophage populations possess the same 
ability as were observed in the present in vitro study.  Additionally, the effects of M0, M1, and 
M2 macrophage populations upon the phenotype and survival of recruited cells has not yet been 
described. 
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5.0  DISSERTATION SYNOPSIS 
The work presented in this dissertation examined the effects of the tissue source and methods 
used to produce extracellular matrix (ECM) scaffold materials upon the structural and 
compositional characteristics of the resultant scaffold, the effects of these characteristics upon 
the ability of the material to support and modulate cell growth in vitro as well as to act as an 
inductive template for the formation of functional site-specific host tissues in vivo, and the role 
of macrophages in determining the ability of an ECM based scaffold material to promote the 
observed “constructive tissue remodeling” outcome.  The major findings for each specific aim 
are outlined below. 
5.1 MAJOR FINDINGS 
The major findings of the present work were: 
 
Specific Aim 1: To determine the effects of tissue source and chemical cross-linking 
upon the structure and composition of ECM scaffold materials, and to show that these 
characteristics have effects upon patterns of cell behavior in vitro. 
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• ECM scaffolds derived from each tissue or organ possess a distinct surface 
ultrastructure and chemical composition 
• Certain ECM scaffolds possess a distinct “sidedness” which is related to the 
function of the tissue or organ of interest 
• Chemical crosslinking changes the ultrastructure and chemical composition of the 
surface of ECM scaffolds 
• Differences in the surface characteristics of ECM scaffolds derived from different 
tissues and organs, or associated with scaffold sidedness, have distinct effects 
upon the behavior of cells in vitro 
• ToF-SIMS is a highly sensitive method for the detection and differentiation of the 
molecular composition of the outermost surface of an ECM scaffold 
 
Specific Aim 2: To determine the effects of the presence of a cellular component within 
an extracellular matrix scaffold and the use of carbodiimide during scaffold production upon the 
capacity of extracellular matrix scaffolds to elicit a constructive tissue remodeling versus 
encapsulation or scar tissue type remodeling response in model of rat abdominal wall 
musculature reconstruction. 
Sub-Aim:  To determine whether the host remodeling response to one ECM scaffold 
material affects the outcome of the host remodeling response to a second material implanted 
concurrently in the same animal. 
• ECM scaffolds were capable of facilitating constructive tissue remodeling in a 
model of rat abdominal wall musculature reconstruction 
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• The presence of a cellular component, even an autologous cellular component, 
within an extracellular matrix scaffold affects the ability of the scaffold material 
to facilitate constructive tissue remodeling following implantation 
• Chemical crosslinking with carbodiimide affected the ability of an ECM scaffold 
to facilitate constructive tissue remodeling following implantation  
• The host response to one implanted ECM scaffold material did not appear to 
affect the host response to a second ECM scaffold material implanted in the same 
animal 
 
 Specific Aim 3: To show that extracellular matrix scaffolds are capable of altering the 
default host macrophage response following implantation, and that the modulation of the host 
macrophage response is related to the ability of the scaffold to promote the constructive versus 
encapsulation or scar tissue type remodeling responses observed in Aim 2. 
Sub-Aim:  To evaluate the effects of polarized macrophages upon the in vitro behavior 
of other cell types. 
• Acellular, non-crosslinked ECM scaffolds alter the default host macrophage 
response following tissue injury 
• Macrophage phenotype is related to tissue remodeling outcome 
• The ability to modulate the host macrophage response was changed when cells 
were present or when the scaffold was crosslinked with carbodiimide 
• The macrophage response to individual test articles was not observed to affect (or 
be affected by) the response to other test articles implanted in the same animal  
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• Macrophage polarization may have an effect upon the tissue remodeling outcome 
through the induction, or inhibition of chemotaxis 
5.2 CONCLUSIONS 
The work contained within this dissertation describes the effects of tissue source and production 
methods upon the characteristics of the resulting ECM scaffold material.  These characteristics 
were shown to have distinct effects upon patterns of cell growth in vitro as well as the ability of 
the scaffold material to function in vivo.  It is clear that an in-depth understanding of the ways in 
which scaffold characteristics affect the behavior of cells both in vitro and in vivo is required for 
the design and production of ECM scaffold materials to be used in the reconstruction of complex 
three-dimensional tissues and organs.  It is also clear that scaffold characteristics have an impact 
upon the host response elicited by the material following in vivo placement.  In particular, the 
phenotype of the macrophages which responds to implanted scaffold materials has been shown 
to play an important role in determining whether the interaction of the host with the implanted 
material results in encapsulation, scar tissue formation, or constructive tissue remodeling.  A 
better understanding of the mechanisms which underlie the macrophage behaviors observed in 
the present work will lead to the design of new biomaterials and strategies for the inductive 
reconstruction of complex tissues and organs. 
 
  165 
APPENDIX A 
SITE SPECIFIC CONSTRUCTIVE TISSUE REMODELING OF AN 
EXTRACELLULAR MATRIX SCAFFOLD IN A MODEL OF CANINE 
TEMPOROMANDIBULAR JOINT MENISCUS RECONSTRUCTION 
A.1  BACKGROUND 
Temporomandibular joint (TMJ) disorders (TMD) are a common problem, which affects women 
up to 9 times more often than men, and usually involves a spatial dislocation and/or a structural 
defect of the enclosed cartilaginous meniscus (226-229).  A variety of procedures, including 
minimally invasive surgical techniques, have been used to treat TMD. However, meniscectomy 
is often indicated when the TMJ meniscus is irreparably damaged or if the meniscus prohibits the 
fluid, smooth movement of the condyle (230-237).  Complications arising from meniscectomy 
without replacement can include articular surface defects, heterotopic bone formation, and joint 
ankylosis.   
The rationale for replacing damaged TMJ menisci with substitute materials is to protect 
the articular surfaces from degenerative changes and to avoid joint adhesion formation.  
Alloplastic materials such as Silastic, silicone and Proplast-Teflon, have been used to replace the 
TMJ meniscus following meniscectomy, but results have been less than satisfactory (238-240).  
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In some cases, joint pathology has been found to be severe following the placement of such 
devices.  Autograft tissues have been used both as meniscus replacement materials following 
meniscectomy and as interpositional materials in the treatment of joint ankylosis.  Autologous 
tissue sources such as the temporalis muscle flap, auricular cartilage and dermis have proven to 
be better options than their alloplastic counterparts. However, the morbidity associated with the 
graft donor site remains an obvious disadvantage of these options(241-245).  Furthermore, 
fibrosis, or in the case of the temporalis muscle flap, devitalization and necrosis, of autologous 
tissue grafts has been observed.  The ideal graft material for the treatment of TMJ pathology 
resulting from meniscus abnormalities would provide a substrate for cellular ingrowth and site-
appropriate tissue deposition, prevent degenerative changes of the condyle and the fossa, and be 
readily implanted without the associated morbidity of autologous tissue harvest. 
 Regenerative medicine approaches to tissue reconstruction often utilize implantable 
synthetic or naturally derived materials with a goal of inducing the restoration, or regeneration, 
of the native structure and function of the tissue of interest.  Scaffolds composed of multiple 
forms of allogeneic and xenogeneic extracellular matrix (ECM) have been successfully used as 
inductive templates for tissue reconstruction in a number of regenerative medicine applications 
(213).  The tissue sources of such ECM scaffolds include the small intestine, urinary bladder, and 
skin, among others.  The typical construct resulting from the processing of these materials 
consists of flat, two-dimensional, sheet-like shapes, which can limit their potential clinical 
application (67).  Recently, the production of a particulate form of an ECM scaffold for the 
development of three-dimensional scaffolds has been described (24). 
In the present study, a device consisting of particulate ECM derived from porcine urinary 
bladder (UBM-ECM) was encased within sheets of UBM-ECM to provide a resorbable “pillow” 
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or interpositional material and an anchoring site while mimicking the shape and size of the native 
canine TMJ meniscus.  The device was implanted in a canine model consisting of either a 
unilateral TMJ meniscectomy or a bilateral minesectomy with implantation on only one side and 
the remodeling of the device was assessed at time points of 3 weeks, 1, 2, 3 and 6 months post-
implantation. 
A.2 MATERIALS AND METHODS 
A.2.1 Overview 
Fifteen female mongrel dogs were subjected to either a unilateral meniscectomy followed by 
replacement of the meniscus with a UBM-ECM device (n=5) or a bilateral meniscectomy with 
replacement of the meniscus on only one side, leaving the contralateral side empty (n=10).  The 
UBM-ECM device consisted of particulate UBM-ECM encapsulated between sheets of UBM-
ECM forming a “pillow-like” device.  At time points of 3 weeks (n=1), 1 (n=1), 2 (n=1), 3 (n=1), 
and 6 months (n=1 unilateral and n=10 bilateral), animals was sacrificed and the condylar head, 
temporal fossa, and the UBM-ECM implant were excised and assessed using histologic and 
immunolabeling methods.  
A.2.2 UBM-ECM Device Preparation 
UBM-ECM was prepared from porcine bladders as previously described (1).  Briefly, urinary 
bladders were harvested from market weight pigs immediately following sacrifice.  The bladder 
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tissue was rinsed in water to facilitate the removal of excess urine and the urothelial cell layer.  
Excess connective and adipose tissue was removed from the serosal surface of the bladder using 
scissors.  The apex of the bladder was removed and the bladder was then split longitudinally 
from the apical opening to the neck of the bladder forming a rectangular sheet. The tunica serosa, 
tunica muscularis externa, tunica submucosa, and the majority of the muscularis mucosa were 
removed by mechanical delamination of the abluminal side of the bladder.  The remaining tissue 
consisted of the basement membrane, tunica propria, and resident cells.   
The tissue was then treated in a 0.1% peracetic acid/4% ethanol solution for two hours to 
initiate decellularization and disinfection of the tissue.  Following treatment in the peracetic 
acid/ethanol solution, the tissue was repeatedly washed in phosphate buffered saline (PBS; pH 
7.4) and water to remove cellular remnants and traces of the peracetic acid/ethanol solution and 
to return the pH of the material to 7.4.  The remaining decellularized tissue was stored in water 
until used and represented the hydrated sheet form of UBM-ECM.  A portion of the hydrated 
sheet form of UBM-ECM was frozen and lyophilized.  The dry sheet was cut into smaller pieces 
and comminuted using a Wiley mill with a #60 mesh screen.  The comminuted UBM-ECM 
represented the particulate form of UBM-ECM.   
A hard plastic mold was milled to create an oval-shaped depression with the approximate 
size of the desired central core of the TMJ device (10 mm x 14 mm oval, 2 mm depth) and a flat 
surface surrounding the depression to allow for the formation of a “pillow-like” core and a flat 
anchoring site.  Two hydrated sheets of UBM-ECM were then cut to size and placed onto the 
mold.  Following placement, the hydrated sheets were pressed to line the inside of the 
depression, creating a pocket into which particulate UBM-ECM was packed.  Approximately 
200-300 mg of the ECM powder was packed into the depression and two hydrated sheets were 
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cut to size and placed over the top of the powder to create an enclosed core.  The constructs were 
subjected to a vacuum of at least 28 inches Hg until dry, forming a multilaminate construct.  
Figures 45A and 45B show macroscopic views of the multilaminate UBM-ECM construct. 
All constructs were terminally sterilized using ethylene oxide prior to implantation. 
 
Figure 45. Macroscopic images of the pre-implantation UBM-ECM device. (A) Whole scaffold, scale 
bar = 1 cm. (B) Cross sectional view of the “pillow” portion of the device, scale bar = 2.5 mm. 
A.2.3 Animal Model 
Adult female mongrel dogs of approximately 15-20 kg were purchased from Marshall Bio-
Resources USA.  All animals were examined by a veterinarian prior to surgery and were found 
to be in good health and all animal procedures were performed in compliance with the 1996 
National Institutes of Health “Guide for The Care and Use of Laboratory Animals” and approved 
by the Institutional Animal Care and Use Committee at the University of Pittsburgh. 
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A.2.4 Unilateral Surgical Procedure 
All animals were sedated with acepromazine (0.1-0.5 mg/kg body weight) prior to intubation and 
maintained in a surgical plane of anesthesia with isoflurane (1-5%).  The surgical site was shaved 
then prepared using a betadine scrub prior to the placement of sterile drapes.  An incision was 
made anterior to the tragus, preserving the local innervation and vasculature.  The native 
meniscus was exposed then completely excised.   
The UBM-ECM implants were hydrated in sterile saline (0.9%) for approximately 10 
minutes prior to implantation as a replacement device for the native meniscus.  The implants 
were placed such that the powder “pillow” was positioned between the temporal fossa and the 
condylar head.  Three holes were created in the temporal fossa and the implants were secured to 
the temporal fossa using slow resorbing fixation sutures.  Fixation sutures were also placed in the 
anterior and posterior aspects of the implant to adjacent soft tissue.  The skin was closed using 
resorbable suture material.  Figure 46 shows images of the surgical procedure. 
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Figure 46. Surgical procedure. (A) Native meniscus is exposed and isolated. (B) Joint space following 
removal of the native meniscus. (C) UBM-ECM device placed between mandibular condyle and temporal 
fossa. (D) UBM-ECM device fixed to fossa with slow resorbing sutures. F = fossa, C=condyle, Arrows = UBM-
ECM device. 
A.2.5 Bilateral Surgical Procedure 
The surgical procedures used for the creation of the bilateral defect were identical to those 
described above for the unilateral defect with the exception that a defect was created on both 
sides of the canine mandible.  One side then underwent reconstruction of the meniscus with the 
UBM-ECM device and the other was left empty as a control.   
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A.2.6 Post Operative Care 
Postoperative care was identical for animals which received either the unilateral or bilateral 
defect.  Following the surgical procedure, the animals were recovered from anesthesia, 
extubated and monitored until resting comfortably in a sternal position. The animals were then 
monitored and the following parameters were recorded every 3 hours for the first 24 hours post 
surgery:  pulse rate, strength of pulse, capillary refill time, respiratory rate and ability to 
maintain an open airway, urinary output, and defecation.  Body temperature was measured and 
recorded every 12 hours. The animals were restricted to confinement housing (not more than 2-
3 days) until stable, and were then placed in 10x14 ft runs and allowed free movement. 
Buprenorphine was administered (0.005 – 0.01 mg/kg body weight) for 5 days post operatively 
and then as needed thereafter for pain management.  The dogs were also given Cephalexin (35 
mg/kg body weight) for 5 days post-operatively.  Animals were fed a soft diet for the first 5-7 
days post operatively and were returned to a normal hard diet thereafter. 
A.2.7 Euthanasia and Sample Harvest 
On the predetermined date of sacrifice, the animals were sedated with acepromazine (0.1-0.5 
mg/kg body weight), anesthetized using isoflurane (5%) and euthanized by intravenous 
administration of pentobarbital sodium (390 mg/4.5 kg body weight).  Following euthanasia, the 
temporal fossa, the condylar head, and the interpositional material between the structures were 
excised and fixed in 10% neutral buffered formalin for histologic examination and 
immunolabeling.  Native fossa, condyle, and meniscus tissues were also harvested as control 
specimens and were treated in identical fashion as the experimental explant tissues.  
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 Animals which were subjected to the unilateral defect were sacrificed at 3 weeks, 1 
month, 2 months, 3 months, and 6 months post-implantation (n=1/time point).  Animals which 
were subjected to the bilateral defect were all sacrificed at 6 months post-implantation (n=10).  
Meniscus tissue from five of the 10 animals sacrificed in the bilateral model were not fixed in 
formalin, but rather harvested and then subjected to the mechanical and biochemical testing 
described below. 
A.2.8 Gross Morphologic Examination 
At the time of explant, the joint space of all animals was examined for signs of pathology 
including degeneration of the articulating surfaces of the temporal fossa and mandibular condyle.  
A.2.9 Histologic Evaluation 
Formalin fixed tissues were embedded in paraffin, cut into 6 µm sections and mounted on glass 
slides.  Sections were deparaffinized by immersion in xylenes followed by a graded series of 
ethanol.  The slides were stained using hematoxylin and eosin or Herovici’s polychrome, and 
were then dehydrated in ethanol and xylenes prior to coverslipping.  The slides were evaluated 
by light microscopy.  Pre-implant UBM-ECM devices were subjected to histologic evaluation 
using the methods described above.   
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A.2.10 Immunolabeling Studies 
Sections of the TMJ meniscus tissue were labeled using antibodies specific for CD31 
(Neomarkers), CD68 (Dako), smooth muscle actin (SMA, Dako), and calsequestrin (CAL, 
Abcam) to determine the presence of blood vessels, macrophages, fibroblasts, and skeletal 
muscle cells, respectively, within the remodeling UBM-ECM implant.  Slides were 
deparaffinized by immersion in xylenes and a graded series of ethanol.  Antigen retrieval was 
then performed by boiling slides in 10 mM citric acid monohydrate (pH 6.0) for 20 minutes.  
Following antigen retrieval, the slides were exposed to a solution consisting of TRIS buffered 
saline and 0.05% Tween 20.  Slides were then washed in PBS (pH 7.4) three times for a total of 
10 minutes and a solution of 3% H2O2 in methanol was applied for 30 minutes at room 
temperature to quench endogenous peroxidase activity.  Slides were blocked in a solution 
consisting of 2% normal serum, 1% BSA, 0.1% Triton-X 100, and 0.05% Tween 20 in PBS for 
30 minutes at room temperature.  Primary antibodies were diluted in the blocking solution 
(CD31 – 1:250, CD68 – 1:100, SMA – 1:200, CAL - 1:400) and applied to the slides overnight 
at 4°C.  Slides were washed in PBS, and peroxidase conjugated secondary antibodies diluted in 
blocking solution (CD31 and CD68 - 1:100, SMA – 1:250, CAL 1:400) were applied for 30 
minutes at room temperature.  The slides were washed in PBS and water prior to development 
using 4% diaminobenzadine substrate solution.  Finally, slides were counterstained using 
hematoxylin, dehydrated using the reverse of the dewaxing procedure above, and coverslipped 
for examination under light microscopy. 
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A.2.11  Quantification of Histologic and Immunolabeled Images 
Changes in the number of cells which were present within the remodeling implants over time 
was assessed by counting the number of hematoxylin stained nuclei in five 20x images taken 
from random locations within the bulk of the remodeling devices at 1, 3, and 6 months post-
implantation.  Nuclei were counted using an automated cell counting algorithm in ImageJ image 
analysis software (National Institutes of Health, http://rsbweb.nih.gov/ij/).  The number of 
CD31+ vessels in each image was also quantified, as was vessel diameter and the total area 
occupied by vasculature in each 20x image.  Quantification of CD31+ vessels was again 
performed using image analysis tools available in ImageJ.  A student’s t-test was used to assess 
the statistical significance of the results with a p-value<0.05 indicating statistical significance. 
A.2.12 Biomechanical Testing 
Mechanical properties of the remodeled UBM-ECM devices explanted from the bilateral defect 
model were tested using an MTS Insight Mechanical Tester.  Briefly, 4 mm cylindrical punches 
were taken from the center of the samples and placed in a 37°C saline bath prior to testing. A 
pre-load of 0.1 N was applied for 30 minutes prior to preconditioning, which consisted of 10 
cycles between 0-10% strain at a 9%/minute strain rate. Samples were then tested in unconfined 
compression to 10% strain.  Samples were then allowed 30 minutes to reach equilibrium and 
stress-relaxation behavior was determined.  Mechanical properties data obtained for remodeled 
samples were compared to values obtained both for the pre-implantation UBM-ECM device and 
for native canine meniscus tissue. 
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A.2.13 Biochemical Content Testing 
Collagen and GAG contents were determined as a percentage of scaffold dry weight using a 
hydroxyproline assay and a Blyscan sulfated glycosaminoglycan assay as per manufacturers 
protocol.  Water content was determined as the percentage of water by weight by allowing the 
tissue to become saturated in a 37°C water bath, measuring the weight of the sample, and then 
comparing to the weight of the sample following complete lyophilization.  All values obtained 
for collagen, GAG, and water content were compared to values obtained for the pre-implantation 
UBM-ECM device and for native canine TMJ tissue. 
A.2.14 Statistical Methods 
Statistical significance of the mechanical properties and biochemical testing data were 
determined using a students T-test.  P-values of p<0.05 were used to determine statistical 
significance. 
A.3 RESULTS 
All of the animals in this study survived the surgical procedure and lived until their 
predetermined sacrifice date without complication.  Appetite and mastication were unaffected. 
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A.3.1 Gross Morphologic Findings 
Gross morphologic examination showed little to no change in the articulating surfaces of the 
temporal fossa or the mandibular condyle at any time point following placement of the UBM-
ECM device.  There were no signs of synovitis, or excess fluid in the joint space. The UBM-
ECM device showed progressive remodeling and was replaced with a structure that highly 
resembled the fibrocartilage of the native TMJ disc by the 6-month post surgical time point. It 
was not possible to differentiate the original UBM-ECM device from newly deposited host tissue 
at any of the time points investigated in this study.  Figure 47 shows gross morphologic images 
of the remodeled UBM-ECM constructs explanted at 1, 2, 3, and 6 months.  There was a thin 
film of vascular connective tissue covering the surface of the white firm tissue that represented 
the remodeled UBM-ECM device.  Similar findings were observed in both the unilateral and 
bilateral reconstruction models. 
 
 
Figure 47. Macroscopic images of remodeled UBM-ECM device at (A) 1 month, (B) 2 months, (C) 3 
months, and (D) 6 months post-implantation. Untreated, contralateral native meniscus (E) is also shown for 
comparison. 
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 Figure 48. Gross morphology of the implant site and explanted tissues at 6 months post 
surgery.  (A) Implant site pre-explantation.  Fossa (F), condyle (C), and interposed UBM-ECM 
device are shown. (B)  Implant site with condyle removed.  Underside of remodeled UBM-ECM 
device is visible.  (C)  Removal of UBM-ECM device from implant site.  (D) Condyle is shown, note 
smooth surface appearance and little to no irregularities or pitting.  (E)  Fossa is shown, note smooth 
shiny articulating surface.  (F)  Explanted meniscus is shown.  A loose network of vasculature was 
observed surrounding the explanted tissue.  
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Figure 49. Control side at explant – six months post surgery.  (A) Site of meniscectomy pre-
explantation.  Fossa (F) and condyle (C) are shown.  No interpositional tissue was observed in the control side 
of any animal.  Some fibrotic tissue was observed within the site (arrow).  (B) Underside of fossa is shown 
following explant of the condyle.  Fibrotic tissue formation was observed (arrow).  (C) Condyle is shown, note 
irregular surface and pitting (asterisk).  (D) Fossa is shown, note irregular surface and pitting. 
A.3.2 Histopathologic Findings 
Histologic evaluation was performed both at the center of the remodeling implant and at the 
periphery of the implant to determine the bulk morphology of the remodeling device and the 
degree of integration of the device with the muscular tissues at the peripheral attachment sites. 
 
Pre-Implantation UBM-ECM Device  
 Histologic staining of the UBM-ECM device showed small particles of mature, well-
organized collagenous extracellular matrix (UBM-ECM powder) encapsulated within sheets of 
the same.  The particles were randomly oriented and the internal structure of the device was 
highly porous.  The exterior surface of the device was also composed of mature, well-organized 
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collagenous extracellular matrix and was characterized by a smooth surface and dense structure 
(UBM-ECM sheets).  Figure 50 shows the histologic appearance of the pre-implantation UBM-
ECM device. 
 
 
 
Figure 50. Microscopic view of pre-implantation UBM-ECM device stained with hematoxylin and 
eosin. (A) Multilaminate sheet portion of UBM-ECM device, (B) junction between UBM-ECM sheet portion 
and “pillow” portion of the device, (C) center of “pillow” portion. Arrows = sheet portion, P = powder 
portion. All images 40X magnification, scale bar = 100um. 
 
Remodeled UBM-ECM Device  
 
Bulk Morphology  
 At three weeks post-implantation the implanted UBM-ECM device was no longer 
identifiable and the site of remodeling was characterized by a dense infiltration of predominantly 
mononuclear cells within newly deposited ECM.  Herovici staining showed that the newly 
deposited ECM was composed of both collagen type I and small amounts of collagen type III.    
At one month post-implantation the site of remodeling was characterized by a dense, 
randomly distributed cellular infiltrate consisting of both mononuclear cells and spindle shaped 
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cells.  There was a decrease in the number of mononuclear cells compared to the three-week time 
point.  Herovici staining indicated that the remodeling site contained both collagen type I and 
small amounts of collagen type III with an increase in both the density and the degree of 
organization of the newly deposited collagen type I. 
At two months post-implantation the site of remodeling was characterized by an 
increased number of spindle shaped cells within the remodeling site with a concomitant decrease 
in the number of mononuclear cells and a decrease in overall cellular density compared to earlier 
time points.  Herovici staining showed that the remodeling site contained both collagen type I 
and collagen type III with a predominance of collagen type I.  The collagen was increased with a 
morphology that more closely resembled the native TMJ than did the collagen deposited in the 
remodeling site at the three week or one month time points. 
At three months post-implantation the density of the cellular infiltrate within the site of 
remodeling was greatly decreased compared to all earlier time points.  The cell population at the 
three month time point was characterized by predominantly spindle shaped cells with a small 
number of randomly distributed mononuclear cells.  Herovici staining showed that, as at 
previous time points, the remodeling site was characterized by a deposition of both collagen type 
I and collagen type III with a predominance of collagen type I at the three month time point.  The 
density of the collagen type I in the remodeling site was greater than any of the previous time 
points, and the morphology of the collagen matrix present in the remodeling site at three months 
highly resembled that of the native TMJ. 
At six months post-implantation the remodeling site was characterized by a sparse 
population of spindle shaped cells within an aligned matrix of collagenous tissue.  Herovici 
staining showed that there were highly organized collagen type I fibers formed within the 
  182 
remodeling site with interspersed collagen type III fibrils.  The morphology of the remodeled 
tissue at 6 months was almost indistinguishable from that of the native TMJ.  Similar results at 
the 6-month time point were observed for both the unilateral and the bilateral models. 
Quantification of the cellularity of the remodeling implants at 1, 3 and 6 months post-
implantation (1444.0±229.2, 530.4±27.7, and 347.6±18.3 cells per 20x field, respectively) 
showed that the number of cells within the remodeling device decreased with time, and was 
similar to that observed for the native TMJ meniscus by 6 months post-implantation. 
Figure 51 shows histologic images of the remodeled UBM-ECM devices at 3 weeks, 1, 2, 
3, and 6 months and a quantitative analysis of the cellularity of the remodeling material at each 
time point. 
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 Figure 51. Microscopic view of hematoxylin and eosin (A, C, E, G, I) as well as Herovici’s 
polychrome (B, D, F, H, J) staining of the central portion of remodeled UBM-ECM devices explanted at 3 
weeks (A, B), 1 month (C, D), 2 months (E, F), 3 months (G, H), and 6 months (I, J). Staining of native 
meniscus is also shown (K, L) for comparison. All images 20X magnification, scale bar = 100 um. (M) 
Number of nuclei per 20X field. * Indicates values significantly higher than native tissue with p<0.05. 
 
Peripheral Musculature Attachment Site  
 Histologic examination showed that the newly deposited ECM within the site of 
remodeling was well integrated with the native musculature at the periphery of the implanted 
device as early as one month post-implantation.  A dense population of small, dark staining cells 
was observed adjacent to bundles of skeletal muscle at the interface between the remodeling 
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UBM-ECM device and native host tissue at one month post-implantation.  The degree of 
integration of the UBM-ECM device with the native host tissue increased with time and 
ingrowth of host skeletal muscle tissue into the site of remodeling was observed.  By six months 
post-implantation, bundles of skeletal muscle were observed within the site of remodeling and 
were surrounded by mature, well-organized collagenous extracellular matrix.  Muscular ingrowth 
was observed only at the periphery, and not in the bulk, of the remodeling UBM-ECM device.  
Similar results were observed in both the unilateral and bilateral model. 
Figure 52 shows histologic images of the peripheral attachment site of the remodeled 
UBM-ECM devices at early (1 month) and late (6 month) time points. 
 
 
Figure 52. Microscopic view of hematoxylin and eosin staining of the peripheral attachment sites of 
the remodeled UBM-ECM explants at (A) 1 month and (B) 6 months. Border between remodeling UBMECM 
implant and peripheral attachment site denoted by dashed line. Remodeled UBM-ECM device = left of 
dashed line, peripheral musculature = right of dashed line. Peripheral tissues of the native disc (C) are also 
shown for comparison. All images 20X magnification, scale bar = 100 um. 
 
Articulating Surfaces 
 Macroscopic and microscopic examination showed that there were no pathologic changes 
in the articulating surfaces of the condyle or the fossa at any of the time points investigated in 
this study.  That is, the articulating surfaces of the fossa and condyle were characterized by the 
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presence of smooth, thin fibrocartilaginous tissue which resembled that observed in the 
contralateral control at all of the time points examined in this study.  
Figure 53 shows histologic staining of the articulating surface of the mandibular condyle 
from contralateral control and from animals at 6 months post-implantation. 
 
Figure 53. Microscopic view of hematoxylin and eosin staining of the articulating surface of the 
mandibular condyle (A) following explant at 6 months. Articulating surface of contralateral control (B) is also 
shown for comparison. All images are 10X magnification, scale bar = 200 um. 
A.3.3 Immunolabeling Findings 
CD31 
 Immunolabeling for CD31 showed that there were a large number of randomly 
distributed blood vessels within the site of remodeling at early time points (3 weeks and 1 month 
post-implantation).  Both the number and size of the vessels were decreased by 3 months post-
implantation (35.0±8.7 vessels per 20x field, 3.4±0.8% of total image area, 33.0±6.2 µm 
diameter at 1 months vs. 9.2±0.7 vessels per 20x field, 0.5±0.2% of total image area, 23.3±9.9 
µm diameter at 3 months).  The number and size of the vessels within the remodeling UBM-
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ECM device were further decreased by 6 months post-implantation (5.6±0.5 vessels per 20x 
field, 0.2±0.1% of total image area, 17.2±5.5 µm diameter) and resembled the vasculature found 
within the native TMJ meniscus (5.8±0.5 vessels per 20x field, 0.1±0.0% of total image area, 
13.5±5.0 µm diameter).   
 Figure 54 shows sections immunolabeled for CD31 at 1, 3, and 6 months post-
implantation and quantitative analysis of the number, area, and diameter of the CD31+ vessels.  
Similar patterns of CD31 labeling were observed in both the unilateral and bilateral models. 
 
Figure 54. Microscopic view of CD31 immunolabeling of UBM-ECM devices explanted at (A) 1 
month, (B) 3 months, and (C) 6 months. CD31 labeling of (D) native meniscus is also shown for comparison. 
Arrows indicate examples of positive staining. All images are 20X magnification, scale bar = 100 um. 
Quantification of the number (E), total area (F), and average diameter (G) of the CD31+ vessels within a 20x 
field. * Indicates values significantly higher than native tissue with p<0.05. 
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CD68 
 Immunolabeling for CD68 showed that a large number of mononuclear macrophages 
were present within the dense cellular infiltrate that was observed during the histologic 
evaluation of tissue 3 weeks, 1 month, and 2 months post-implantation.  The number of CD68+ 
macrophages decreased with time and few, if any, mononuclear cells were observed by 3 months 
post-implantation.  By 6 months post-implantation, the dense mononuclear macrophage 
population observed at early time points was replaced by a population of spindle shaped CD68- 
cells resembling those found in the native TMJ meniscus.   
 Figures 55A and B show sections immunolabeled for CD68 at early (1 month post-
implantation) and late (6 month post-implantation) time points. 
 It should be noted that the temporal and spatial patterns of angiogenesis and macrophage 
infiltration seen in this study are similar to those observed in numerous other studies utilizing 
acellular ECM scaffold materials for tissue reconstruction (69, 100, 166). 
 
SMA 
 Immunolabeling for SMA showed that there were a number of SMA positive cells 
surrounding the newly formed vasculature as well as throughout the bulk of the remodeling 
device at 1-month post implantation.  By 3 months post-implantation SMA labeling was 
observed predominantly surrounding the vasculature, with few if any cells labeling positive 
within the bulk of the remodeling device.  A similar pattern of labeling was observed at 6 months 
post-implantation.  The results for the remodeling devices at 3 and 6 months post-implantation 
were qualitatively similar to those observed for native TMJ tissue. 
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 Figures 55C and D show sections immunolabeled for SMA at early (1 month post-
implantation) and late (6 months post-implantation) time points. 
 
CAL 
 Immunolabeling for CAL (a marker of skeletal muscle) showed that there were CAL 
positive bundles of skeletal muscle at the periphery of the remodeling device as early as 1 month 
post-implantation.  CAL positive bundles of skeletal muscle were also observed at the periphery 
of the remodeling device at 6 months post-implantation.  No immunolabeling for CAL was 
observed within the bulk of the remodeling device at any time point post-implantation. 
Figures 55E and F show sections immunolabeled for CAL at early (1 month post-
implantation) and late (6 months post-implantation) time points. 
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Figure 55. Microscopic view of immunolabeling of UBM-ECM devices explanted at (A, C, E) 1 
month and 6 (B, D, F) months. Immunolabeling for CD68 (A, B), SMA (C, D), and CAL (E, F) are shown. 
Images A, B, C, and D are 40X magnification, scale bar = 100 um. Images E and F are 20X, scale bar = 100 
um. 
A.3.4 Biomechanical Properties 
Biomechanical testing showed that the pre-implantation UBM-ECM device had a significantly 
higher initial max stress, equilibrium stress, and tangent modulus (16.38±5.78 kPa, 11.29±4.23 
kPa, and 179.96±48.29 kPa) than did native TMJ meniscus tissue (2.68±0.57 kPa, 1.46±0.35 
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kPa, and 23.45 kPa) and a lower percent relaxation (31.38±2.20% vs. 45.35±9.48%). By 6 
months post implantation the remodeled tissue had a max stress, equilibrium stress, tangent 
modulus, and percent relaxation (3.71±1.69 kPa, 1.81±0.65 kPa, and 50.72±32.10 kPa, and 
48.10±16.46) which were approaching that of the native meniscus, suggesting that the UBM-
ECM device had remodeled and was replaced with tissue which had mechanical properties 
approaching those of the native meniscus tissue.  While the remodeled tissue was observed to 
have a slightly higher tangent modulus (50.72±32.10 kPa vs. 23.45±6.01 kPa), these differences 
were not statistically significant and it is likely that the mechanical properties of the remodeling 
tissue would continue to approach those of the native TMJ meniscus with time.  
 
 
 
Figure 56. Max stress, equilibrium stress, tangent modulus, and percent stress relaxation for pre-
implantation UBM construct, remodeled UBM construct and native TMJ meniscus. 
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A.3.5 Biochemical Content 
Biochemical content testing showed that both the pre-implantation UBM-ECM device and the 
remodeled host tissue had a collagen content which was similar to that observed in the native 
meniscus tissues (59.71±29.97%, 60.39±18.68%, and 61.95±17.40%).  A similar pattern was 
observed for water content (69.47±16.72%, 82.54±2.09%, and 77.63±5.26%); however the 
remodeled UBM-ECM device was found to have a significantly higher GAG content than the 
pre-implantation device and the native tissue (1.03±0.08% vs. 0.47±0.23% or 0.55±0.11%) No 
differences were observed for collagen or GAG content between the pre-implantation UBM-
ECM device, the remodeled UBM-ECM device at 6 months post-implantation, and the native 
TMJ meniscus tissue. 
  
 
Figure 57. Biochemical content of pre-implantation UBM construct, remodeled UBM construct and 
native TMJ meniscus. 
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A.4 DISCUSSION 
The results of the present study show that the initially acellular UBM-ECM device acted as an 
inductive template for constructive remodeling of the TMJ meniscus following meniscectomy.  
The remodeling of the bulk of the UBM-ECM device was characterized by infiltration of a cell 
population consisting predominantly of CD68+ mononuclear macrophages and SMA+ spindle 
shaped cells accompanied by rapid degradation of the scaffold material, deposition of new site-
appropriate host-derived tissue, and angiogenesis at early time points changing to a sparse 
population of SMA- spindle shaped cells and small blood vessels within mature, highly aligned 
collagen with time. By six months post-implantation, the morphology of the remodeled ECM 
scaffold site closely resembled that of the native TMJ meniscus both in terms of its shape and 
size as well as its components, collagen fiber organization, and the makeup and spatial 
organization of the cell population.  The remodeled tissue was shown to be well integrated with 
the native musculature at the periphery of the implant and host derived CAL+ skeletal muscle 
tissue was observed at the periphery of the site of tissue remodeling.  Additional testing showed 
that the remodeled tissues possessed both biomechanical properties and biochemical content 
which was similar to that of the native TMJ meniscus.  Further, implantation of the UBM-ECM 
device was not associated with any pathologic changes in the articulating surface of the fossa or 
condyle at any of the time points investigated. 
 Acellular, non-crosslinked ECM scaffolds such as the UBM-ECM used in the present 
study have been shown to promote a process of constructive remodeling following placement in 
a wide variety of tissue and organ systems including bone, muscle, nerve, and epithelial tissues 
among numerous others (19, 20, 26, 29-31, 42, 43, 53, 134, 246).  That is, ECM scaffolds have 
been shown to induce the formation of new, site-appropriate, functional, host tissue that is 
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arranged in a spatially appropriate pattern for the tissue of interest.  This remodeling process is in 
distinct contrast to the default mechanism of mammalian tissue repair following injury, which 
generally results in inflammation and scarring with minimal functional recovery.  The exact 
mechanisms by which this ECM mediated tissue specific constructive remodeling occurs are not 
fully understood. However, a number of factors including mechanical forces, scaffold 
degradation with concomitant release of bioactive ECM molecules and matricryptic peptides, 
and the ability of ECM scaffolds to modulate the host immune response are known to play 
important roles in determining remodeling outcomes (25, 48, 72-74, 76, 78, 83, 84, 86, 96-99, 
247). 
The present study represents the first report of an intact ECM scaffold material used in an 
in vivo study of TMJ meniscus replacement.  A small number of studies have described the use 
of intact ECM scaffolds or individual ECM components, such as collagen I, in knee meniscus 
repair applications with promising results (33, 248-250).  Intact ECM scaffolds such as those 
used in the present study have been shown to retain a large number of tissue specific ECM 
constituent molecules in a three-dimensional ultrastructure similar to that of the native ECM, 
and, thus, may offer an advantage over the use of single purified ECM components (1, 251).  
Further, studies have shown that the molecules that remain following the decellularization of an 
intact ECM scaffold, such as vascular endothelial growth factor (VEGF), basic fibroblast growth 
factor (bFGF), and transforming growth factor beta (TGFβ) retain their biologic activity (83).   
Degradation products of the ECM are released during a period of rapid scaffold 
degradation beginning immediately following the implantation of a non-chemically crosslinked 
ECM scaffold (98).  The resultant degradation products have been shown to have 
chemoattractant activity for of a variety of cells with implications for downstream tissue 
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remodeling outcomes (74, 76, 78).  Chemical crosslinking, a process commonly used during the 
production of certain ECM scaffolds to increase strength or inhibit the recognition of surface 
epitope by the host, has been shown to slow or inhibit the degradation of ECM scaffolds and, 
thus, inhibit the release of the bioactive molecules contained within the scaffold (72).  Chemical 
crosslinking of ECM scaffolds has generally been associated with a process of chronic 
inflammation and encapsulation of the device within dense collagenous connective tissue as 
opposed to the constructive and typically functional remodeling outcome which has been 
observed with non-crosslinked ECM scaffolds.  However the exact mechanisms by which 
chemical crosslinking affects the end outcome of tissue remodeling associated with an implanted 
ECM scaffold are not completely understood (69). 
The non-crosslinked UBM-ECM device used in the present study was rapidly degraded 
and was indistinguishable from newly deposited host tissue at the three week time point, 
indicating that scaffold degradation in the TMJ location occurs very rapidly.  Rapid degradation 
of ECM scaffolds has also been observed, and quantified, in other soft tissue locations which 
experience significant shear or compressive loads; specifically, approximately 50% degradation 
of non-crosslinked ECM scaffold materials was shown to occur within the first 28 days 
following implantation in a model of canine Achilles tendon repair (98).  Rapid degradation and 
mechanical loading have both been shown to be critical to the formation of a constructive 
remodeling response following ECM scaffold implantation (25, 69).  A recent study using UBM-
ECM as an implantable scaffold material following partial cystectomy in a canine model showed 
that animals that were prevented from loading the implanted ECM scaffold material via long 
term catheterization experienced significantly less constructive remodeling than those animals 
that were allowed to return to normal micturition and, thus, functional loading of the ECM 
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scaffold following ECM (25).  The TMJ meniscus is known to experience both dynamic and 
static tensile, compressive, and shear forces which occur both during motion and while at rest 
(252).  These constant and diverse forces coupled with the complex synovial fluid milieu may 
have contributed to the rapid scaffold degradation and concomitant formation and site 
appropriate spatial arrangement of the newly deposited fibrocartilage, vasculature, and muscle 
tissue observed in this study.  It was not possible, however, to assess the specific contribution of 
these forces to the tissue remodeling process in the present study. Future studies are planned to 
address the importance of these factors in the remodeling of UBM-ECM devices in the TMJ 
location. 
Other studies have utilized tissue engineering and regenerative medicine strategies 
toward the goal of reconstruction of the articulating structures (i.e. mandibular condyle) and the 
meniscus of the TMJ (253-275).  To date, tissue engineering and regenerative medicine studies 
of the TMJ meniscus have focused primarily upon the characterization of the mechanical and 
biochemical properties of the disc prior to implantation and the identification of ideal cell 
sources and scaffolds for the development of tissue-engineered miniscal constructs.  While these 
studies have shown promise, very few have addressed the in vivo implantation of a tissue-
engineered construct in the TMJ meniscus location.  The present study described the 
development of a UBM-ECM construct which mimicked the shape and size of the native 
meniscus and included peripheral anchoring sites for in vivo implantation.  When placed in the 
TMJ location, the device was shown to remodel with a composition and organization that highly 
resembled the native TMJ meniscus. 
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A.5 CONCLUSIONS 
The UBM-ECM device described in the present study showed promise as an effective template 
for TMJ meniscus reconstruction and may represent an “off-the-shelf” solution to TMJ meniscus 
replacement. 
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